Term	Overlap	P.value	Adjusted.P.value	Old.P.value	Old.Adjusted.P.value	Odds.Ratio	Combined.Score	Genes
Allergic disease (asthma, hay fever or eczema)	62/172	1.43400236477287e-06	0.00213092751405248	0	0	2.21295539243365	29.7754059052958	RERE;TNFAIP8;RORC;IKZF1;ETS1;SPPL3;BACH2;KYNU;CCR7;JAK2;IL6R;HLA-DPA1;MANBA;RNASET2;HLA-B;AP5B1;RUNX3;ARID1B;RUNX1;TLR1;ITPKB;PSMA6;RASA2;FAM76B;GSAP;ANAPC1;HLA-DQB1;DDX6;RTEL1;STX18;CLEC16A;GATA3;TNFRSF11A;RTF1;ARHGAP15;TOB2;LPP;AIF1;ATXN2;BCL2L11;INPP5D;LMAN2;TNFRSF14;STAT6;D2HGDH;HLA-DQA1;MICA;ATG5;SMARCE1;STAT5B;SMAD3;NDFIP1;NFATC2;ARHGAP27;DIAPH1;GLB1;IL2RA;CDK2AP1;IL7R;MAP3K14;ZNF652;IL18R1
Primary sclerosing cholangitis	20/36	3.6699841946204e-06	0.00272679825660296	0	0	4.88597246127367	61.1495245115987	MANBA;BCL2A1;CLEC16A;HLA-B;BACH2;NFKB1;ATXN2;INPP5A;BCL2L11;SLCO3A1;IL2RA;CD28;TNFRSF14;PRKD2;CD226;PSMG1;UBASH3A;SH2B3;HLA-DQA1;HLA-DRB1
Rheumatoid arthritis	62/182	1.1719501998488e-05	0.0058050599899177	0	0	2.02725879917184	23.0180159239387	CEP57;CD83;ICAM3;PTPN22;AFF3;ETS1;BACH2;UBE2L3;LBH;CASP8;C1QBP;TAGAP;CTLA4;UBASH3A;IL6R;FADS1;EOMES;MED1;PRKCH;GIN1;ARL15;IFNGR2;VPS37C;TYK2;RUNX1;ILF3;CD200R1;TRAF6;MTF1;SLC9A9;ELMO1;ARHGEF3;IRF8;PRKCQ;CD226;IRF5;DNASE1L3;HLA-DQB1;DDX6;PVT1;ABHD6;GATA3;RASGRP1;INPP5B;TNFRSF14;ICOS;SH2B3;HLA-DQA1;ATG5;GCH1;PLCL2;PTPN11;CFLAR;FLI1;FCGR2A;CDK4;CD5;IL2RA;IL2RB;CD28;PPIL4;HLA-DRB1
Ankylosing spondylitis	22/47	4.41664071360936e-05	0.0164078202510588	0	0	3.43946863468635	34.4894302160457	EOMES;ERAP2;GPR65;ERAP1;HLA-B;LNPEP;TYK2;ANTXR2;RUNX3;BACH2;UBE2L3;NPEPPS;HHAT;FCGR2A;ZMIZ1;TBX21;PSMG1;KIF21B;LTBR;IL7R;IL6R;SH2B3
Sum eosinophil basophil counts	56/173	0.00014671752584793	0.0332929030789428	0	0	1.87558388302621	16.5557815850814	RERE;HBS1L;IFITM2;IKZF1;BACH2;XPO1;AUH;ENSA;JAK2;FADS1;JAK1;BRD3;IL4R;GPX4;LARP4B;RUNX1;APBB1IP;CD200R1;ELMO1;SIK3;RIN3;GLCCI1;EXOC2;ZNF398;BCL2A1;SP140;PVT1;TCF7;CLEC16A;LPP;ABO;ATXN2;BCL2L11;UNK;IRAK2;INPP5D;STAT6;D2HGDH;BAK1;PAK2;S1PR4;BPTF;FARP2;CCL24;SMAD3;NDFIP1;LIMK2;PLCL2;NFATC2;NFKB1;KANSL1;GLB1;BCL2;BAX;BUD13;IL18R1
Rheumatoid arthritis (ACPA-positive)	29/74	0.000165628102612366	0.0332929030789428	0	0	2.51997152401292	21.9382814789167	DDX6;ICAM3;PTPN22;GATA3;AFF3;ETS1;RASGRP1;UBE2L3;LBH;TAGAP;CTLA4;UBASH3A;ICOS;IL6R;EOMES;GIN1;ACTN1;TYK2;FLI1;RUNX1;FCGR2A;CD5;IL2RA;IL2RB;CD28;IRF8;IRF5;PRKCQ;DNASE1L3
Eosinophil percentage of granulocytes	50/152	0.000209314230846124	0.0332929030789428	0	0	1.91986380878832	16.2644601938973	IFITM3;RERE;HBS1L;IKZF1;BACH2;AUH;ENSA;HLA-DPA1;JAK1;BRD3;GPX4;EPS15L1;RUNX1;APBB1IP;TMEM259;ELMO1;PPARG;EXOC2;FKBP5;ZNF398;HLA-DQB1;BCL2A1;SP140;PVT1;CLEC16A;TUBD1;RTF1;LPP;CNN2;ATXN2;BCL2L11;IRAK2;INPP5D;STAT6;D2HGDH;S1PR4;MICA;BPTF;FARP2;CCL24;SMAD3;NDFIP1;LIMK2;NFKB1;KANSL1;GLB1;BCL2;HLA-DPB1;ZNF652;IL18R1
Systemic lupus erythematosus	103/365	0.000210253899284392	0.0332929030789428	0	0	1.54439609583372	13.0767024579474	CD86;NCF2;IKZF1;PRDM1;NADSYN1;TSEN2;ETS1;BACH2;UBE2L3;RNF114;IL6R;SKP1;GTF2I;EOMES;MED1;PDHX;HLA-B;HLA-A;ILF3;CSNK2B;MSH5;VDAC1;SKAP2;NOTCH2;DDX6;LRRC56;TNKS;TCF7;CLEC16A;MTMR9;ABHD6;GATA3;UBE2J2;LPP;RASGRP1;RASGRP3;SBNO2;ATXN2;ATXN1;ST8SIA4;SMYD3;SLC15A4;HLA-DQA1;ATG5;LYN;RABGAP1L;ARHGAP27;PRDX6;FLI1;LRRC63;CD28;GRB2;COPS8;XKR6;HLA-DRB1;ITGAM;APIP;PTPN22;SMG7;SPPL3;LYST;DDA1;DSTYK;XPO1;LBH;FCGR3B;TAGAP;ITGAX;JAK2;PGPEP1;IKBKE;TNPO3;KLF12;TYK2;ELF1;TET3;IRF8;PPARG;IRF5;LCP1;CD44;HLA-DQB1;PRIM2;PVT1;LEF1;PDHB;DDO;DRAM1;PERP;RAB23;CEPT1;SH2B3;CAMK2G;LRRC25;KDM4B;KDM4C;STAT1;STAT3;DEF6;GALC;FCGR2A;IL2RA;SSBP4
Eosinophil percentage of white cells	52/160	0.000221935726615115	0.0332929030789428	0	0	1.88595162696774	15.8667425151627	IFITM3;RERE;HBS1L;BACH2;ENSA;HLA-DPA1;JAK1;BRD3;KLF12;IL4R;GPX4;HLA-B;RUNX1;APBB1IP;ELMO1;SIK3;PPARG;EXOC2;FKBP5;ZNF398;BCL2A1;SP140;PVT1;CLEC16A;LPP;ATXN2;BCL2L11;IRAK2;INPP5D;STAT6;D2HGDH;BAK1;S1PR4;MICA;BPTF;FARP2;CCL24;SMAD3;NDFIP1;LIMK2;NFATC2;CDC7;NFKB1;KANSL1;WNK1;GLB1;BCL3;BCL2;HLA-DPB1;NDUFAF1;ZNF652;IL18R1
Eosinophil counts	62/199	0.000224043762307825	0.0332929030789428	0	0	1.7737897266174	14.9063420179001	RERE;HBS1L;IFITM2;IKZF1;BACH2;XPO1;AUH;ENSA;JAK2;FADS1;JAK1;PELP1;BRD3;IL4R;GPX4;HLA-B;UNC13D;EMSY;RUNX1;APBB1IP;CD200R1;SIK3;ELMO1;RIN3;PPARG;EXOC2;ZNF398;BCL2A1;SP140;PVT1;CLEC16A;GATA3;LPP;ATXN2;UNK;BCL2L11;IRAK2;INPP5D;SYMPK;STAT6;D2HGDH;BAK1;PAK2;S1PR4;SH2B3;MICA;BPTF;FARP2;CCL24;NDFIP1;SMAD3;SEC16A;LIMK2;NFKB1;RCL1;KANSL1;WNK1;GLB1;BCL2;BAX;IL18R1;ZNF652
Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	17/37	0.000423175441832095	0.0571671551420449	0	0	3.3191769041769	25.7824491322806	ATP8B2;ERAP2;PTPN22;LNPEP;TYK2;AFF3;RUNX3;UBE2L3;RUNX1;ATXN2;IRF1;IL2RA;IL2RB;LTBR;IL6R;SH2B3;HLA-DQB1
Lymphocyte counts	54/174	0.000608446752010406	0.0753459894572886	0	0	1.76217455988098	13.0481997837552	RERE;ZBTB25;PLEK;PTPN22;ARRB2;ANTXR2;ETS1;BACH2;UBE2L3;ICAM1;CASP8;SCML4;DIP2A;CCR7;IKBKE;KLF12;MANBA;ARRDC2;TET2;EPS15L1;TYK2;TBC1D1;ELF1;MTHFD1;PAX8;RILPL2;HKDC1;ARHGEF3;PPARD;L3MBTL3;SLC35D1;PVT1;CLEC16A;CLECL1;ARHGAP15;LY9;ZFP36L2;FUT7;PPP2R3C;FAM177A1;PAK2;SH2B3;HLA-DQA1;RAP1GAP2;CDKN2A;ATP2B4;KLF2;IL7;IL2RA;BCL2;UBE2O;CD69;IL7R;HLA-DRB1
Nodular sclerosis Hodgkin lymphoma	7/10	0.000987906474077702	0.112925309267651	0	0	9.09885620915033	62.963380047646	CLEC16A;HLA-DPB1;HLA-DRA;GATA3;LPP;HLA-DRB1;HLA-DQB1
Primary biliary cirrhosis	19/47	0.00137757040605191	0.146219258813796	0	0	2.64973135271808	17.4549301567317	DDX6;DENND1B;MANBA;POGLUT1;STAT1;CLEC16A;TYK2;NFKB1;ATXN2;ELMO1;IRF8;IRF5;LTBR;IL7R;SH2B3;TNPO3;HLA-DQA1;HLA-DRB1;HLA-DQB1
B-cell malignancies (CLL, Hodgkin lymphoma or multiple myeloma) (pleiotropy)	9/16	0.00172549667637426	0.150105017602092	0	0	5.01485321936523	31.9057014594948	EOMES;BCL2L11;DTNB;SP110;PVT1;IRF8;BAK1;LPP;NCK1
Myasthenia gravis	5/6	0.00177085086769404	0.150105017602092	0	0	19.4904458598726	123.497217216419	CTLA4;PTPN22;TNFRSF11A;HLA-DQA1;HLA-DRB1
Strep throat	5/6	0.00177085086769404	0.150105017602092	0	0	19.4904458598726	123.497217216419	ERRFI1;HLA-B;HLA-DQA1;HLA-DRB1;HLA-DQB1
Crohn's disease	155/613	0.00181823036126357	0.150105017602092	0	0	1.33021463126424	8.39351010125802	DCLRE1B;ERRFI1;DGKD;RP4-583P15.15;GPR65;LST1;LY75;RORC;STMN3;KEAP1;ICAM3;IKZF1;PRDM1;TNF;BACH2;UBE2L3;ICAM1;KIAA1109;ZMIZ1;FAM53B;PMPCA;MAP3K8;KIF21B;LGALS9;HLA-DOB;FADS1;IFNAR2;HLA-H;USP4;SP110;NFKBIL1;ENTPD7;ACSL6;HLA-B;CDKAL1;HLA-A;HLA-F;LEMD2;RUNX3;HLA-G;SCAMP3;TUFM;CDC37;UTS2;PRKCQ;GSAP;IFNAR1;DAP3;RTEL1;PFKFB3;SLC35D1;COX15;TXK;SP140;CUL1;CREM;THADA;LPP;RASGRP1;ZFP36L2;STIP1;PRDX5;ATXN2;SBNO2;FIGNL1;INPP5D;MIER1;RP11-514O12.4;HLA-DQA1;ATP6V0A1;STAT5B;HLA-DRB5;NDFIP1;SMAD3;TNFSF15;SEC16A;TMA7;PBX2;LNPEP;NFATC1;AP4B1;NFKB1;UBAC1;CYLD;PPP5C;UBLCP1;ATG16L1;HLA-DRA;HLA-DRB1;LAT;DENND1B;CCDC122;PTPN22;PHTF1;GM2A;TAGAP;ANXA6;WDR6;QSOX2;JAK2;DUSP5;ITGA4;GPX4;SPHK2;RIPK2;IFNGR2;RNASET2;TYK2;TERF1;LIME1;SLC25A15;TBC1D1;ELF1;TST;IRF1;RFT1;ATG4B;USP40;LTB;GART;VAMP3;HLA-DQB1;SLC43A3;CCDC69;DCTN4;GBA;TUBD1;ADCY7;AIF1;AKAP1;CLN3;TCOF1;MSTO1;CCL2;PTK2B;ASCC2;SH2B3;CCDC71;CAMK2G;CD74;ERAP2;IL10RB;STAT3;PSMB9;NUDT22;GALC;TSPAN14;RIT1;PER3;RPS6KB1;IL2RA;SERBP1;LYRM7;LTBR;IL18R1
Monocyte percentage of white cells	51/171	0.00221619451831711	0.160020084689921	0	0	1.66303889990089	10.1644334459646	IFITM2;EIF4E3;SIGLEC9;IKZF1;LSP1;BACH2;DOCK10;AKAP13;ENSA;TNFSF10;TSPO;RRP12;IL6R;FADS1;ITGA4;ARRDC2;SH2D3C;HLA-B;PLAUR;EPS15L1;APBB1IP;DDX39B;RASA2;C22ORF34;IRF8;KDELR2;PIGL;PRR13;CSNK1G1;CSF1R;BCL2A1;LPP;ABO;BCL2L11;DPP8;CHSY1;PPP2R3C;FAM177A1;KCNN4;S1PR4;SH2B3;LRRC25;TCF7L2;KDM4B;PCGF3;LYZ;NFKB1;PAN3;BCL2;LTBR;PIK3AP1
Systemic lupus erythematosus or rheumatoid arthritis	7/11	0.00223678690410668	0.160020084689921	0	0	6.82371323529412	41.6431761660945	ICAM3;IRF5;PTPN22;TYK2;TNPO3;ATG5;UBE2L3
Chronic lymphocytic leukemia	26/74	0.00232994585488582	0.160020084689921	0	0	2.11611466797997	12.8276971958359	CAMK2D;SP140;LEF1;LPP;TSPAN32;CASP8;BCL2L11;CASP10;BAK1;HLA-DQA1;EOMES;PIAS4;KLF10;FARP2;HLA-DRB5;SP110;MBD1;SERPINB6;PRKD3;IRF2;BCL2;IRF8;PRKD2;CLPTM1L;HLA-DRB1;HLA-DQB1
Primary biliary cholangitis	36/112	0.00236907258625723	0.160020084689921	0	0	1.85182346139355	11.1947482135651	DDX6;DENND1B;NAB1;CLEC16A;CISD2;FGFRL1;ATXN2;LBH;IL21R;CTLA4;ICOS;SH2B3;TNPO3;MANBA;IL4R;GIN1;PRKCB;TNFSF15;STAT1;PLCL2;IL16;TYK2;DEXI;NFKB1;UBLCP1;POU2AF1;SERBP1;CD28;HLA-DPB1;HLA-DRA;IRF5;IL7R;PAM;HLA-DRB1;IL18R1;HLA-DQB1
Neutrophil percentage of granulocytes	45/148	0.00258356361711075	0.165018476332887	0	0	1.70887717798072	10.1824909212175	IFITM3;RERE;HBS1L;BCL2A1;SP140;PVT1;CLEC16A;MRPS31;LPP;BACH2;ZFP36L2;ATXN2;BCL2L11;INPP5D;ENSA;STAT6;D2HGDH;BAK1;S1PR4;HLA-DQA1;MICA;BPTF;JAK1;BRD3;FARP2;NDFIP1;GPX4;STAT1;LIMK2;PLAUR;LARP4B;EPS15L1;NFKB1;RUNX1;APBB1IP;KANSL1;GLB1;ELMO1;BCL2;BAX;PPARG;ZNF652;EXOC2;IL18R1;ZNF398
Celiac disease or Rheumatoid arthritis	8/14	0.00275958708872035	0.165018476332887	0	0	5.19964043474708	30.6397871222074	DDX6;LBH;IFI16;CDK4;ELMO1;UBASH3A;SH2B3;UBE2L3
Chronic inflammatory diseases (pleiotropy)	52/177	0.0028700449173511	0.165018476332887	0	0	1.62770954151177	9.52767995293295	DENND1B;RORC;KEAP1;PTPN22;PRDM1;ANTXR2;ETS1;BACH2;UBE2L3;NPEPPS;ZMIZ1;UBASH3A;JAK2;IL6R;PRKCB;IFNGR2;FAM118A;SLC39A11;CDKAL1;TYK2;SLC9A8;PRKCQ;CD226;IRF5;SKAP2;SP140;CLEC16A;CREM;THADA;SBNO2;PPP2R3C;GNA12;TNFRSF14;SH2B3;SMAD3;NDFIP1;ERAP2;TNFSF15;STAT3;ERAP1;IFNLR1;NFATC1;NFKB1;PPP5C;TSPAN14;FCGR2A;RPS6KB1;ATG16L1;IL2RA;CD28;LTBR;IL18R1
Vitiligo	38/121	0.00288726809196169	0.165018476332887	0	0	1.78994069634924	10.4665789174811	RERE;DDX6;RAB5C;AHCY;PTPN22;TNFRSF11A;TOB2;LPP;BACH2;PPP3CA;PRDX5;ATXN2;CASP7;BCL2L11;ZMIZ1;AFMID;CTLA4;UBASH3A;SH2B3;HLA-DQA1;FARP2;PTPN1;RNASET2;HLA-B;UBE2E2;SERPINB9;PPP4R3B;HLA-A;PA2G4;TICAM1;CBFA2T3;SCAF1;FLI1;IRF3;IL2RA;HLA-DRA;HLA-DRB1;CD44
IgA nephropathy	15/36	0.00303094311236145	0.166814128332189	0	0	2.78767892225653	16.1654195899556	KLF10;ST6GAL1;ITGAM;TAP2;HLA-B;HLA-A;ACCS;PSMB9;ITGAX;HLA-DPB1;HLA-DQA1;HLA-DRB1;HLA-DPA1;HLA-DPB2;HLA-DQB1
Sjogren's syndrome	19/51	0.00414282852130794	0.219865827952271	0	0	2.3179311086529	12.7170427787195	ITSN2;HLA-DRB5;SATB1;PRDM1;RASGRP3;ATXN2;MIS18BP1;HLA-DPB1;HLA-DRA;IRF5;PHIP;CCDC174;TNPO3;HLA-DQA1;HLA-DRB1;GTF2I;HLA-DPA1;HLA-DQB1;KLRG1
Inflammatory bowel disease	173/709	0.00504678708410349	0.255081905845931	0	0	1.26803752697931	6.70665486651153	ERRFI1;CRTC3;RP4-583P15.15;GPR65;LST1;LY75;RORC;STMN3;KEAP1;ICAM3;STK19;IKZF1;TNF;ETS1;BACH2;UBE2L3;ICAM1;KIAA1109;ZMIZ1;POFUT1;RASSF5;RPS6KA2;TOM1;FAM53B;PMPCA;MAP3K8;CCNL2;KIF21B;FADS1;IL15RA;PRKCB;USP4;SP110;NFKBIL1;SLC11A1;ACSL6;HLA-B;CDKAL1;SCAMP3;TUFM;DOK3;DDX39B;CDC37;MSH5;CSNK2B;UTS2;CD226;KDELR2;TTPAL;DAP3;RTEL1;SLC35D1;SP140;CUL1;CREM;THADA;UBE2J2;LPP;AGER;ZFP36L2;BAG6;ATXN2;SBNO2;DVL1;MIER1;NEU1;PLCG2;NLRP2;RP11-514O12.4;TNFRSF14;ICOS;HLA-DQA1;ATP6V0A1;STAT5B;HLA-DRB5;NDFIP1;SMAD3;TNFSF15;VDR;SMURF1;SEC16A;TMA7;PBX2;LNPEP;NFATC1;NFKB1;UBAC1;PRRC2A;CYLD;UBLCP1;ARPC2;ATG16L1;TMEM117;CD28;HLA-DRA;PSMG1;SKIV2L;PPT2;TAB1;HLA-DRB1;DENND1B;CCDC122;CTSW;LSP1;PCSK5;FCGR3B;GM2A;AUH;ANXA6;CTLA4;WDR6;QSOX2;JAK2;TCF19;ITGA4;GPX4;IFNGR2;TNFRSF18;RNASET2;SLC39A11;TYK2;LIME1;CDYL2;TST;IRF1;IRF8;CD48;LTB;DLD;ERGIC1;VAMP3;HLA-DQB1;ATF6B;CCDC69;DCTN4;GBA;PPT2-EGFL8;TUBD1;PBXIP1;ADCY7;AIF1;TM9SF4;AKAP1;CLN3;TCOF1;MSTO1;GNA12;CCL2;PTK2B;ASCC2;SH2B3;CCDC71;MICA;CD74;ERAP2;STAT1;CDKN2A;STAT3;ERAP1;LILRB4;GALC;TSPAN14;RIT1;FCGR2A;PER3;RPS6KB1;CD5;IL2RA;SERBP1;LYRM7;LTBR;IL18R1;OTUD3
Beta-2 microglubulin plasma levels	5/7	0.00514970200227316	0.255081905845931	0	0	9.74461048505635	51.3425638238823	ATXN2;HLA-B;HLA-A;SH2B3;MICA
Alopecia areata	30/94	0.0058442937354201	0.274627732294015	0	0	1.83120994577274	9.41661171970024	DCLRE1B;USP15;TRAF3IP3;PFKFB3;CLEC16A;PTPN22;THADA;LPP;PHTF1;HHAT;KIAA1109;ATXN2;PRDX5;BCL2L11;CTLA4;PLXNC1;TRIM27;NANS;ICOS;SH2B3;IL15RA;DEXI;AP4B1;IL2RA;CD28;CCDC6;VDAC1;ANP32B;EXOC2;HLA-DQB1
Sarcoidosis (non-Lofgren's syndrome without extrapulmonary manifestations)	12/28	0.00591392155680248	0.274627732294015	0	0	2.9258282208589	15.0108040482411	HLA-DRB5;TSPAN14;NFKBIL1;TAP2;HLA-DPB1;ANXA11;HLA-DRA;AGER;AIF1;HLA-DQA1;PSMB9;HLA-DQB1
Allergic rhinitis	35/114	0.00613968244822893	0.276471761153582	0	0	1.73125944993565	8.81727366024918	RERE;DDX6;DYRK4;SLC35D1;CELF2;CLEC16A;GATA3;RTF1;LPP;SPPL3;BACH2;ABO;ATXN2;MIER1;OSTF1;SH2B3;HLA-DQA1;MANBA;SMAD3;ENTPD6;HLA-B;NFATC2;NFKB1;RNF144A;TLR1;DLG1;DHRS7;CROCC;SIK3;TAX1BP1;CDK2AP1;AAGAB;TLR10;IL7R;HLA-DQB1
Plantar warts	6/10	0.00710533549620685	0.3003623554397	0	0	5.84746385689782	28.9268733281686	HLA-DPB1;HLA-B;HLA-A;HLA-DQA1;HLA-DRB1;HLA-DQB1
Diabetes in response to antihypertensive drug treatment (treatment strategy interaction)	4/5	0.00728614876901816	0.3003623554397	0	0	15.5885378398237	76.7233562966248	TLR1;TLR10;THADA;TLR6
Thyroid peroxidase antibody positivity	4/5	0.00728614876901816	0.3003623554397	0	0	15.5885378398237	76.7233562966248	ATXN2;SH2B3;BACH2;HLA-DPB2
Multiple sclerosis	66/244	0.00757273242214291	0.3003623554397	0	0	1.45096390019812	7.08534883651128	CD86;GPR65;PLEK;IKZF1;IFI30;ETS1;BACH2;NPEPPS;ZMIZ1;TAGAP;CTLA4;CTSH;KIF21B;EOMES;TSFM;MANBA;SYK;ITGA4;IFNGR2;CSGALNACT2;HLA-B;TET2;EPS15L1;TYK2;CDC37;SLC9A8;ELMO1;IRF8;CARD11;HLA-DQB1;L3MBTL3;SHMT1;SP140;PVT1;TCF7;CLECL1;CLEC16A;BCL10;THADA;LPP;RASGRP1;MALT1;PRDX5;EXTL2;TBX21;VTI1A;ZNF746;TNFRSF14;MAPK3;NDFIP1;STAT3;PLCL2;NFKB1;GALC;MPHOSPH9;RPS6KB1;IL7;CD5;IL2RA;CD28;HLA-DRA;CD69;LTBR;IL7R;MAP3K14;HLA-DRB1
Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis)	7/13	0.00790428621781397	0.3003623554397	0	0	4.54857026143791	22.0166725535777	ITGAM;IL2RA;CTLA4;PTPN22;ICOS;LPP;BACH2
Bipolar disorder (inflammation and infection response interaction)	7/13	0.00790428621781397	0.3003623554397	0	0	4.54857026143791	22.0166725535777	AUH;GLIPR2;RNF38;SRBD1;ANTXR2;RECK;GNE
Hodgkin's lymphoma	12/29	0.00824077956419596	0.3003623554397	0	0	2.75354745579213	13.2133389490237	EOMES;HBS1L;PVT1;POU2AF1;ERAP1;CLEC16A;HLA-DRA;PTPN22;GATA3;TCF3;LPP;MAPK3
Melanoma	16/43	0.00828725206798633	0.3003623554397	0	0	2.31243574697272	11.0835897260655	PIGU;SETDB1;PARP1;CDKN2A;MX2;TET2;CDKAL1;PLA2G6;RAD23B;MTAP;AFG3L1P;CASP8;BASP1;CLPTM1L;TMEM38B;EXOC2
Neutrophil percentage of white cells	34/113	0.00953749140828931	0.334323593838878	0	0	1.68137994359546	7.82266185756447	IFITM2;SLC35D1;IKZF1;ANTXR2;ZFP36L2;UBE2L3;BCL2L11;SCML4;CHSY1;ZMIZ1;NLRP3;S1PR4;DCAF12;HLA-DQA1;SEC31A;BRD3;KDM4B;GOLPH3L;TET2;PLAUR;EPS15L1;TYK2;NFKB1;TBC1D1;ELF1;KANSL1;IL7;SP1;IRF8;KDELR2;PIGL;CD69;IL7R;TNRC6B
Glycated hemoglobin levels	22/66	0.00975613087274567	0.334323593838878	0	0	1.95190651906519	9.03705271423432	HBS1L;TCF7L2;USP4;FNDC3B;TMC8;CDKAL1;CYBA;MYO9B;ATP11A;TMC6;SMG5;BET1L;ABO;HK1;SENP1;MTAP;ATXN2;G6PC3;KCNQ1;TMEM79;TUBGCP3;GAS6
Allergic sensitization	16/44	0.0106002788690349	0.334323593838878	0	0	2.22970839035688	10.1382052700905	PVT1;HLA-B;SLC41A1;LPP;NFKB1;TLR1;KIAA1109;STAT6;TLR10;TLR6;BRD7;MICA;HLA-DQA1;ANAPC1;IL18R1;HLA-DQB1
Granulocyte percentage of myeloid white cells	45/159	0.0108099295422409	0.334323593838878	0	0	1.54291127373109	6.98520703531398	OSER1;CSF1R;IFITM2;EIF4E3;SIGLEC9;BCL2A1;DOCK8;LST1;IKZF1;THADA;LSP1;LPP;ABO;DOCK10;AKAP13;BCL2L11;DPP8;CHSY1;ENSA;POC1B;RRP12;KCNN4;MARK3;S1PR4;DCAF12;FADS1;HLA-DQA1;BRD3;CD164;TCF7L2;KDM4B;ITGA4;ARRDC2;SH2D3C;PCGF3;PLAUR;LYZ;PAN3;RASA2;IRF8;KDELR2;PIGL;GLCCI1;LTBR;PRR13
Allergy	14/37	0.0111549343103884	0.334323593838878	0	0	2.37470511000331	10.6763733942339	RERE;DDX6;SMAD3;CLEC16A;GATA3;LPP;ABO;TLR1;CDK2AP1;STAT6;D2HGDH;TLR6;HLA-DQA1;HLA-DQB1
Self-reported allergy	14/37	0.0111549343103884	0.334323593838878	0	0	2.37470511000331	10.6763733942339	SMAD3;IL4R;CLEC16A;NFATC2;GATA3;LPP;ETS1;TLR1;IL21R;TLR10;TLR6;MICA;HLA-DQA1;HLA-DQB1
Diffuse large B cell lymphoma	5/8	0.011424024241816	0.334323593838878	0	0	6.49599869345092	29.0503448940255	CD86;ITSN2;PVT1;HLA-B;EXOC2
Pneumonia	5/8	0.011424024241816	0.334323593838878	0	0	6.49599869345092	29.0503448940255	HLA-B;MICA;HLA-DQA1;HLA-DRB1;HLA-DQB1
Limited cutaneous systemic scleroderma	9/20	0.0114740937320207	0.334323593838878	0	0	3.19046769806946	14.2539360945777	FCGR3B;STAT1;IRF8;IRF5;TLR10;DNASE1L3;TNPO3;EXOC2;ATG5
Response to hepatitis B vaccine	9/20	0.0114740937320207	0.334323593838878	0	0	3.19046769806946	14.2539360945777	DDR1;OXA1L;TAP2;HLA-DPB1;HLA-DRA;HLA-DQA1;HLA-DPB2;HLA-DPA1;HLA-DQB1
QRS interval (sulfonylurea treatment interaction)	8/17	0.0124298799754382	0.352560186768915	0	0	3.46577320149274	15.2066068214719	PLAC8;COQ2;PAIP2B;ZNF638;LANCL2;LRRC63;MDN1;CNTLN
Asthma (moderate or severe)	11/27	0.0128361957045331	0.352560186768915	0	0	2.68135120215898	11.6785884514687	RERE;KIAA1109;SMAD3;CLEC16A;STAT6;D2HGDH;GATA3;BACH2;HLA-DQA1;ZNF652;HLA-DQB1
Rheumatoid arthritis (ACPA-negative)	6/11	0.0129476094729	0.352560186768915	0	0	4.67767703994119	20.3331328641224	RNASEH2B;HLA-B;CLYBL;MICA;HLA-DQA1;HLA-DRB1
Myositis	7/14	0.0130489974914471	0.352560186768915	0	0	3.89852941176471	16.9158905310851	DDX39B;HLA-B;HLA-DPB1;HLA-DQA1;HLA-DRB1;HLA-DPA1;HLA-DQB1
Platelet distribution width	47/170	0.0145190071429905	0.385272225258641	0	0	1.49345971182484	6.32076453602093	SLC43A3;TXK;DOCK8;TRANK1;TESK2;IQGAP2;ABO;DDO;FAM107B;DOCK10;TUBA1C;CLN3;ATXN2;GRK5;CUX1;ZMIZ1;ERI1;PLCG2;PACSIN2;EPC1;TLK1;RAB11FIP3;MICA;ANKRD28;BRD3;USP7;TPM4;SYK;ACTN1;SWAP70;DAPK2;AP2B1;VAV1;PSMB9;ST7L;CUL4A;INPP4B;EHD3;LRCH1;STIM1;ARPC2;TBC1D5;CAPZA2;ELMO1;CD226;FXYD5;SSBP3
Cervical cancer	12/31	0.0149747057330622	0.390393205602288	0	0	2.46339037778495	10.3496705616389	MEF2A;ELF1;LRRC28;TBXAS1;HLA-B;TNF;MICA;HLA-DQA1;HLA-DRB1;HLA-DPB2;HLA-DQB1;EXOC1
Asthma (bronchodilator response)	4/6	0.0183167807314108	0.469288554601317	0	0	7.79377908400686	31.1746304675172	IL15RA;IL2RA;SPATS2L;PRKCQ
Tonsillectomy	20/62	0.0193538261294473	0.487453993700996	0	0	1.85827859543129	7.33065846316702	RERE;RAP1GAP2;LST1;TET2;HLA-B;ENO1;IKZF1;ABO;NFKB1;MDFIC;GNA12;SURF6;ASCC2;LTBR;SH2B3;MICA;HLA-DQA1;HLA-DRB1;HLA-DQB1;MAPK3
Acute lymphoblastic leukemia in childhood (B cell precursor)	5/9	0.0214104871897695	0.513161031677379	0	0	4.87169279764821	18.7261753337774	CDKN2A;PIP4K2A;IKZF1;GATA3;LHPP
Giant cell arteritis	5/9	0.0214104871897695	0.513161031677379	0	0	4.87169279764821	18.7261753337774	HLA-B;HLA-DRA;PTPN22;HLA-DQA1;HLA-DRB1
Hepatitis B	5/9	0.0214104871897695	0.513161031677379	0	0	4.87169279764821	18.7261753337774	HLA-DPB1;HLA-DRA;HLA-DPA1;HLA-DQB1;UBE2L3
Reticulocyte fraction of red cells	48/180	0.0259404095818511	0.611864264105249	0	0	1.42078372234351	5.18863581850569	PPP1R15A;GCDH;HBS1L;RNF10;DNMT1;TFRC;UBXN2A;TCF25;USP10;PIGQ;EIF4A3;GMPR;FOXK2;IQGAP2;UBE2L3;HK1;SBNO2;ATXN2;BCL2L11;NDOR1;ATXN1;RMND5A;PSMB5;CUX1;PIEZO1;FLNB;SLFN12L;RBM38;TAF15;ARL15;USP4;HSPA4;SWAP70;NFKBIL1;STX7;TMC8;MYO9B;ATP11A;TMC6;AP2B1;AIMP2;CTU2;EHD3;KANSL1;KBTBD2;ARHGEF3;R3HDM4;ATR
Hemoglobin A1c levels	13/37	0.0270984806711419	0.629192848083077	0	0	2.11255318278514	7.62267836303259	HBS1L;TCF7L2;CDC123;CDKAL1;TMC6;SMG5;SND1;EML2;HK1;KCNQ1;PIEZO1;EXOC6;YKT6
Red cell distribution width	59/230	0.0317646884288901	0.65408149378799	0	0	1.3484236078445	4.65125243731732	HBS1L;BTG2;TFRC;CD82;UBXN2A;PDCD5;UBE2L3;HK1;DSTYK;CHAF1A;LUC7L;CEP170;DIP2B;CD36;RAC1;SKP2;FBXO7;FADS1;ILKAP;BRD3;BNIP3L;STX7;FNDC3B;WIPI1;TMC6;ATP11A;BET1L;NT5C3A;TUBB2A;RBL1;TMEM259;GAS6;CSNK1G2;PPP1R15A;WDR20;C10ORF88;TUBD1;FOXK2;PIK3R1;PDS5A;ABO;INPP5B;UGCG;ARL17A;PSMB5;ZNHIT3;SLC12A2;RRM1;ANKRD27;DONSON;ATP2B4;MYO9B;GATAD2A;RCL1;NPLOC4;KANSL1;BUD13;AVL9;ATR
Follicular lymphoma	6/13	0.0331009501428132	0.65408149378799	0	0	3.34077782056219	11.3860165574014	CD86;PVT1;BCL2;LPP;ETS1;HLA-DQB1
IgG galactosylation phenotypes (multivariate analysis)	6/13	0.0331009501428132	0.65408149378799	0	0	3.34077782056219	11.3860165574014	ST6GAL1;B4GALT1;DERL3;HLA-B;IKZF1;TAB1
Lymphoma	6/13	0.0331009501428132	0.65408149378799	0	0	3.34077782056219	11.3860165574014	HLA-DRB5;TAP2;HLA-DRA;HLA-DQA1;HLA-DRB1;HLA-DQB1
Midgestational circulating levels of PBDEs (fetal genetic effect)	5/10	0.0357156630592786	0.65408149378799	0	0	3.89710926016659	12.9858147616807	MDFIC;TBC1D5;TRIM5;PTPRM;LCLAT1
Neonatal lupus	5/10	0.0357156630592786	0.65408149378799	0	0	3.89710926016659	12.9858147616807	NFKBIL1;TMTC2;LTB;TNF;AIF1
Paget's disease	5/10	0.0357156630592786	0.65408149378799	0	0	3.89710926016659	12.9858147616807	CSF1;RIN3;TNFRSF11A;OPTN;PML
Acute lymphoblastic leukemia (B-cell precursor)	4/7	0.0358729215524841	0.65408149378799	0	0	5.19552616540126	17.2895293165428	CDKN2A;PIP4K2A;IKZF1;GATA3
Decline in glucose metabolism in posterior cingulate cortex	4/7	0.0358729215524841	0.65408149378799	0	0	5.19552616540126	17.2895293165428	VPS53;TBC1D8;TYW1;PPP4R3A
Helicobacter pylori serologic status	4/7	0.0358729215524841	0.65408149378799	0	0	5.19552616540126	17.2895293165428	TLR1;FCGR2A;TLR10;TLR6
IgG disialylation phenotypes (multivariate analysis)	4/7	0.0358729215524841	0.65408149378799	0	0	5.19552616540126	17.2895293165428	ST6GAL1;DERL3;IKZF1;TAB1
Neuromyelitis optica	4/7	0.0358729215524841	0.65408149378799	0	0	5.19552616540126	17.2895293165428	HLA-B;HLA-DQA1;HLA-DRB1;HLA-DQB1
Neuromyelitis optica (AQP4-IgG-positive)	4/7	0.0358729215524841	0.65408149378799	0	0	5.19552616540126	17.2895293165428	HLA-B;HLA-DQA1;HLA-DRB1;HLA-DQB1
Staphylococcus aureus infection	4/7	0.0358729215524841	0.65408149378799	0	0	5.19552616540126	17.2895293165428	PDE4B;HLA-DRA;VRK1;HLA-DRB1
Suicide in bipolar disorder	4/7	0.0358729215524841	0.65408149378799	0	0	5.19552616540126	17.2895293165428	ITGB1;TMX3;IL7;CCDC7
Systemic sclerosis (anti-centromere-positive)	4/7	0.0358729215524841	0.65408149378799	0	0	5.19552616540126	17.2895293165428	FCGR3B;IRF8;IRF5;TNPO3
Psoriasis vulgaris	15/46	0.0360342480541994	0.65408149378799	0	0	1.88723936878129	6.27183514988376	ERAP1;PLCL2;HLA-B;IFNLR1;CDKAL1;TYK2;ETS1;RUNX3;PRDX5;ILF3;RNF114;ZMIZ1;BHLHE40;ELMO1;CAMK2G
Nephropathy	8/20	0.0360933260367532	0.65408149378799	0	0	2.59883958486557	8.63242850335934	TAP2;HLA-DPB1;HLA-DQA1;HLA-DRB1;PSMB9;HLA-DPB2;HLA-DPA1;HLA-DQB1
Glucose homeostasis traits	21/70	0.037205765553957	0.659453976782107	0	0	1.6721242358232	5.50344835404124	SETD5;KLF12;PLEKHB1;ATP2A3;PTPRM;VPS13B;CDKAL1;IKZF1;THADA;PCSK5;LPP;ZFP36L2;ZZEF1;MFSD8;GNA15;KCNQ1;RPS6KA1;OSTF1;HMGN3;PAK2;ATG5
Reticulocyte count	45/171	0.0372773445825687	0.659453976782107	0	0	1.39490704743055	4.58836472604164	PPP1R15A;GCDH;HBS1L;DNMT1;UBXN2A;TCF25;USP10;PIGQ;EIF4A3;GMPR;FOXK2;IQGAP2;ABO;UBE2L3;HK1;SBNO2;DSTYK;NDOR1;ATXN1;RMND5A;PSMB5;CUX1;PIEZO1;FLNB;CCDC92;SH2B3;SLFN12L;NEK8;RBM38;TAF15;ARL15;USP4;SWAP70;NFKBIL1;STX7;MYO9B;TMC6;AP2B1;KANSL1;SP1;BCL2;ARHGEF3;R3HDM4;HLA-DRB1;ATR
Mean platelet volume	70/281	0.0382813151963949	0.669247463315799	0	0	1.29678723246109	4.23114876585008	HBS1L;MAST4;DOCK8;PDCD5;TESK2;GCC2;DCAF5;SIRPB1;NPEPPS;KIAA1109;TRIM5;FNTB;FAM53B;CD36;LDLRAP1;RAB8A;FADS1;BRD3;DENND2D;TPM4;ACTN1;TCF12;HLA-B;ACSL5;RP4-576H24.4;CBFA2T3;VAV1;BET1L;ST7L;DDX39B;BIN2;STIM1;TBC1D4;TBC1D5;ARHGEF3;ELMO1;SIDT1;KDELR2;CD226;CD151;PSMD13;PDS5B;IQGAP2;STYXL1;DDO;SAV1;CNN2;PDLIM1;CUX1;GRK5;RBBP5;PLCG2;PACSIN2;BAK1;ANKMY1;RBM38;NFATC1;MYO9B;AP2B1;KIAA0232;DIAPH1;EHD3;NIN;LRCH1;ARPC2;REEP3;CAPZA2;BCL2;ESYT2;FXYD5
Lymphocyte percentage of white cells	35/129	0.0406262235388642	0.696557134040775	0	0	1.45361628615236	4.65642940489708	IFITM2;ZBTB25;ANTXR2;GIMAP7;ETS1;LY9;ZFP36L2;UBE2L3;HELZ2;SCML4;ZMIZ1;MIER1;S1PR4;KLF12;KDM4B;ITGA4;TET2;PLAUR;EPS15L1;NFKB1;KLF2;TADA2B;TBC1D1;ELF1;KANSL1;IL7;IL2RA;UBE2O;RIN3;KDELR2;PIGL;CD69;IL7R;CRK;HLA-DQB1
High light scatter reticulocyte percentage of red cells	45/172	0.0407809358422257	0.696557134040775	0	0	1.38383586514823	4.42763898659144	PPP1R15A;HBS1L;CD82;TFRC;UBXN2A;TCF25;USP10;EIF4A3;TESK2;GMPR;FGFRL1;UBE2L3;HK1;PGS1;SBNO2;ATXN2;BCL2L11;NDOR1;ATXN1;RMND5A;PSMB5;PIEZO1;PLEK2;FLNB;RBM38;BNIP3L;USP48;ITGA4;USP4;SWAP70;NFKBIL1;STX7;TMC8;MYO9B;TMC6;AP2B1;RCL1;CTU2;EHD3;HOOK2;KANSL1;KBTBD2;PPIF;R3HDM4;STRN
Leprosy	10/28	0.0444813988870476	0.751129076660827	0	0	2.16594445807102	6.74190104882369	CYLD;IL4R;MED30;TNFSF15;RIPK2;COX4I1;IL21R;BBS9;IL18R1;CTSB
Gut microbiota (beta diversity)	8/21	0.0481506445299036	0.798940921818251	0	0	2.39877798102853	7.27650291417411	PLSCR1;RNF114;VDR;SLC9A8;AK2;CLEC16A;PRKAG2;DEXI
Fibrinogen	13/40	0.0501978246489349	0.798940921818251	0	0	1.87747049946363	5.61698542520289	FARP2;LRPAP1;ARSA;ACTN1;SPPL2A;SNX13;PLRG1;MS4A6A;IRF1;NLRP3;PSMG1;DIP2B;IL6R
Itch intensity from mosquito bite	19/64	0.050634963280419	0.798940921818251	0	0	1.64695728176554	4.91305962395564	HLA-DRB5;SATB1;PRR3;STAT3;HLA-B;FOXK1;IKZF1;RTF1;ETS1;RUNX3;LPP;RUNX2;KIAA1109;DPH1;IRF1;HLA-DRA;CD48;STAT6;IL6R
Cortical amyloid beta load	5/11	0.0546890641079532	0.798940921818251	0	0	3.2473869018455	9.43720351956381	PRMT5;ATXN1;POLR2E;C14ORF93;RBM23
Cutaneous lupus erythematosus	5/11	0.0546890641079532	0.798940921818251	0	0	3.2473869018455	9.43720351956381	TRIM39;CSNK2B;MSH5;MICA;HLA-DQA1
Depression (quantitative trait)	5/11	0.0546890641079532	0.798940921818251	0	0	3.2473869018455	9.43720351956381	ITGB1;DDX21;EIF3F;SLFN12L;GPHN
Tonometry	5/11	0.0546890641079532	0.798940921818251	0	0	3.2473869018455	9.43720351956381	PREX1;SLC9A9;EXOC4;VPS37A;TGFBR2
IgE levels	7/18	0.0567049330468579	0.798940921818251	0	0	2.48025846702317	7.11807906519522	IL4R;WWP2;STAT6;HLA-A;LPP;HLA-G;HLA-DQB1
Response to fenofibrate (adiponectin levels)	7/18	0.0567049330468579	0.798940921818251	0	0	2.48025846702317	7.11807906519522	ZBP1;KDM4C;OAS1;OAS2;DDX54;PMEPA1;PCSK5
Menopause (age at onset)	26/94	0.0570949618448841	0.798940921818251	0	0	1.49184495270652	4.2712108784435	RPAIN;DIDO1;ABAT;SPPL3;GSPT1;PNP;U2AF2;RAD21;UIMC1;STX6;POLR2E;TLK1;KNTC1;BUB3;KPNA3;EIF4E;POLG;STARD3;PARP2;INO80;APTX;PRRC2A;APEX1;MSH5;CDK12;ZCCHC2
Calcium levels	18/61	0.0591223036537291	0.798940921818251	0	0	1.63265072842307	4.61737632065818	VKORC1L1;PHTF2;BCAS3;DGKD;SERPINF1;SPPL2A;ITPR1;GATA3;ARID1B;PRPF8;NAP1L4;STIM1;SLC22A18;ATG4C;SMYD4;BCAT1;KPNA1;DGKH
High light scatter reticulocyte count	44/172	0.059163270312093	0.798940921818251	0	0	1.34209590650507	3.79471492716149	PPP1R15A;HBS1L;CD82;TFRC;UBXN2A;TCF25;USP10;EIF4A3;GMPR;IQGAP2;FGFRL1;UBE2L3;HK1;SBNO2;ATXN2;BCL2L11;NDOR1;ATXN1;RMND5A;PSMB5;PIEZO1;PLEK2;FLNB;RBM38;BNIP3L;USP48;ITGA4;ARL15;NFKBIL1;STX7;TMC8;MYO9B;HLA-A;TMC6;AP2B1;RCL1;EHD3;HOOK2;KANSL1;KBTBD2;PPIF;BCL2;R3HDM4;NCOA7
Current cigarettes per day in chronic obstructive pulmonary disease	4/8	0.0603218512030078	0.798940921818251	0	0	3.89639970609846	10.9413275331773	SETX;BST1;CD96;IREB2
Estradiol levels	4/8	0.0603218512030078	0.798940921818251	0	0	3.89639970609846	10.9413275331773	EHD3;FKBP14;ZNF407;BEST1
IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis)	4/8	0.0603218512030078	0.798940921818251	0	0	3.89639970609846	10.9413275331773	ST6GAL1;DERL3;IKZF1;TAB1
Systemic sclerosis (anti-topoisomerase-positive)	4/8	0.0603218512030078	0.798940921818251	0	0	3.89639970609846	10.9413275331773	TLR1;MBD4;TLR10;TNPO3
Ulcerative colitis	107/456	0.0605984547168301	0.798940921818251	0	0	1.1989373803113	3.36120402384571	ERRFI1;CRTC3;MAML2;RP4-583P15.15;LST1;RORC;STMN3;STK19;TNF;ETS1;UBE2L3;TOM1;FAM53B;PMPCA;MAP3K8;CCNL2;KIF21B;MED1;STARD3;PRKCB;USP4;NFKBIL1;SLC11A1;ACSL6;HLA-B;DDX39B;GPD2;MSH5;CSNK2B;UTS2;KDELR2;TTPAL;CARD11;RTEL1;SLC35D1;RTF1;UBE2J2;AGER;BAG6;DVL1;MIER1;NEU1;PLCG2;TNFRSF14;ICOS;HLA-DQA1;ATP6V0A1;STAT5B;HLA-DRB5;SMAD3;TNFSF15;SMURF1;SEC16A;TMA7;PBX2;INO80;NFKB1;UBAC1;PRRC2A;UBLCP1;CD28;HLA-DRA;PSMG1;SKIV2L;PPT2;NDUFAF1;IL7R;HLA-DRB1;DDR1;LSP1;TRIM8;FCGR3B;CTLA4;WDR6;QSOX2;JAK2;TNPO3;TCF19;MANBA;ITGA4;SLC39A11;LIME1;IRF1;EXOC3;IRF8;IRF5;LTB;DLD;VAMP3;HLA-DQB1;ATF6B;USP12;PPT2-EGFL8;ADCY7;TSPAN33;HDAC9;AIF1;GNA12;CCDC71;MICA;STAT3;KIR3DL2;FCGR2A;PER3;SERBP1;LYRM7;OTUD3
Birdshot chorioretinopathy	3/5	0.0612915646616962	0.798940921818251	0	0	5.84390303623898	16.3168379478624	ERAP2;ERAP1;LNPEP
Bone mineral density (femoral neck) in inflammatory bowel disease	3/5	0.0612915646616962	0.798940921818251	0	0	5.84390303623898	16.3168379478624	KANK1;PARM1;BUD13
Diastolic blood pressure night-to-day ratio in hypertension	3/5	0.0612915646616962	0.798940921818251	0	0	5.84390303623898	16.3168379478624	ERAP2;GPR65;SNX30
Isovolumetric relaxation time	3/5	0.0612915646616962	0.798940921818251	0	0	5.84390303623898	16.3168379478624	MCTP1;SLC30A5;DENND3
Liver fibrosis in pediatric non-alcoholic fatty acid liver disease	3/5	0.0612915646616962	0.798940921818251	0	0	5.84390303623898	16.3168379478624	RAB37;ACTR5;ETS1
Neuritic plaques or neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)	3/5	0.0612915646616962	0.798940921818251	0	0	5.84390303623898	16.3168379478624	ADI1;TRAPPC12;HDAC9
Pulmonary arterial hypertension	3/5	0.0612915646616962	0.798940921818251	0	0	5.84390303623898	16.3168379478624	DNAJC10;HLA-DPB1;HLA-DPA1
Vascular brain injury	3/5	0.0612915646616962	0.798940921818251	0	0	5.84390303623898	16.3168379478624	AGBL3;ARHGAP15;PCSK5
Yeast infection	3/5	0.0612915646616962	0.798940921818251	0	0	5.84390303623898	16.3168379478624	PRKCH;HLA-DRB1;HLA-DQB1
Non-glioblastoma glioma	8/22	0.0625441187430432	0.808178786540541	0	0	2.22729660631107	6.17380575797852	RTEL1;MAML2;CDKN2A;AKT3;LRIG1;VTI1A;MDM4;LMF1
Moyamoya disease	6/15	0.0667570346070124	0.840936895954915	0	0	2.5980560320183	7.03214683011513	RNF213;TCN2;MTHFR;HDAC9;SBF2;FADS1
Sarcoidosis	6/15	0.0667570346070124	0.840936895954915	0	0	2.5980560320183	7.03214683011513	MANBA;ATXN2;PRDX5;ANXA11;TYK2;SH2B3
Central corneal thickness	19/66	0.0667769540529475	0.840936895954915	0	0	1.57667524425197	4.26710955649583	BRD3;SMAD3;FNDC3B;CWC27;RUNX2;NR3C2;ARL4C;AKAP13;RABGEF1;STAG1;RXRA;POLR2A;CHSY1;NDUFAF6;TBL1XR1;COL6A2;REEP3;PDE8A;BANP
Multiple myeloma	10/30	0.0689921300451573	0.861531976866419	0	0	1.94910473387295	5.21144380520179	TCF19;PREX1;DTNB;CDKN2A;CDCA7L;RFWD3;TOM1;DTNBP1;PRDM1;ATG5
Graves' disease	12/38	0.0712993095392135	0.875626231200588	0	0	1.79937706465314	4.75191845346393	ITGAM;RNASET2;IL2RA;HLA-B;CD28;CTLA4;RHOH;PTPN22;ICOS;LPP;ABO;BACH2
Heschl's gyrus morphology	12/38	0.0712993095392135	0.875626231200588	0	0	1.79937706465314	4.75191845346393	TNFAIP8;KLF12;ACAA2;CCDC149;DTNB;VPS8;METTL4;CD28;PRKCA;MYOM2;FDFT1;DCBLD2
Subjective response to lithium treatment	7/19	0.0744728752812071	0.90710403826126	0	0	2.2734272875817	5.90481886752305	EPM2AIP1;GOLGA4;FGGY;TRANK1;ATP11B;MLH1;MCF2L2
Alzheimer's disease progression score	5/12	0.078415765542405	0.913997623557203	0	0	2.78329950304473	7.08552982526893	RPS6KA2;SYN3;LCORL;PCSK5;RHOBTB2
Frontotemporal dementia with GRN mutation	5/12	0.078415765542405	0.913997623557203	0	0	2.78329950304473	7.08552982526893	NEDD1;NEIL2;STARD3NL;TMEM106B;ATP9B
IgG N-glycosylation phenotypes (multivariate analysis)	5/12	0.078415765542405	0.913997623557203	0	0	2.78329950304473	7.08552982526893	ST6GAL1;B4GALT1;DERL3;IKZF1;TAB1
Lactate dehydrogenase levels	5/12	0.078415765542405	0.913997623557203	0	0	2.78329950304473	7.08552982526893	CSF1;SNX13;GAB2;LILRB2;ABO
Polymyositis	5/12	0.078415765542405	0.913997623557203	0	0	2.78329950304473	7.08552982526893	MMAB;NAB1;PTPN22;UBE3B;IL18R1
Bone ultrasound measurement (broadband ultrasound attenuation)	8/23	0.0793443428256253	0.913997623557203	0	0	2.07867941488927	5.26728659989228	BCAS3;MTMR9;GPATCH1;MCTP2;GIMAP7;TBC1D22A;SPTBN1;XKR6
IgG glycosylation	8/23	0.0793443428256253	0.913997623557203	0	0	2.07867941488927	5.26728659989228	ST6GAL1;B4GALT1;DERL3;IKZF1;TAB1;ABCF2;RECK;BACH2
Systemic sclerosis	19/68	0.0861073848359621	0.963802411977642	0	0	1.51213051592318	3.70798611830964	DDX6;STAT1;PRDM1;PCSK5;NFKB1;HOPX;HLA-DPB1;IRF8;HLA-DRA;IRF5;OSTF1;ESYT1;DNASE1L3;TNPO3;HLA-DQA1;HLA-DRB1;HLA-DPA1;HLA-DQB1;ATG5
Alzheimer's disease (late onset)	18/64	0.0882819747998973	0.963802411977642	0	0	1.52588500539605	3.70365757757402	HLA-DRB5;TOMM40;AHNAK;SPPL2A;GAB2;SCIMP;SORL1;MS4A6A;MTHFD1L;NDUFAF6;INPP5D;BSG;BCL3;PLCG2;PTK2B;RIN3;ATXN7L1;HLA-DRB1
Granulocyte count	34/133	0.0887453256816799	0.963802411977642	0	0	1.34001251099697	3.24548955876235	HBS1L;IFITM2;DOCK8;PTPN22;THADA;ETS1;RCBTB1;ABO;CNN2;BCL2L13;ATXN1;CHSY1;ZMIZ1;NLRP3;PMPCA;S1PR4;SH2B3;FADS1;LYN;TRAP1;NDFIP1;PCGF3;PLAUR;TBC1D8;TADA2B;NPC1;RAB37;RASA2;IRF8;RIN3;PIGL;GLCCI1;CRK;SPC25
Interleukin-10 levels	6/16	0.0889801938086924	0.963802411977642	0	0	2.33810340602793	5.65667054419107	BCL2L13;DCUN1D5;NMD3;IPO7;YWHAZ;CDYL2
Albumin-globulin ratio	17/60	0.0904236305913449	0.963802411977642	0	0	1.54156905319696	3.70477528044964	ST6GAL1;ATP8B2;HLA-B;IKZF1;AFF3;AP5B1;HLA-F;ETS1;RUNX3;NFKB1;FLI1;RASGRP3;MPHOSPH9;ZFP57;ENSA;BCL2;IL6R
Asparaginase hypersensitivity in acute lymphoblastic leukemia	4/9	0.0914509691042043	0.963802411977642	0	0	3.11692383051678	7.45553314748411	DERL2;NFATC2;PPT2;HLA-DRB1
Disc degeneration (lumbar)	4/9	0.0914509691042043	0.963802411977642	0	0	3.11692383051678	7.45553314748411	PIGQ;PFKP;ARL8B;PSMB9
Excessive hairiness	4/9	0.0914509691042043	0.963802411977642	0	0	3.11692383051678	7.45553314748411	BCL2;ATP11B;GCC2;LIMS1
IgG digalactosylation phenotypes (multivariate analysis)	4/9	0.0914509691042043	0.963802411977642	0	0	3.11692383051678	7.45553314748411	ST6GAL1;DERL3;IKZF1;TAB1
IgG monogalactosylation phenotypes (multivariate analysis)	4/9	0.0914509691042043	0.963802411977642	0	0	3.11692383051678	7.45553314748411	ST6GAL1;DERL3;IKZF1;TAB1
Susceptibility to persistent hepatitis B virus infection	4/9	0.0914509691042043	0.963802411977642	0	0	3.11692383051678	7.45553314748411	CSGALNACT1;INTS10;HLA-DPB1;ATP6V1B2
Vogt-Koyanagi-Harada syndrome	4/9	0.0914509691042043	0.963802411977642	0	0	3.11692383051678	7.45553314748411	HLA-DRB5;HLA-DRA;HLA-DQA1;HLA-DRB1
Blood osmolality (transformed sodium)	7/20	0.0951387980995806	0.986878038549252	0	0	2.09841628959276	4.93635313461517	CYB5B;NQO1;ATXN2;LSG1;KATNAL1;MBP;HMGB1
Red blood cell traits	22/82	0.0991171782180971	0.986878038549252	0	0	1.429954899549	3.30527284233118	RBM38;HBS1L;CD164;TFRC;PRKAG2;NME4;IKZF1;KIF22;ABO;HK1;UBE2L3;LMF1;RCL1;ATXN2;CCND2;FNTB;RASA2;NUDT19;PIEZO1;FARSA;FBXO7;SH2B3
Celiac disease	33/130	0.0997687018173961	0.986878038549252	0	0	1.32725728439266	3.05919631540853	DDX6;PFKFB3;PLEK;CLEC16A;LSP1;ETS1;LPP;BACH2;UBE2L3;KIAA1109;ATXN2;ZMIZ1;TAGAP;CTLA4;TNFRSF14;UBASH3A;ICOS;SH2B3;HLA-DQA1;ITGA4;FRMD4B;MRPL23;RUNX3;ARHGAP31;NFIA;GLB1;POU2AF1;ELMO1;CD28;PRKCQ;EAPP;IL18R1;HLA-DQB1
Gestational age at birth (maternal effect)	11/36	0.100292036548508	0.986878038549252	0	0	1.71509322865554	3.94414670173672	CDC42;EEFSEC;MEF2A;MOB1A;RUVBL1;LRRC28;TET3;IRF8;CDC7;HACD2;TGFBR1
Hippocampal atrophy	10/32	0.100663540265966	0.986878038549252	0	0	1.77169041407452	4.0677508883817	ZBP1;GCFC2;CAND1;TLE1;CHD6;IKZF1;ARID2;SCAMP1;TTC27;ARSB
Parental longevity (combined parental attained age, Martingale residuals)	10/32	0.100663540265966	0.986878038549252	0	0	1.77169041407452	4.0677508883817	DCLRE1B;ATXN2;PGPEP1;AP5B1;IL6R;SH2B3;LDLR;MICA;HLA-DQA1;HLA-DRB1
Pulmonary function	17/61	0.10251732896547	0.986878038549252	0	0	1.50643846325664	3.43125018604646	HDAC4;CDC123;GSTCD;RHBDD1;FAM13A;ITGA1;TET2;ADARB1;AGER;PITPNC1;ADAM19;CFDP1;AEBP2;ZKSCAN3;PPT2;IL6R;HLA-DQB1
Breast milk fatty acid composition (infant genotype effect)	3/6	0.104266387652916	0.986878038549252	0	0	3.89569049951028	8.8074013707118	SNX29;COG3;FADS1
Cognitive test performance	3/6	0.104266387652916	0.986878038549252	0	0	3.89569049951028	8.8074013707118	POLR3B;NCAPD3;TARBP1
Malaria	3/6	0.104266387652916	0.986878038549252	0	0	3.89569049951028	8.8074013707118	SCO1;ATP2B4;ABO
Plasma factor VII activating protease levels	3/6	0.104266387652916	0.986878038549252	0	0	3.89569049951028	8.8074013707118	METTL25;USP10;B3GNTL1
Plasma trimethylamine N-oxide levels	3/6	0.104266387652916	0.986878038549252	0	0	3.89569049951028	8.8074013707118	MOB3B;PHACTR4;RHOBTB2
Possible neuropathic pain in post total joint replacement surgery for osteoarthritis	3/6	0.104266387652916	0.986878038549252	0	0	3.89569049951028	8.8074013707118	GPD2;PRKCA;MAT2B
Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	3/6	0.104266387652916	0.986878038549252	0	0	3.89569049951028	8.8074013707118	PFKFB3;MAML2;TGFBR2
Thyroid peroxidase antibody levels	3/6	0.104266387652916	0.986878038549252	0	0	3.89569049951028	8.8074013707118	ATXN2;PTPN22;SH2B3
Urinary magnesium-to-creatinine ratio	3/6	0.104266387652916	0.986878038549252	0	0	3.89569049951028	8.8074013707118	ARL15;NMRK1;OSTF1
Pediatric autoimmune diseases	13/45	0.113183499277007	0.999994527882068	0	0	1.58361714531173	3.45029776297271	SMAD3;ERAP2;FNBP1;TNFSF15;PTPN22;TYK2;ADCY7;ZMIZ1;ATG16L1;IL2RA;PSMG1;JAK2;IL18R1
Coronary artery disease	99/433	0.114638229650691	0.999994527882068	0	0	1.15790560303665	2.5079933591491	TDRKH;NDUFA12;CEP120;PPFIA1;CCDC97;DENND5A;CCDC92;IL6R;TRIM22;MAP1S;ARL15;SWAP70;FNDC3B;CFDP1;DOK3;RAB37;SLC9A8;SPECC1L;PRKD2;SRFBP1;CSNK1G2;FKBP5;RAB5C;THADA;RTF1;PDS5B;ARHGAP15;ABO;DYNC2LI1;ATXN2;PLCG2;DHX38;SYMPK;MARK3;MDN1;NEK9;SMAD3;MTHFR;DSTN;ARHGAP26;HNRNPM;STAG1;TBXAS1;PEMT;SKIV2L;ANP32B;ZNF652;SWSAP1;MAST4;MIA3;N4BP2L2;AKAP13;SCML4;TRIM5;GUK1;MCF2L;RAC1;PGPEP1;ACTR2;BCAS3;PARP1;ITGA1;PPHLN1;WDR33;NPC1;NOA1;PECAM1;TMEM106B;EXOC6;AIDA;MFGE8;TOMM40;GOSR2;NEDD9;HSD17B12;HDAC9;PRAM1;ARNTL;FCHO1;MAT2A;LDLR;SH2B3;PDLIM7;SF3A3;TCF7L2;MAP3K1;CDKN2A;NOS3;C1GALT1;MYO9B;RRP1B;WDR12;TTC39B;CLCN6;LYRM2;TSPAN14;CCM2;BUD13;B9D2
Hypothyroidism	20/75	0.117412554431198	0.999994527882068	0	0	1.41788676039967	3.03720055584094	HLA-DRB5;HLA-B;PTPN22;ZDHHC21;PTPN11;BACH2;PHTF1;NR3C2;ATXN2;CAPZB;MTF1;SPATA13;SACS;CTLA4;CCL2;ICOS;SH2B3;HLA-DQA1;HLA-DRB1;HLA-DQB1
Type 2 diabetes	91/397	0.120143945210586	0.999994527882068	0	0	1.16148583223747	2.46126364018273	TMEM45B;GALNT14;UBE3C;CALCOCO2;ZFAND3;ZBTB20;CISD2;ADARB1;PEPD;ETS1;OASL;CCND2;ZMIZ1;SACS;HLA-DOB;TCF19;IFNAR2;ST6GAL1;KLF12;TLE1;ANXA2;SYK;ARL15;ACSL1;NFKBIL1;ITGA1;HLA-B;UBE2E2;CDKAL1;CHD1L;GTF2F2;COMMD7;ARID1B;SND1;FAM234A;POC5;KCNQ1;PPARG;DEPDC5;ARF5;HLA-DQB1;NOTCH2;MACF1;CDC123;TOMM40;TNKS;YTHDC2;SRBD1;ITPR2;VPS26A;FITM2;THADA;HSD17B12;LPP;RASGRP1;ABO;CAMKK2;ATP6AP1L;SNX29;BCL2L11;MTHFD1L;GRK5;ATXN7;LRIG1;SSR1;YKT6;CAMK2G;HLA-DQA1;ZBED3;RBM38;TCF7L2;HLA-DRB5;OSBPL7;MAP3K1;ATP8B2;XRCC4;PLEKHA1;CDKN2A;STAT3;BRAF;SNF8;ZZEF1;CPPED1;GATAD2A;MPHOSPH9;BCL2;OSBPL1A;PAM;INTS8;ASB3;LIMS2
Atopic dermatitis	18/67	0.125382866339398	0.999994527882068	0	0	1.43219263620907	2.97378086100852	IL15RA;RTEL1;STAT3;HLA-B;CLEC16A;ETS1;DEXI;PPP2R3C;GLB1;IL2RA;IL7R;IL6R;RNF111;CARD11;MICA;HLA-DQA1;IL18R1;HLA-DRB1
Uterine fibroids	14/50	0.126146518886895	0.999994527882068	0	0	1.51593147284284	3.13844990560754	PDHX;KANK1;STN1;EDEM1;ITPR1;BET1L;SIRT3;CDC42;SLC4A7;SULT1B1;SLK;CYTH4;ZNF346;TNRC6B
Cold sores	4/10	0.128607859681508	0.999994527882068	0	0	2.59727324679566	5.32697457827277	HLA-B;HLA-A;MICA;HLA-DRB1
Hip minimal joint space width	4/10	0.128607859681508	0.999994527882068	0	0	2.59727324679566	5.32697457827277	SLBP;DDX6;PIK3R1;RUNX2
IgG fucosylation phenotypes (multivariate analysis)	4/10	0.128607859681508	0.999994527882068	0	0	2.59727324679566	5.32697457827277	ST6GAL1;B4GALT1;DERL3;TAB1
IgG sialylation phenotypes (multivariate analysis)	4/10	0.128607859681508	0.999994527882068	0	0	2.59727324679566	5.32697457827277	ST6GAL1;DERL3;IKZF1;TAB1
Interstitial lung disease	4/10	0.128607859681508	0.999994527882068	0	0	2.59727324679566	5.32697457827277	DUSP23;DPP9;FAM13A;ATP11A
Parental longevity (mother's attained age)	4/10	0.128607859681508	0.999994527882068	0	0	2.59727324679566	5.32697457827277	ATXN2;SH2B3;HLA-DQA1;HLA-DRB1
Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	4/10	0.128607859681508	0.999994527882068	0	0	2.59727324679566	5.32697457827277	PPIL2;PTPN22;PDHB;SH2B3
White matter integrity	4/10	0.128607859681508	0.999994527882068	0	0	2.59727324679566	5.32697457827277	CRBN;GNA12;EPS15L1;CARD11
Tuberculosis	19/72	0.134745675077314	0.999994527882068	0	0	1.39765496001929	2.80141231305871	DYNC2H1;LRPAP1;GRAMD2B;HLA-DRB5;DCUN1D5;C2CD2;HLA-B;HTT;MTHFR;TNFRSF1B;VWA8;CLCN6;IL2RB;DROSHA;HLA-DRA;HLA-DQA1;HLA-DRB1;HLA-DQB1;RNF187
Corneal structure	11/38	0.136437861823781	0.999994527882068	0	0	1.58784938029295	3.16281493918256	VKORC1L1;PPP3CA;AKAP13;RXRA;SMAD3;CHSY1;TBL1XR1;POU2AF1;FNDC3B;NR3C2;BANP
Lung function (FEV1/FVC)	21/81	0.138604582234155	0.999994527882068	0	0	1.36462124938515	2.69666916956877	CYFIP2;EEFSEC;CDC123;MGA;LST1;FAM13A;ITGA1;C1GALT1;TET2;DCAF8;KLHL22;CDC7;DDHD1;MED15;AGER;DCBLD2;ADAM19;CFDP1;ZKSCAN3;TMEM38B;HLA-DQB1
Breastfeeding duration	5/14	0.139291782951642	0.999994527882068	0	0	2.16451630464369	4.26666074745723	CELF2;PHF11;MTA3;RCBTB1;ZCCHC2
Response to SSRI (symptom remission)	5/14	0.139291782951642	0.999994527882068	0	0	2.16451630464369	4.26666074745723	TBC1D1;KYNU;DDX51;ARHGAP15;KCTD15
Shingles	5/14	0.139291782951642	0.999994527882068	0	0	2.16451630464369	4.26666074745723	HLA-B;HLA-A;HLA-DQA1;HLA-DRB1;HLA-DQB1
Feeling miserable	10/34	0.139484999574698	0.999994527882068	0	0	1.62384514757583	3.19864727058664	RERE;KIAA1109;ACBD4;TMA7;ACP2;TRIM27;LIN7C;METTL16;ARNTL;KLHL20
Non-albumin protein levels	18/68	0.139522042372641	0.999994527882068	0	0	1.40346030965839	2.76416094546491	DUSP5;DDX6;ST6GAL1;HLA-H;HLA-B;IKZF1;AFF3;ETS1;RUNX3;HLA-G;ABO;NFKB1;FLI1;UBE2L3;RASGRP3;NPLOC4;ENSA;BCL2
Optic cup area	9/30	0.142101932545672	0.999994527882068	0	0	1.67014643032299	3.25880749200572	RERE;BCAS3;PNPT1;TMTC2;ASB7;FLNB;DDHD1;ABO;TRIOBP
Peanut allergy	6/18	0.143703071525886	0.999994527882068	0	0	1.94817446704239	3.7794703724364	CHCHD3;EXOC4;ITGA6;HLA-DQA1;HLA-DRB1;HLA-DQB1
Chronic obstructive pulmonary disease	13/47	0.147431673384101	0.999994527882068	0	0	1.49027549163995	2.852969156876	EEFSEC;GSTCD;IREB2;FAM13A;TET2;AGER;TM9SF4;ADAM19;CFDP1;RRM2B;POFUT1;KLHL7;RIN3
Mosquito bite size	24/95	0.148861123328408	0.999994527882068	0	0	1.31800203138595	2.51045312128385	BRD3;STARD3NL;TNKS;ACTN1;FOXK1;IKZF1;ETS1;RUNX3;LPP;BACH2;RUNX2;NCOR2;HHAT;KIAA1109;LRCH1;DDX39B;KCNQ1;SP3;IL21R;STAT6;SFXN1;IL6R;MICA;HLA-DQB1
Mean corpuscular volume	83/365	0.150112613903554	0.999994527882068	0	0	1.1490043644299	2.1789368403534	CDA;HBS1L;BTG2;TRAF3IP3;TFRC;PDCD5;IKZF1;HMGB1;CHTF18;BACH2;UBE2L3;HK1;AKAP13;CHAF1A;SLK;CCND2;RPS6KA1;FNTB;LUC7L;PIEZO1;KAT7;CD36;FBXO7;RAB8A;ILKAP;TPM3;SWAP70;COMMD1;TMC6;ATP11A;WIPI2;KLF16;BET1L;SLC7A5;PSMA3;FAM234A;RRM2B;TBC1D4;RASA2;GCDH;CEP104;RGS19;FECH;ATF6B;PVT1;OPRL1;GMPR;PIK3R1;THADA;TYMS;ABO;ATXN2;TIMM23B;PPP4C;PSMB5;NDOR1;RMND5A;EPB41L2;EXOSC9;ALOX5;TBX21;LRIG1;KCNN4;SH2B3;RBM38;CD164;STAT3;PLCL2;RPA1;ATP2B4;MYO9B;RAB11A;QKI;RCL1;SLC2A9;RAB10;CLCN6;KANSL1;SP1;IL2RB;BCL2;ATR;TNRC6B
Plateletcrit	54/231	0.150903070880092	0.999994527882068	0	0	1.19038273228912	2.25115369170489	HBS1L;DGKD;PLEK;LY75;TESK2;ENO1;AFF3;ETS1;CAPZB;DIP2B;JAK2;ABCC4;TPM4;TANGO2;ITPK1;HLA-B;TET2;HLA-A;TMC6;BET1L;RUNX1;ST7L;CTU2;MAU2;TBC1D5;IRF1;ARHGEF3;RIN3;CD226;RTEL1;USP15;PVT1;THADA;HDAC9;ABO;EPB41L5;NPAT;ATXN2;CUX1;GNA12;BAK1;PAK2;SH2B3;NDFIP1;CDKN2A;MYO9B;FLI1;TADA2B;RCL1;EHD3;MPHOSPH9;CAPZA2;BCL2;LTBR
Type 1 diabetes	23/91	0.154462763635679	0.999994527882068	0	0	1.31873480199166	2.4631357957087	CLEC16A;PTPN22;PTPN11;IKZF1;TYK2;AFF3;DEXI;RASGRP1;BACH2;PHTF1;FAM120B;IL2RA;IL2RB;CTLA4;CTSH;CCR7;PRKCQ;CD226;UBASH3A;CD69;IL7R;SH2B3;HLA-DRB1
Breast milk fatty acid composition (maternal genotype effect)	3/7	0.155561511131477	0.999994527882068	0	0	2.92158423114594	5.43623284352039	SNX29;COG3;FADS1
Drug-induced liver injury (flucloxacillin)	3/7	0.155561511131477	0.999994527882068	0	0	2.92158423114594	5.43623284352039	ST6GAL1;HLA-B;MCTP2
Hepatitis B vaccine response	3/7	0.155561511131477	0.999994527882068	0	0	2.92158423114594	5.43623284352039	HLA-DPB1;HLA-DRA;HLA-DRB1
Large artery stroke	3/7	0.155561511131477	0.999994527882068	0	0	2.92158423114594	5.43623284352039	TTLL5;HDAC9;ALKBH8
Multiple sclerosis and HDL levels (pleiotropy)	3/7	0.155561511131477	0.999994527882068	0	0	2.92158423114594	5.43623284352039	SYK;UBASH3B;PLCL2
Remission after SSRI treatment in MDD or neuroticism	3/7	0.155561511131477	0.999994527882068	0	0	2.92158423114594	5.43623284352039	PRAG1;PLXNC1;XKR6
Response to platinum-based chemotherapy (carboplatin)	3/7	0.155561511131477	0.999994527882068	0	0	2.92158423114594	5.43623284352039	AKAP13;NBAS;LILRB4
Sensory disturbances after bilateral sagittal split ramus osteotomy	3/7	0.155561511131477	0.999994527882068	0	0	2.92158423114594	5.43623284352039	CSF1;STAT6;ARID1B
Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)	11/39	0.15680281595804	0.999994527882068	0	0	1.53104409084537	2.83666676107674	DDR1;HLA-DMA;ZKSCAN3;HLA-B;HLA-DRA;STK19;TRIM27;HLA-DOB;HLA-G;HLA-DQA1;HLA-E
HIV-1 susceptibility	8/27	0.170010696363506	0.999994527882068	0	0	1.64064979806712	2.90705740881354	IL32;ZCCHC7;KDM4C;HLA-B;NEDD9;BUD13;PAX5;SIGLEC17P
Survival in pancreatic cancer	8/27	0.170010696363506	0.999994527882068	0	0	1.64064979806712	2.90705740881354	PAIP2B;ZNF207;GTF2H1;LIN7C;SBF2;CLYBL;RUNX2;B4GALT4
Erythema nodosum in inflammatory bowel disease	4/11	0.170847184128903	0.999994527882068	0	0	2.22609425842343	3.93347690424104	MCEE;CLEC4F;SOS2;ARF6
Hippocampal tail volume	4/11	0.170847184128903	0.999994527882068	0	0	2.22609425842343	3.93347690424104	FBXW8;MAST4;FAM53B;LHPP
Optic nerve measurement (cup-to-disc ratio)	4/11	0.170847184128903	0.999994527882068	0	0	2.22609425842343	3.93347690424104	RFTN1;DPH6;CDC7;RPAP3
Peripheral artery disease	4/11	0.170847184128903	0.999994527882068	0	0	2.22609425842343	3.93347690424104	ATXN2;RAP2A;HDAC9;SH2B3
QRS complex (12-leadsum)	4/11	0.170847184128903	0.999994527882068	0	0	2.22609425842343	3.93347690424104	USP25;LRCH1;PRKCA;NSRP1
Sitting height ratio	4/11	0.170847184128903	0.999994527882068	0	0	2.22609425842343	3.93347690424104	BCKDHB;MYO18A;PTPRM;NFATC2
Takayasu arteritis	22/88	0.174644637842248	0.999994527882068	0	0	1.29946699466995	2.26757251828612	DDR1;ATP8A1;ATF6B;GPR65;HLA-B;SH2D1B;GATA3;PCSK5;HLA-G;AIF1;UHMK1;FCGR2A;MSH5;PTK2B;HLA-DRA;PSMG1;HLA-DOB;MICA;HLA-DQA1;HLA-DRB1;HLA-DPA1;HLA-DQB1
Sum neutrophil eosinophil counts	32/133	0.174742960397998	0.999994527882068	0	0	1.23544823039641	2.15516430108483	HBS1L;IFITM2;DOCK8;PTPN22;THADA;ETS1;RCBTB1;ABO;BCL2L13;ATXN1;CHSY1;NLRP3;PMPCA;S1PR4;SH2B3;FADS1;LYN;TRAP1;NDFIP1;PCGF3;PLAUR;TBC1D8;TADA2B;NPC1;RAB37;RASA2;IRF8;RIN3;PIGL;GLCCI1;CRK;SPC25
Chronic hepatitis B infection	5/15	0.175559165688016	0.999994527882068	0	0	1.94794218520333	3.3889892312914	TCF19;HLA-DPB1;HLA-DOA;HLA-DPA1;HLA-DQB1
Late-onset myasthenia gravis	5/15	0.175559165688016	0.999994527882068	0	0	1.94794218520333	3.3889892312914	PTPN22;HLA-A;HLA-DQA1;HLA-DRB1;HLA-DQB1
Sulfasalazine-induced agranulocytosis	5/15	0.175559165688016	0.999994527882068	0	0	1.94794218520333	3.3889892312914	TMEM245;IFT88;HLA-B;MROH6;SERINC5
Frontotemporal dementia	6/19	0.175655476377025	0.999994527882068	0	0	1.7982017982018	3.12748781354416	NEDD1;HLA-DRB5;NEIL2;HLA-DRA;TMEM106B;ATP9B
Beard thickness	10/36	0.184956327185062	0.999994527882068	0	0	1.49874530669233	2.52933586153204	RANBP2;SLC12A2;EDAR;MACF1;UBIAD1;AKIRIN1;EXOSC10;TARDBP;SRM;LIMS1
Brown vs. black hair color	10/36	0.184956327185062	0.999994527882068	0	0	1.49874530669233	2.52933586153204	PIGU;CCND2;MAP3K1;PPFIBP2;TCF25;ZMIZ1;ARL15;IL16;GAB2;EXOC2
Immature fraction of reticulocytes	30/125	0.187941087141834	0.999994527882068	0	0	1.23124424321835	2.05818079000437	DNMT1;BTG2;UBXN2A;EIF4A3;TESK2;IKZF1;THADA;SPPL3;HK1;PGS1;SBNO2;ATXN2;BCL2L11;RMND5A;PLEK2;FLNB;ASCC2;PCBD1;BNIP3L;USP48;ITGA4;FNDC3B;WIPI2;TMC6;RCL1;APBB1IP;R3HDM4;CD226;STRN;ANP32B
Bone mineral density	22/89	0.18959920202888	0.999994527882068	0	0	1.27999118797158	2.12842425626562	RERE;STARD3NL;GPATCH1;CDKAL1;TNFRSF11A;LIN7C;NTAN1;FGFRL1;BET1L;MPP7;CYLD;RPS6KA5;FUBP3;IL21R;CTNNB1;ABCF2;MARK3;CTNNBL1;ANAPC1;SPTBN1;SCYL1;CBR3
Endometrial cancer	12/45	0.193941499735304	0.999994527882068	0	0	1.41706636921361	2.3242704352318	EEFSEC;KLF12;CDKN2A;RNASET2;RUVBL1;NF1;AKT1;CDKAL1;NCOA7;PPARG;SH2B3;BPTF
Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)	27/112	0.196095843967405	0.999994527882068	0	0	1.23835410026079	2.01746673648176	ACAA2;SETD3;PRAG1;TNKS;HSD17B4;STK19;LSP1;COX5A;DYNC2LI1;ATXN2;MED30;ERI1;RSRC1;DPYSL2;DYM;POC1B;SH2B3;MTHFR;PTPN11;AP5B1;EXT1;SLC4A7;INPP4B;CLCN6;CFDP1;CD5;TERF2IP
Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)	23/94	0.19729340320351	0.999994527882068	0	0	1.26277448153488	2.04956291952014	PRAG1;TNKS;MTHFR;STK19;PTPN11;LSP1;COX5A;DYNC2LI1;SLC4A7;INPP4B;CLCN6;ATXN2;CFDP1;RSRC1;ERI1;CLMN;DPYSL2;AKT3;TERF2IP;POC1B;CEP170;SH2B3;SDCCAG8
Amyotrophic lateral sclerosis	14/54	0.199422337449425	0.999994527882068	0	0	1.36399459857599	2.19920996273708	ZNF142;NSMCE2;SUSD1;SLC39A11;ITPR2;SOD1;SCFD1;TBK1;ATXN1;ZFP64;ZNF746;PIGL;KIFAP3;DISC1
QT interval	28/117	0.202402143995756	0.999994527882068	0	0	1.22649349067546	1.95932181671697	SETD6;CLEC16A;GMPR;NUCKS1;PPP6R3;SLC38A7;PDE4B;SMARCAD1;TNFRSF17;RFFL;MCF2L2;FADS1;KCNJ2;KCNH2;KLF12;ACOT7;GINS3;GOT2;LIG3;PRKCA;CNOT1;KCNQ1;RNF207;SP3;ELMO1;EXOC4;SPATS2L;L3MBTL4
Relative hand skill in reading disability	7/24	0.204282570898935	0.999994527882068	0	0	1.6042675893887	2.5479797508831	CHSY1;SCO1;DAD1;SLC39A11;SNRPA1;ATG7;ACTB
Blood metabolite ratios	13/50	0.207763125908979	0.999994527882068	0	0	1.3691836166063	2.15147580289365	ABCC1;PDXDC1;MBOAT7;GOT2;ABO;PRRC2A;SLC2A9;SLC7A6;IVD;THEM4;ACADM;TKT;FADS1
Glomerular filtration rate in non diabetics (creatinine)	10/37	0.209909797382336	0.999994527882068	0	0	1.44314537741077	2.2528616001331	BCAS3;GATM;WDR37;UBE2Q2;KCNQ1;ALMS1;PRKAG2;NFATC1;INO80;CDK12
Breast cancer	50/219	0.210158323476237	0.999994527882068	0	0	1.15382416786735	1.79984352459171	DCLRE1B;MUS81;TMEM45B;CDCA7L;PTPN22;LSP1;N4BP2L2;WDR43;CASP8;ZMIZ1;TNFSF10;ABCC4;KLF12;ATG10;TET2;CDKAL1;RAD23B;CDYL2;TGFBR2;EWSR1;RIN3;L3MBTL3;ANKRD16;ITPR1;PLA2G6;ABO;ATXN1;BCL2L11;CUX1;COX11;KCNN4;TCF7L2;METAP1D;MAP3K1;CDKN2A;HSPA4;SIAH2;AP4B1;GATAD2A;RNF146;GALC;SLC4A7;MLLT10;KANSL1;TNIP3;CCDC88C;ECHDC1;MDM4;RPL23AP53;SSBP4
Dimensional psychopathology (Arousal)	6/20	0.210162627560449	0.999994527882068	0	0	1.66965379633843	2.60444892983447	MED30;DCTN4;RTCB;GOLIM4;EPSTI1;TFB1M
Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)	3/8	0.212705317387853	0.999994527882068	0	0	2.33712047012733	3.61750621154019	PRDM1;ERGIC1;GAS7
Adverse response to chemotherapy in breast cancer (alopecia) (FDC/DC)	3/8	0.212705317387853	0.999994527882068	0	0	2.33712047012733	3.61750621154019	DENND1A;LCORL;SMARCA2
Bronchopulmonary dysplasia in preterm infants	3/8	0.212705317387853	0.999994527882068	0	0	2.33712047012733	3.61750621154019	ABAT;STK32C;RASGRP3
Cocaine dependence	3/8	0.212705317387853	0.999994527882068	0	0	2.33712047012733	3.61750621154019	NCOR2;CDK1;FAM53B
Disrupted circadian rhythm (low relative amplitude of rest-activity cycles)	3/8	0.212705317387853	0.999994527882068	0	0	2.33712047012733	3.61750621154019	RNF157;DAXX;SFMBT1
Idiopathic inflammatory myopathy	3/8	0.212705317387853	0.999994527882068	0	0	2.33712047012733	3.61750621154019	MGAT4A;TRAF6;PTPN22
Iris color (L* coordinate)	3/8	0.212705317387853	0.999994527882068	0	0	2.33712047012733	3.61750621154019	ARHGAP32;SCML4;TRANK1
Parental longevity (father's age at death)	3/8	0.212705317387853	0.999994527882068	0	0	2.33712047012733	3.61750621154019	ATXN2;CDKN2A;SH2B3
Response to treatment for acute lymphoblastic leukemia	3/8	0.212705317387853	0.999994527882068	0	0	2.33712047012733	3.61750621154019	MAML2;NCOA3;ELMO1
Schizophrenia (inflammation and infection response interaction)	3/8	0.212705317387853	0.999994527882068	0	0	2.33712047012733	3.61750621154019	GLT1D1;SGK1;SGPP2
Soluble interleukin-2 receptor subunit alpha	3/8	0.212705317387853	0.999994527882068	0	0	2.33712047012733	3.61750621154019	IL15RA;IL2RA;ADK
Type 1 diabetes nephropathy	3/8	0.212705317387853	0.999994527882068	0	0	2.33712047012733	3.61750621154019	RNF10;MCTP2;AFF3
Fibrinogen levels	17/68	0.212999489381141	0.999994527882068	0	0	1.2990990990991	2.00901195153973	FARP2;ARSA;TMEM87A;RAB5C;ACTN1;SPPL2A;SNX13;PLRG1;MS4A6A;RAB37;PDE4B;NLRP3;HLA-DRA;PSMG1;DIP2B;IL6R;SH2B3
Monocyte count	51/224	0.21371319534359	0.999994527882068	0	0	1.14968176584153	1.77409735363281	HBS1L;IFITM2;CSF1;SLC2A1;PIK3CD;IKZF1;LSP1;ETS1;RCBTB1;BBC3;DOCK10;ENSA;TSPO;RRP12;ITGA4;ARRDC2;HLA-B;RAB37;RASA2;C22ORF34;IRF8;FAM76B;RIN3;KDELR2;TTLL12;CSNK1G1;CSF1R;BCL2A1;CCDC69;TUBD1;SLC41A1;ABO;CNN2;ATXN2;BCL2L11;DPP8;GNA12;POC1B;KCNN4;PAK2;MARK3;S1PR4;SH2B3;CDKN2A;LYZ;TADA2B;PAN3;HOOK2;HLA-DPB1;BCL2;SSBP4
Bone mineral density (paediatric, skull)	5/16	0.214913247823159	0.999994527882068	0	0	1.77074517838849	2.72255759777348	PPP6R3;TNFRSF11A;FAM3C;LIN7C;MPP7
Cholangiocarcinoma in primary sclerosing cholangitis (time to event)	5/16	0.214913247823159	0.999994527882068	0	0	1.77074517838849	2.72255759777348	SP100;MAPKAPK3;SP110;SP140;SP140L
Multiple system atrophy (pathologically confirmed)	5/16	0.214913247823159	0.999994527882068	0	0	1.77074517838849	2.72255759777348	DDX18;NDE1;FOXN3;ARID1B;RASGRP3
Chronic bronchitis and chronic obstructive pulmonary disease	4/12	0.217062899016433	0.999994527882068	0	0	1.94771001714426	2.97525971015259	CHID1;IREB2;FAM13A;MCTP2
Food addiction	4/12	0.217062899016433	0.999994527882068	0	0	1.94771001714426	2.97525971015259	RNF146;TEP1;PRKCA;OSGEP
Ischemic stroke (small-vessel)	4/12	0.217062899016433	0.999994527882068	0	0	1.94771001714426	2.97525971015259	CAMK2D;WDR12;PMF1;SH2B3
Ossification of the posterior longitudinal ligament of the spine	4/12	0.217062899016433	0.999994527882068	0	0	1.94771001714426	2.97525971015259	CCDC91;EMC2;CDC5L;EIF3E
Response to anti-retroviral therapy (ddI/d4T) in HIV-1 (Grade 2 peripheral neuropathy)	4/12	0.217062899016433	0.999994527882068	0	0	1.94771001714426	2.97525971015259	WDHD1;NFE2L3;KIF20B;IL6R
QRS duration	14/55	0.22029866462756	0.999994527882068	0	0	1.3306426017857	2.01295765484721	KLF12;GOSR2;PRKCA;CD1E;SENP2;MYL12A;SLC25A26;NFIA;HEATR5B;NACA;VTI1A;LRIG1;STRN;TKT
Serum uric acid levels	14/55	0.22029866462756	0.999994527882068	0	0	1.3306426017857	2.01295765484721	PRDM8;CYB5B;BCAS3;SFMBT1;ENTPD5;TMC6;SELENOO;SLC2A9;NDUFAF6;SESTD1;RFT1;MICALL2;ALDH16A1;SBF2
Platelet count	81/366	0.225941740728255	0.999994527882068	0	0	1.10874740520798	1.64923748071857	HBS1L;IFITM2;MAST4;DOCK8;IPP;LY75;TESK2;ETS1;MRPL42;TRIM5;FNTB;PIEZO1;DIP2B;CD36;LDLRAP1;JAK2;HLA-DOA;ZNF444;TBC1D22B;FADS1;SLFN12L;BRD3;TSC22D4;ABCC4;USP7;PARP1;TPM4;TPM3;ACTN1;ITPK1;HLA-B;TYK2;BET1L;RUNX1;SIRT3;EWSR1;NOA1;TBC1D5;IRF1;ARHGEF3;NHP2;PPARG;SATB1;PSMD13;PXN;ABHD6;THADA;IQGAP2;ABO;ZFP36L2;DDO;ATXN2;KCTD20;BTBD2;MXI1;GNA12;PACSIN2;NLRP3;BAK1;RAB11FIP3;PAK2;SH2B3;NDFIP1;CDKN2A;NFYC;MYO9B;PTPN11;AP2B1;KIAA0232;FLI1;RCL1;EHD3;MPHOSPH9;ARPC2;CAPZA1;REEP3;CAPZA2;BCL2;BUD13;FXYD5;SIPA1
Height	115/527	0.22667350465929	0.999994527882068	0	0	1.08930902237996	1.6168010367266	MAML2;ZBTB24;CEP120;GOLIM4;ZDHHC7;TXNDC15;CCDC91;CCND2;ZMIZ1;HABP4;ENPP2;PIP4K2B;FADS1;MAP2K2;FNDC3B;HLA-B;PRKCA;PASK;RUNX2;PDIA4;BCR;ILF3;KCNQ1;PPIF;DGKH;IPPK;SLBP;DDX6;L3MBTL3;PDXDC1;RTF1;PDS5B;PPP3R1;DYM;SLC38A9;LTA4H;LYN;CD164;PNPT1;ACBD4;CRADD;DTNB;BOD1;CPSF2;FANCC;NUP153;LYZ;NTAN1;FLI1;EXT1;CCDC88A;STAG1;FUBP3;ZNF652;CDCA7L;ECE1;PCSK5;COIL;SENP6;MRPL42;LBH;SIN3A;RSRC1;KIF13A;QSOX2;POLG;BCKDHA;BCAS3;ADSL;CAMLG;STARD3NL;BCKDHB;TET2;SLC39A13;PEX1;SYN3;ETV6;DNM2;CTU2;PPM1B;RBL1;ZNF638;RFT1;EIF4E2;LCORL;DTL;PPARD;USP10;AIF1;PRAM1;NSD1;RSBN1L;TGS1;GNA12;PDE6D;RAB28;KCNJ2;MICA;SLC12A2;PLEKHA1;MYO9B;DEF6;PML;GATAD2A;TTLL5;ZNFX1;LYRM4;SGSM3;CAPZA1;CYP20A1;ATP13A2;CRLF3;MYO1F;TNRC6B;NUP37
Diverticular disease	36/156	0.23235517397384	0.999994527882068	0	0	1.1695630708467	1.70696344922347	USP36;SLC35D1;INSIG1;ADK;TMTC2;CWC27;ARHGAP15;PCSK5;ABO;TBX21;UBTF;PMPCB;PIEZO1;UBASH3A;KCNH2;UPF2;SMAD3;PRMT2;EDEM1;IFNGR2;WWP2;GTPBP1;SIRT1;KLF16;MPP7;RNF146;AEBP2;VAPA;LACTB2;POU2AF1;KIF26B;AGBL3;CENPK;PI16;LCORL;TNRC6B
Triglycerides	42/184	0.234263970105829	0.999994527882068	0	0	1.15319208203485	1.67363542047233	LRPAP1;TNFAIP8;PPP1R13B;TOMM40;PDXDC1;PDE3B;TRANK1;THADA;PLA2G6;PEPD;PGS1;DSTYK;INPP5A;TNFSF10;CCDC92;ARID2;CCDC93;FADS1;BBS4;CTSB;PLA2G12A;MAP3K1;ARL15;AP3B1;BTN3A3;TYW1B;WWP2;GAB2;SCAMP1;MAU2;NPC1;RPS6KB1;REEP3;SIK3;BCL2;ATG4C;PEMT;TMEM106B;BUD13;ERGIC3;GAS6;XKR6
Acute lymphoblastic leukemia (childhood)	10/38	0.236149774445786	0.999994527882068	0	0	1.39151687164932	2.00836104672568	SLCO3A1;CDKN2A;SP4;INTS10;TBXAS1;PDE4B;PIP4K2A;IKZF1;AIG1;LHPP
Periodontal disease-related phenotypes	10/38	0.236149774445786	0.999994527882068	0	0	1.39151687164932	2.00836104672568	NIN;KIAA1328;IFI16;SEL1L;RAB28;STT3B;SLC15A4;SOS2;TPGS2;SAV1
Vertical cup-disc ratio	10/38	0.236149774445786	0.999994527882068	0	0	1.39151687164932	2.00836104672568	RERE;BCAS3;VCAN;TMTC2;ASB7;FLNB;CDC7;RPAP3;EXOC2;SCYL1
Coronary artery calcified atherosclerotic plaque score in type 2 diabetes	7/25	0.236998413732666	0.999994527882068	0	0	1.5150462962963	2.18121492679803	TLR1;POU2F1;ZBTB49;OLA1;FRY;BDP1;RAB11FIP3
Basal cell carcinoma	12/47	0.24034678961702	0.999994527882068	0	0	1.33592287467134	1.90458842685329	CASP8;CUX1;CASP10;CDKN2A;RCC2;NEU1;HLA-B;PLIN3;GATA3;CLPTM1L;LPP;EXOC2
Serum metabolite ratios in chronic kidney disease	6/21	0.246774524754146	0.999994527882068	0	0	1.55824552805685	2.18042213675337	CERS4;ACADM;NTAN1;SPPL3;SYNE2;FADS1
Systemic lupus erythematosus and Systemic sclerosis	6/21	0.246774524754146	0.999994527882068	0	0	1.55824552805685	2.18042213675337	ITGAM;DNPEP;IRF8;IRF5;TNPO3;ATG5
Type 1 diabetes and autoimmune thyroid diseases	6/21	0.246774524754146	0.999994527882068	0	0	1.55824552805685	2.18042213675337	DDR1;NFKBIL1;TAP2;PTPN22;PHTF1;MICA
Bipolar disorder with mood-incongruent psychosis	5/17	0.2566672316141	0.999994527882068	0	0	1.62308100604279	2.20734935050805	INPP4A;BASP1;TRANK1;NUMB;ATP6V1H
Thrombin-activatable fibrinolysis inhibitor activation peptide	8/30	0.258627372250048	0.999994527882068	0	0	1.41665738037398	1.915840649607	DOCK10;IGSF6;CD82;CUL3;DENND1A;BHLHE40;ITPR1;METTL9
Verbal declarative memory	14/57	0.264600347111767	0.999994527882068	0	0	1.26859237519913	1.68663760260307	ZBP1;MTRR;TOMM40;ZRANB2;CHD6;C1ORF174;VPS26B;SLC39A14;TBC1D1;PPP3CC;NARS2;MBP;NCAPD3;MAP2K5
ALT levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	12/48	0.264993147728179	0.999994527882068	0	0	1.29873210633947	1.72478287640964	HDAC4;CAST;TSFM;RNF213;PDCD6IP;FNBP1;PERP;CDKAL1;PDCD2;SEPHS1;DEPDC5;SFI1
Airway responsiveness in chronic obstructive pulmonary disease	4/13	0.266096389863473	0.999994527882068	0	0	1.73118894059379	2.29191527001291	RPTOR;ABCC4;BCAS3;PDSS2
Multiple sclerosis (OCB status)	4/13	0.266096389863473	0.999994527882068	0	0	1.73118894059379	2.29191527001291	HLA-DRA;HLA-DQA1;HLA-DRB1;HLA-DQB1
Type 2 diabetes nephropathy	4/13	0.266096389863473	0.999994527882068	0	0	1.73118894059379	2.29191527001291	AUH;LIMK2;ELMO1;LRP8
Headache	7/26	0.271252967630452	0.999994527882068	0	0	1.43521671826625	1.87253218030252	MACF1;UFL1;CFDP1;NUFIP2;BTN2A2;STAT6;FXN
Perceived unattractiveness to mosquitoes	7/26	0.271252967630452	0.999994527882068	0	0	1.43521671826625	1.87253218030252	SUN1;INPP5D;ACSL6;HLA-DRA;STAT6;MICA;PDE9A
Scalp hair shape	7/26	0.271252967630452	0.999994527882068	0	0	1.43521671826625	1.87253218030252	RANBP2;EDAR;SETD3;PITRM1;GATA3;PFKP;LIMS1
Serum thyroid-stimulating hormone levels	7/26	0.271252967630452	0.999994527882068	0	0	1.43521671826625	1.87253218030252	LYN;CAPZB;TGS1;ITGA1;AAK1;ANP32B;ABO
Amyloid A serum levels	2/5	0.271642278696132	0.999994527882068	0	0	2.59649122807018	3.38392712379382	LDHA;GTF2H1
Amyotrophic lateral sclerosis (C9orf72 mutation interaction)	2/5	0.271642278696132	0.999994527882068	0	0	2.59649122807018	3.38392712379382	EGR1;CAND1
Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals	2/5	0.271642278696132	0.999994527882068	0	0	2.59649122807018	3.38392712379382	HDAC4;PPP2R2D
Barrett's esophagus x pack-years of smoking exposure interaction	2/5	0.271642278696132	0.999994527882068	0	0	2.59649122807018	3.38392712379382	SLFN11;SLC12A6
Breast cancer (early onset)	2/5	0.271642278696132	0.999994527882068	0	0	2.59649122807018	3.38392712379382	SLC4A7;MAP3K1
Conduct disorder	2/5	0.271642278696132	0.999994527882068	0	0	2.59649122807018	3.38392712379382	ARHGAP22;ZNF330
Coronary atherosclerosis (increased number of diseased vessels) (traffic exposure interaction)	2/5	0.271642278696132	0.999994527882068	0	0	2.59649122807018	3.38392712379382	RARS2;SAMSN1
Coronary heart disease (SNP X SNP interaction)	2/5	0.271642278696132	0.999994527882068	0	0	2.59649122807018	3.38392712379382	CDKN2A;HSP90B1
Crohn's disease-related phenotypes	2/5	0.271642278696132	0.999994527882068	0	0	2.59649122807018	3.38392712379382	LY75;PHLDB2
Dementia with Lewy bodies	2/5	0.271642278696132	0.999994527882068	0	0	2.59649122807018	3.38392712379382	BCL7C;GBA
Formal thought disorder in schizophrenia	2/5	0.271642278696132	0.999994527882068	0	0	2.59649122807018	3.38392712379382	INSIG1;KCNJ2
Myeloproliferative neoplasms	2/5	0.271642278696132	0.999994527882068	0	0	2.59649122807018	3.38392712379382	HBS1L;JAK2
Pediatric bone mineral content (radius)	2/5	0.271642278696132	0.999994527882068	0	0	2.59649122807018	3.38392712379382	MTAP;FAM3C
Plasma plasminogen activator levels	2/5	0.271642278696132	0.999994527882068	0	0	2.59649122807018	3.38392712379382	STXBP5;STX2
Recalcitrant atopic dermatitis	2/5	0.271642278696132	0.999994527882068	0	0	2.59649122807018	3.38392712379382	NBAS;GATA3
Response to antineoplastic agents	2/5	0.271642278696132	0.999994527882068	0	0	2.59649122807018	3.38392712379382	ACOX3;DISC1
Response to exercise (triglyceride level interaction)	2/5	0.271642278696132	0.999994527882068	0	0	2.59649122807018	3.38392712379382	DOCK10;CRTC3
Response to methylphenidate treatment in ADHD (blood pressure)	2/5	0.271642278696132	0.999994527882068	0	0	2.59649122807018	3.38392712379382	PTCD3;ST6GAL1
Response to platinum-based chemotherapy (cisplatin)	2/5	0.271642278696132	0.999994527882068	0	0	2.59649122807018	3.38392712379382	DTNB;LPP
Rheumatoid arthritis (rheumatoid factor and/or anti-CCP seropositive)	2/5	0.271642278696132	0.999994527882068	0	0	2.59649122807018	3.38392712379382	CD200R1;HLA-DRB1
Schizophrenia, bipolar disorder and depression (combined)	2/5	0.271642278696132	0.999994527882068	0	0	2.59649122807018	3.38392712379382	IFT88;ANXA1
Spontaneous preterm birth (preterm birth)	2/5	0.271642278696132	0.999994527882068	0	0	2.59649122807018	3.38392712379382	RNASET2;SORL1
Suffering from nerves	2/5	0.271642278696132	0.999994527882068	0	0	2.59649122807018	3.38392712379382	DENND1A;ACP2
Suicide behavior	2/5	0.271642278696132	0.999994527882068	0	0	2.59649122807018	3.38392712379382	RNF31;STK3
Thiopurine-induced leukopenia in inflammatory bowel disease	2/5	0.271642278696132	0.999994527882068	0	0	2.59649122807018	3.38392712379382	SUCLA2;MED4
Thyroid function	2/5	0.271642278696132	0.999994527882068	0	0	2.59649122807018	3.38392712379382	CAPZB;NR3C2
Urinary metabolite ratios in chronic kidney disease	2/5	0.271642278696132	0.999994527882068	0	0	2.59649122807018	3.38392712379382	ALMS1;THEM4
Vestibular neuritis	2/5	0.271642278696132	0.999994527882068	0	0	2.59649122807018	3.38392712379382	MED30;NR3C2
High density lipoprotein cholesterol levels	17/71	0.272351848515618	0.999994527882068	0	0	1.22669487669488	1.59551355682126	TRIO;CCDC149;IKZF1;RLF;UBE2L3;STK10;RILPL2;UBC;EXOC6;PPARG;JHY;CD36;INTS9;TMED5;FADS1;HLA-DQA1;HLA-DRB1
Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	3/9	0.273332490228743	0.999994527882068	0	0	1.94747796278159	2.52600805874167	LRIG1;CRYL1;FLNB
Bladder cancer (smoking interaction)	3/9	0.273332490228743	0.999994527882068	0	0	1.94747796278159	2.52600805874167	INSIG1;TAGAP;FMN1
Bone mineral density (paediatric, lower limb)	3/9	0.273332490228743	0.999994527882068	0	0	1.94747796278159	2.52600805874167	FUBP3;RIN3;FAM3C
Cerebrospinal fluid t-tau levels in Alzheimer's disease dementia	3/9	0.273332490228743	0.999994527882068	0	0	1.94747796278159	2.52600805874167	C5ORF22;GOLIM4;DROSHA
Chronic hepatitis C infection	3/9	0.273332490228743	0.999994527882068	0	0	1.94747796278159	2.52600805874167	DEPDC5;HLA-DQA1;HLA-DQB1
Chronic obstructive pulmonary disease (moderate to severe)	3/9	0.273332490228743	0.999994527882068	0	0	1.94747796278159	2.52600805874167	FAM13A;SCLT1;RIN3
Clozapine-induced cytotoxicity	3/9	0.273332490228743	0.999994527882068	0	0	1.94747796278159	2.52600805874167	PCMTD2;MDFIC;B4GALT4
Diffuse cutaneous systemic sclerosis	3/9	0.273332490228743	0.999994527882068	0	0	1.94747796278159	2.52600805874167	DDX6;IRF5;TNPO3
Economic and political preferences	3/9	0.273332490228743	0.999994527882068	0	0	1.94747796278159	2.52600805874167	PCM1;CD200R1;ACBD4
Food antigen IgG levels	3/9	0.273332490228743	0.999994527882068	0	0	1.94747796278159	2.52600805874167	CREB1;GPR65;HLA-DRA
Glucocorticoid-induced osteonecrosis	3/9	0.273332490228743	0.999994527882068	0	0	1.94747796278159	2.52600805874167	KLF12;CCND2;PCSK5
High altitude adaptation	3/9	0.273332490228743	0.999994527882068	0	0	1.94747796278159	2.52600805874167	EGLN1;MTHFR;HLA-DQB1
Idiopathic intracranial hypertension	3/9	0.273332490228743	0.999994527882068	0	0	1.94747796278159	2.52600805874167	RPH3AL;PARP4;FOXN3
Left ventricular obstructive tract defect (inherited effect)	3/9	0.273332490228743	0.999994527882068	0	0	1.94747796278159	2.52600805874167	MGAT4A;FLI1;CAMKK2
Type 1 diabetes in high risk HLA genotype individuals (time to event)	3/9	0.273332490228743	0.999994527882068	0	0	1.94747796278159	2.52600805874167	PPIL2;PLEKHA1;RNASET2
Testicular germ cell tumor	21/90	0.284353292788541	0.999994527882068	0	0	1.18595350627687	1.4913813931212	MAP2K1;PIK3CD;GAB2;TYMS;GSPT1;CLCN6;RSL1D1;MCM3AP;RAD51C;ENOSF1;ZNF638;KATNA1;RFWD3;G3BP2;SMARCAD1;TNFRSF17;BAK1;CLPTM1L;SLC25A44;PDE8A;LHPP
Lung function (FEV1)	16/67	0.284572810816135	0.999994527882068	0	0	1.2223811656817	1.5362472501802	CDC123;MAP3K1;AHNAK;GSTCD;TET2;AP3B1;SMARCA2;DCBLD2;NCOR2;RPUSD4;CCDC91;CFDP1;KANSL1;ZKSCAN3;ME3;HLA-DQB1
Lung function (FVC)	16/67	0.284572810816135	0.999994527882068	0	0	1.2223811656817	1.5362472501802	MED1;CDC123;SMAD3;CRADD;ARL15;GSTCD;AP3B1;ETS1;SMARCA2;DCBLD2;EDAR;CCDC91;KANSL1;PDXDC2P;ZKSCAN3;CDK12
Asthma and hay fever	6/22	0.285012099626756	0.999994527882068	0	0	1.46076329331046	1.83358462519576	TLR1;SMAD3;IL2RA;CLEC16A;XKR6;HLA-DQB1
Glomerular filtration rate (creatinine)	19/81	0.288876145028236	0.999994527882068	0	0	1.19409157230311	1.48277186306583	BCAS3;WDR37;ARL15;PRKAG2;NFATC1;PIK3R1;THADA;INO80;AP5B1;SIPA1L3;NFKB1;SLC7A6;GATM;UBE2Q2;KCNQ1;KBTBD2;ALMS1;CDK12;SDCCAG8
Chronotype	8/31	0.29087933085387	0.999994527882068	0	0	1.35497830883529	1.6731905859384	POLR2J3;RNF10;LMAN1;RASA4;SGSM3;FKBP1B;TARS2;TNRC6B
Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)	25/109	0.292315229014203	0.999994527882068	0	0	1.15977644134956	1.42643514899071	PRAG1;TNKS;NEDD9;STK19;LSP1;COX5A;DYNC2LI1;ATXN2;ERI1;RSRC1;DPYSL2;AKT3;POC1B;CEP170;SH2B3;MTHFR;PTPN11;ARID1B;SLC4A7;INPP4B;CLCN6;CFDP1;TERF2IP;ASB3;SDCCAG8
Hand grip strength	35/156	0.295832742692894	0.999994527882068	0	0	1.12732820441696	1.37304183546756	ADPGK;PLEKHB1;ITPR1;OLA1;HSD17B12;ANTXR2;AFF3;ACTG1;SMARCAD1;CIR1;KNTC1;FAM3C;TRIM27;CCDC92;PGPEP1;TRMT1L;HLA-DQA1;BPTF;HLA-DRB5;KDM2B;SFMBT1;FBXL17;WWP2;HLA-A;KCTD3;GTPBP1;LRPPRC;PRRC2A;MLLT10;GNPDA2;KANSL1;ZFP64;LCORL;HLA-DRB1;TNRC6B
Hemoglobin concentration	29/128	0.297782014208787	0.999994527882068	0	0	1.14154357771903	1.38285853404944	HBS1L;PMS2CL;POP7;PVT1;POMP;GMPR;PRKAG2;ABO;C12ORF43;HK1;PTBP1;PSD4;LUC7L;PIEZO1;KCNN4;SBF2;SH2B3;ZNF641;EGLN1;UVRAG;BCAS3;ATP2B4;AP3D1;HLA-A;RAB11A;PRKAR1B;NDUFAF6;EXOC3;PPARG
Food allergy	5/18	0.300114980767239	0.999994527882068	0	0	1.49813439867335	1.80313899442563	CHCHD3;EXOC4;SLC39A10;ITGA6;SSBP3
JT interval (sulfonylurea treatment interaction)	5/18	0.300114980767239	0.999994527882068	0	0	1.49813439867335	1.80313899442563	NFIA;STAT1;HSD17B4;ME3;FARS2
Lead levels in blood	5/18	0.300114980767239	0.999994527882068	0	0	1.49813439867335	1.80313899442563	ALAD;CAPZB;PEPD;ABO;BSPRY
Plasma omega-3 polyunsaturated fatty acid level (eicosapentaenoic acid)	5/18	0.300114980767239	0.999994527882068	0	0	1.49813439867335	1.80313899442563	NFIA;MAT2B;FADS1;RUNX1;BEST1
Potassium levels	5/18	0.300114980767239	0.999994527882068	0	0	1.49813439867335	1.80313899442563	PRDM8;SPPL2A;PPARG;LSP1;CLASP1
Retinal vascular caliber	5/18	0.300114980767239	0.999994527882068	0	0	1.49813439867335	1.80313899442563	ATXN2;MTMR9;PTPN11;SH2B3;XKR6
Lead levels	11/45	0.304987909019592	0.999994527882068	0	0	1.26038359406569	1.49668427509404	ATP6AP1L;IVNS1ABP;TTLL5;TESPA1;SWT1;ITPR1;MLYCD;MKI67;PCSK5;SMARCA2;RUNX3
Seasonality and depression	7/27	0.306687758121802	0.999994527882068	0	0	1.36337009803922	1.61140137148487	GSTM4;FGGY;ZBTB20;UBE2E2;QKI;CAMKMT;MPHOSPH6
Activated partial thromboplastin time	9/36	0.307117032363973	0.999994527882068	0	0	1.29851234265163	1.5329280897033	PRELID1;ADAMTS13;RFC4;LMAN2;NSD1;GRK6;UIMC1;PLXDC2;ABO
Total body bone mineral density	9/36	0.307117032363973	0.999994527882068	0	0	1.29851234265163	1.5329280897033	RERE;DUSP5;DGKD;ATXN1;CSF1;APC;PSMD13;FAM3C;CD44
Myocardial infarction	14/59	0.311681644521302	0.999994527882068	0	0	1.21205772430914	1.41298414790116	BCAS3;SMAD3;RNF13;YTHDF3;CDKN2A;EIF4A3;ITGA1;PLCL2;AP3D1;MIA3;ABO;IL6R;SH2B3;LDLR
Common carotid intima-media thickness	4/14	0.316818225549533	0.999994527882068	0	0	1.55797207935342	1.7907753143339	EXT1;MED30;MAT2B;SLU7
Cutaneous squamous cell carcinoma	4/14	0.316818225549533	0.999994527882068	0	0	1.55797207935342	1.7907753143339	SEC16A;BUD13;LPP;CNTLN
Hepatocellular carcinoma	4/14	0.316818225549533	0.999994527882068	0	0	1.55797207935342	1.7907753143339	GLB1;MICA;HLA-DQA1;HLA-DRB1
Mammographic density (dense area)	4/14	0.316818225549533	0.999994527882068	0	0	1.55797207935342	1.7907753143339	SGSM3;LSP1;PLA2G6;TNRC6B
Moderate to vigorous physical activity levels	4/14	0.316818225549533	0.999994527882068	0	0	1.55797207935342	1.7907753143339	EXOC4;PBX2;PAX5;HLA-DQB1
Myocardial infarction (early onset)	4/14	0.316818225549533	0.999994527882068	0	0	1.55797207935342	1.7907753143339	CDKN2A;MIA3;WDR12;LDLR
Neurofibrillary tangles	4/14	0.316818225549533	0.999994527882068	0	0	1.55797207935342	1.7907753143339	KLF12;ITGA4;RASSF5;HLA-DRB1
Obstetric antiphospholipid syndrome	4/14	0.316818225549533	0.999994527882068	0	0	1.55797207935342	1.7907753143339	C1D;HLA-DRA;GATA3;PTBP3
Response to Vitamin E supplementation	4/14	0.316818225549533	0.999994527882068	0	0	1.55797207935342	1.7907753143339	SIK3;BRAF;BUD13;CD44
Response to quetiapine in schizophrenia	4/14	0.316818225549533	0.999994527882068	0	0	1.55797207935342	1.7907753143339	RGS2;PIGO;DNAJB5;GALNT10
HDL cholesterol	52/238	0.317262209818479	0.999994527882068	0	0	1.08966436156747	1.25096376662838	TNFAIP8;ACAA2;RAB3D;FAM13A;PDE3B;SNX13;IKZF1;UBE3B;PEPD;UBE2L3;LACTB;UBASH3B;TOM1;AKT1;ACP2;CD36;CCDC92;JAK2;FADS1;MAP3K5;STARD3;PLA2G12A;ARL15;RUNX1;POC5;NPC1;SIK3;TMEM106B;PPARG;AGPAT5;MACF1;TOMM40;TRANK1;ARNTL;LILRA5;PGS1;ATXN2;ALOX5;VPS53;ATG7;BPTF;CNTLN;UVRAG;MMAB;EDEM2;LILRB2;SCAF1;SULF2;TTC39B;STAG1;HDGF;SIPA1
Childhood ear infection	10/41	0.320877017172663	0.999994527882068	0	0	1.25661658240167	1.42839274337361	HLA-DRB5;HLA-H;SLC25A39;HLA-A;HLA-G;ABO;HLA-DQA1;HLA-DRB1;DCBLD2;HLA-DQB1
Body fat percentage	6/23	0.324387710005507	0.999994527882068	0	0	1.37474955676953	1.54771483084988	TOMM40;WDR41;PICK1;DYM;PLA2G6;TUFM
Osteoarthritis (hip)	6/23	0.324387710005507	0.999994527882068	0	0	1.37474955676953	1.54771483084988	SENP6;SMAD3;NCOA3;IFRD1;HDAC9;RUNX2
Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	6/23	0.324387710005507	0.999994527882068	0	0	1.37474955676953	1.54771483084988	AHNAK;PDXDC1;RPL7L1;NTAN1;FADS1;BEST1
Depression	16/69	0.329079727749502	0.999994527882068	0	0	1.17610526364576	1.30718833924085	RERE;DENND1B;CCDC122;SLC30A9;NUFIP2;DENND1A;DLST;TCAIM;ELP4;SYNE2;CPPED1;RSRC1;GPD2;MYO18A;TMEM106B;DHX38
Acute graft versus host disease in bone marrow transplantation (recipient effect)	3/10	0.335357320956197	0.999994527882068	0	0	1.66916188610606	1.82365731680899	CUL3;HLA-DPB1;PTK2
Amyotrophic lateral sclerosis (age of onset)	3/10	0.335357320956197	0.999994527882068	0	0	1.66916188610606	1.82365731680899	IFRD1;PCSK5;ST3GAL3
Coagulation factor levels	3/10	0.335357320956197	0.999994527882068	0	0	1.66916188610606	1.82365731680899	ADAMTS13;SURF6;ABO
Endometrial endometrioid carcinoma	3/10	0.335357320956197	0.999994527882068	0	0	1.66916188610606	1.82365731680899	KLF12;AKT1;NCOA7
Epstein-Barr virus immune response (EBNA-1)	3/10	0.335357320956197	0.999994527882068	0	0	1.66916188610606	1.82365731680899	HLA-B;HLA-DRB1;HLA-DQB1
Erythrocyte cadmium concentration in never smokers	3/10	0.335357320956197	0.999994527882068	0	0	1.66916188610606	1.82365731680899	LACTB2;ATP6V1B2;MBP
Laryngeal squamous cell carcinoma	3/10	0.335357320956197	0.999994527882068	0	0	1.66916188610606	1.82365731680899	VCAN;AIF1;FADS1
N-glycan levels	3/10	0.335357320956197	0.999994527882068	0	0	1.66916188610606	1.82365731680899	SLC9A9;C12ORF43;OASL
Plasminogen activator inhibitor type 1 levels (PAI-1)	3/10	0.335357320956197	0.999994527882068	0	0	1.66916188610606	1.82365731680899	PPARG;SLC12A9;ARNTL
Response to selective serotonin reuptake inhibitors in depression	3/10	0.335357320956197	0.999994527882068	0	0	1.66916188610606	1.82365731680899	PREX1;ACAA2;EXOC4
Seasonality	3/10	0.335357320956197	0.999994527882068	0	0	1.66916188610606	1.82365731680899	POLR2M;PVT1;FXN
Superior frontal gyrus grey matter volume	3/10	0.335357320956197	0.999994527882068	0	0	1.66916188610606	1.82365731680899	STIM2;NFE2L3;SMARCA2
vWF and FVIII levels	3/10	0.335357320956197	0.999994527882068	0	0	1.66916188610606	1.82365731680899	LBH;VPS8;SAFB2
Methadone dose in opioid dependence	9/37	0.33836220949524	0.999994527882068	0	0	1.25205808169271	1.35677813065484	MS4A6A;MAML2;GRK5;STK24;UQCRFS1;LSP1;MAT2B;ZNF146;LZTFL1
Myeloid white cell count	31/140	0.339161065657987	0.999994527882068	0	0	1.10816459475599	1.19823639531123	HBS1L;IFITM2;DOCK8;LY75;PTPN22;THADA;ETS1;RCBTB1;ABO;BCL2L13;ATXN1;CHSY1;NLRP3;PMPCA;S1PR4;SH2B3;FADS1;LYN;SPHK2;PCGF3;PLAUR;TBC1D8;TADA2B;NPC1;RAB37;RASA2;RIN3;PIGL;CRK;CSNK1G1;SPC25
Coronary artery disease in type 1 diabetes	5/19	0.344564795045862	0.999994527882068	0	0	1.3910373066424	1.48211286178899	SMAD2;ARL5B;NUP210;MAP1B;PAX5
Coronary artery disease or ischemic stroke	5/19	0.344564795045862	0.999994527882068	0	0	1.3910373066424	1.48211286178899	PEMT;WDR12;SH2B3;LDLR;ABO
Liver enzyme levels	5/19	0.344564795045862	0.999994527882068	0	0	1.3910373066424	1.48211286178899	POU2F1;ADAMTS13;REEP3;ABO;C12ORF43
Mean corpuscular hemoglobin	72/336	0.345224703291572	0.999994527882068	0	0	1.06299105626627	1.13055451276443	HBS1L;BTG2;TRAF3IP3;TFRC;PDCD5;IKZF1;CTDSPL2;HMGB1;CHTF18;UBE2L3;HK1;CHAF1A;SLK;CCND2;ZMIZ2;FNTB;LUC7L;KAT7;FBXO7;RAB8A;ILKAP;TPM3;HLA-B;TMC6;WIPI2;CBFA2T3;KLF16;SLC7A5;PSMA3;FAM234A;RRM2B;TBC1D4;XRN2;RASA2;GCDH;FECH;PVT1;GMPR;PIK3R1;THADA;TYMS;ABO;TIMM23B;PSMB5;NDOR1;RMND5A;DPP8;ERI1;EXOSC9;ALOX5;TBX21;LRIG1;MARK3;SH2B3;RBM38;CD164;RRM1;PLCL2;RRP1B;PTK2;RAB11A;QKI;RCL1;RAB10;CLCN6;KANSL1;SP1;BCL2;ANP32B;CRLF3;ATR;TNRC6B
Blond vs. brown/black hair color	35/160	0.355081902054431	0.999994527882068	0	0	1.09097729516288	1.12960531671626	HDAC4;CD82;AHNAK;TCF25;WIPF2;DOCK8;LEF1;SYNE2;NR3C2;AKAP1;KIAA0930;DSTYK;CCND2;AFG3L1P;ERMP1;ZMIZ1;ATXN7L1;TMEM38B;MARK3;SLC12A9;MAP3K1;TBCD;TET2;CDKAL1;GAB2;THNSL2;PPFIBP2;NFIA;MSH5;UTS2;PLXNB2;TACC1;ATXN10;SGK1;EXOC2
Body mass index (change over time) in chronic obstructive pulmonary disease	2/6	0.355330205392244	0.999994527882068	0	0	1.94724602203182	2.0148305809181	HHAT;JAKMIP2
Chronic obstructive pulmonary disease (severe)	2/6	0.355330205392244	0.999994527882068	0	0	1.94724602203182	2.0148305809181	FAM13A;RIN3
Corrected insulin response	2/6	0.355330205392244	0.999994527882068	0	0	1.94724602203182	2.0148305809181	CDKAL1;C12ORF75
Corrected insulin response adjusted for insulin sensitivity index	2/6	0.355330205392244	0.999994527882068	0	0	1.94724602203182	2.0148305809181	CDKAL1;C12ORF75
Cytomegalovirus antibody response	2/6	0.355330205392244	0.999994527882068	0	0	1.94724602203182	2.0148305809181	CD53;MCPH1
Depression and alcohol dependence	2/6	0.355330205392244	0.999994527882068	0	0	1.94724602203182	2.0148305809181	SPATA13;WDR7
EGFR mutation-positive lung adenocarcinoma	2/6	0.355330205392244	0.999994527882068	0	0	1.94724602203182	2.0148305809181	HLA-DPB1;BPTF
Egg allergy (maternal genetic effects)	2/6	0.355330205392244	0.999994527882068	0	0	1.94724602203182	2.0148305809181	TAF1B;ZNF652
Event free survival in diffuse large B-cell lymphoma treated with immunochemotherapy	2/6	0.355330205392244	0.999994527882068	0	0	1.94724602203182	2.0148305809181	HDAC2;SNX2
Eye color traits	2/6	0.355330205392244	0.999994527882068	0	0	1.94724602203182	2.0148305809181	NPLOC4;HGS
Glycemic traits	2/6	0.355330205392244	0.999994527882068	0	0	1.94724602203182	2.0148305809181	OAS1;CDKAL1
Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)	2/6	0.355330205392244	0.999994527882068	0	0	1.94724602203182	2.0148305809181	CDKN2A;ANKRD44
Mean diameter of HDL particles	2/6	0.355330205392244	0.999994527882068	0	0	1.94724602203182	2.0148305809181	SYS1;ACAA2
Neutrophil count in HIV-infection	2/6	0.355330205392244	0.999994527882068	0	0	1.94724602203182	2.0148305809181	IFI16;PYHIN1
Otitis media	2/6	0.355330205392244	0.999994527882068	0	0	1.94724602203182	2.0148305809181	SERTAD1;PLD3
Otitis media (chronic)	2/6	0.355330205392244	0.999994527882068	0	0	1.94724602203182	2.0148305809181	SERTAD1;PLD3
Otitis media (recurrent)	2/6	0.355330205392244	0.999994527882068	0	0	1.94724602203182	2.0148305809181	SERTAD1;PLD3
Parental lifespan	2/6	0.355330205392244	0.999994527882068	0	0	1.94724602203182	2.0148305809181	HLA-DQA1;HLA-DRB1
Peanut allergy (maternal genetic effects)	2/6	0.355330205392244	0.999994527882068	0	0	1.94724602203182	2.0148305809181	MRPL42;FAM118A
Reading and spelling	2/6	0.355330205392244	0.999994527882068	0	0	1.94724602203182	2.0148305809181	DAZAP1;PRKCH
Remission after SSRI treatment in MDD or openness	2/6	0.355330205392244	0.999994527882068	0	0	1.94724602203182	2.0148305809181	SNX29;GBP1
Response to mTOR inhibitor (everolimus)	2/6	0.355330205392244	0.999994527882068	0	0	1.94724602203182	2.0148305809181	USP10;PBX3
Response to mTOR inhibitor (rapamycin)	2/6	0.355330205392244	0.999994527882068	0	0	1.94724602203182	2.0148305809181	MCTP2;APBA2
Retinal arteriolar caliber	2/6	0.355330205392244	0.999994527882068	0	0	1.94724602203182	2.0148305809181	MXRA7;MFSD11
Schizophrenia or bipolar disorder	2/6	0.355330205392244	0.999994527882068	0	0	1.94724602203182	2.0148305809181	TRANK1;PIK3C2A
Tandem gait	2/6	0.355330205392244	0.999994527882068	0	0	1.94724602203182	2.0148305809181	MANSC1;GPHN
Urate levels (BMI interaction)	8/33	0.357792013054566	0.999994527882068	0	0	1.24642314292719	1.28107798219344	DDX18;MAP3K1;PTER;ERAP2;ERAP1;RFTN1;TNFRSF1B;GPR155
Coronary artery disease or large artery stroke	6/24	0.364422747202708	0.999994527882068	0	0	1.29829290206649	1.31054968525604	PEMT;WDR12;HDAC9;SH2B3;LDLR;ABO
Bone mineral density (paediatric, total body less head)	4/15	0.368185143928806	0.999994527882068	0	0	1.41624919288402	1.41507279799413	FUBP3;PPP6R3;RIN3;FAM3C
Bone ultrasound measurement (velocity of sound)	4/15	0.368185143928806	0.999994527882068	0	0	1.41624919288402	1.41507279799413	CCDC91;GPATCH1;VRK1;SPTBN1
Neonatal cytokine/chemokine levels (fetal genetic effect)	4/15	0.368185143928806	0.999994527882068	0	0	1.41624919288402	1.41507279799413	CCL24;PLCL2;FBXO25;FOXN3
Prostate cancer (advanced)	4/15	0.368185143928806	0.999994527882068	0	0	1.41624919288402	1.41507279799413	TOR1A;BCL2L11;PPFIBP2;LARP4B
Psychosis (atypical)	4/15	0.368185143928806	0.999994527882068	0	0	1.41624919288402	1.41507279799413	PVT1;UBE2E2;TNF;RASGRP1
Neuroticism	31/142	0.371539001869155	0.999994527882068	0	0	1.08805995344457	1.07728972180672	MTCH2;PRR3;CTNND1;ZDHHC5;MSMO1;DCAF5;TOB2;MAP1LC3B;ERI1;RSRC1;C22ORF46;ACP2;ZNF621;SBF2;ARRDC4;PDCD6IP;TMEM192;KLHL2;PRKCA;SLC39A13;ARHGAP27;HLA-E;FBXO31;PPP5C;TMX2;TRIM39;KANSL1;TMEM106B;XKR6;CSNK1G1;PAFAH1B1
Lung adenocarcinoma	27/123	0.372296568228003	0.999994527882068	0	0	1.09569735221675	1.08261967389732	PARM1;DCTN4;LPCAT1;TFPI;AQP3;SLK;TBK1;CEACAM21;FAM3C;SBF2;HLA-DQA1;BPTF;CNTLN;ACTR2;TLE1;RNASET2;HLA-A;HLA-G;MORF4L1;MTAP;RAB31;COPS2;NAF1;CLPTM1L;HLA-DRB1;GALK2;MPHOSPH6
Fractures	7/29	0.379653971393507	0.999994527882068	0	0	1.23927139037433	1.20022819814644	RPS6KA5;STARD3NL;FUBP3;PPP6R3;CTNNB1;FGFRL1;SPTBN1
Mild influenza (H1N1) infection	10/43	0.380513313691207	0.999994527882068	0	0	1.18030934807977	1.1404551551842	L3MBTL3;B4GALT1;TFDP1;TUBGCP2;BRAF;ESYT2;GHITM;GATA3;ACSL3;CEP128
Glaucoma (primary open-angle)	17/76	0.381388465536667	0.999994527882068	0	0	1.12238370882439	1.0819069928738	DGKD;PNPT1;TCF12;PRKAG2;TMEM181;TMTC2;LPP;MPP7;TMCO1;LSM8;ATXN2;FAM120B;BNIP1;EXOC6;EXOC2;LRP12;GAS7
Cardiovascular disease risk factors	5/20	0.389365505119373	0.999994527882068	0	0	1.29821982688225	1.22452868231315	TOMM40;WDR1;PCSK7;LDLR;OASL
Carotid intima media thickness	5/20	0.389365505119373	0.999994527882068	0	0	1.29821982688225	1.22452868231315	ZHX2;LRIG1;LDLR;NEK11;GBP3
Nasopharyngeal carcinoma	5/20	0.389365505119373	0.999994527882068	0	0	1.29821982688225	1.22452868231315	CDKN2A;HLA-B;HLA-A;CLPTM1L;HLA-F
Renal function-related traits (BUN)	5/20	0.389365505119373	0.999994527882068	0	0	1.29821982688225	1.22452868231315	BCAS3;PAX8;GBA;LRIG1;LPP
Total bilirubin levels	5/20	0.389365505119373	0.999994527882068	0	0	1.29821982688225	1.22452868231315	AUH;SLC22A18;EXOC6;HLA-DQA1;HLA-DRB1
Insulin resistance/response	3/11	0.39704860355781	0.999994527882068	0	0	1.46042482859941	1.34898941761234	ZFAND3;ATP10A;AP3B1
LDL peak particle diameter (total fat intake interaction)	3/11	0.39704860355781	0.999994527882068	0	0	1.46042482859941	1.34898941761234	NBAS;FNBP1;OPRL1
Lateral ventricular volume in normal aging	3/11	0.39704860355781	0.999994527882068	0	0	1.46042482859941	1.34898941761234	MLLT10;GNA12;TRIOBP
Non-alcoholic fatty liver disease histology (other)	3/11	0.39704860355781	0.999994527882068	0	0	1.46042482859941	1.34898941761234	SLC9A9;LCP1;FDFT1
Parental longevity (combined parental age at death)	3/11	0.39704860355781	0.999994527882068	0	0	1.46042482859941	1.34898941761234	ATXN2;FPGT;SH2B3
Protein C levels	3/11	0.39704860355781	0.999994527882068	0	0	1.46042482859941	1.34898941761234	MAP3K2;EDEM2;SAYSD1
Upper eyelid sagging severity	3/11	0.39704860355781	0.999994527882068	0	0	1.46042482859941	1.34898941761234	ATP8A1;SMYD3;TTC27
Endometrial cancer (endometrioid histology)	9/39	0.402055046938856	0.999994527882068	0	0	1.16844041196665	1.06464348844648	EEFSEC;KLF12;CDKN2A;RUVBL1;NF1;NCOA7;PPARG;SH2B3;BPTF
Restless legs syndrome	9/39	0.402055046938856	0.999994527882068	0	0	1.16844041196665	1.06464348844648	CCDC167;SMAD3;CRBN;C1D;APLF;DPH6;PKP4;BTBD9;MAP2K5
Systolic blood pressure x smoking status (ever vs never) interaction (2df test)	21/96	0.402344931327002	0.999994527882068	0	0	1.09066404328578	0.992990192187893	SETD3;PRAG1;TNKS;MTHFR;STK19;PTPN11;LSP1;AP5B1;COX5A;DYNC2LI1;SLC4A7;INPP4B;CLCN6;ATXN2;CFDP1;RSRC1;ERI1;CD5;TERF2IP;POC1B;SH2B3
Waist-hip ratio	13/58	0.404531919872613	0.999994527882068	0	0	1.12520591283478	1.01833906907175	TNFAIP8;TOMM40;MAP3K1;QPCTL;ITPR2;HSD17B4;PEPD;WARS2;PCM1;ZFP64;NFE2L3;PEMT;PPARG
Alzheimer's disease biomarkers	6/25	0.40466199845065	0.999994527882068	0	0	1.22988431627955	1.11268019299883	TOMM40;ITGA1;ITGA6;PIK3R1;C12ORF75;ARID1B
Anger	6/25	0.40466199845065	0.999994527882068	0	0	1.22988431627955	1.11268019299883	ARFGEF2;PPP1R11;CSE1L;PLEK;ABAT;HIPK3
Antineutrophil cytoplasmic antibody-associated vasculitis	6/25	0.40466199845065	0.999994527882068	0	0	1.22988431627955	1.11268019299883	TSC22D1;KATNAL1;HLA-DPB1;PTPN22;HLA-DQA1;HLA-DPA1
Facial emotion recognition (sad faces)	6/25	0.40466199845065	0.999994527882068	0	0	1.22988431627955	1.11268019299883	PTCD3;ZNF394;SMURF1;POLR1A;ARPC1B;MRPL35
Breast cancer (estrogen-receptor negative)	7/30	0.416488142359789	0.999994527882068	0	0	1.18531543052003	1.03821457043021	L3MBTL3;KLF12;TNFSF10;MDM4;LSP1;WDR43;RPL23AP53
C-reactive protein levels	7/30	0.416488142359789	0.999994527882068	0	0	1.18531543052003	1.03821457043021	IRF1;NLRP3;PSMG1;IL6R;ARHGAP12;C12ORF43;OASL
Pubertal anthropometrics	7/30	0.416488142359789	0.999994527882068	0	0	1.18531543052003	1.03821457043021	ZNF483;TAP2;HLA-DRA;NUCKS1;TMEM38B;MICA;MAPK3
Toenail selenium levels	7/30	0.416488142359789	0.999994527882068	0	0	1.18531543052003	1.03821457043021	DYNC2H1;DCUN1D5;KYNU;ARHGAP15;MYOM2;ARSB;SDCCAG8
Very long-chain saturated fatty acid levels (fatty acid 20:0)	7/30	0.416488142359789	0.999994527882068	0	0	1.18531543052003	1.03821457043021	NPEPPS;SEC14L1;CLPTM1;ATG4C;PPARA;SAMSN1;C12ORF43
Sum basophil neutrophil counts	30/140	0.4179831800696	0.999994527882068	0	0	1.06233894279248	0.926693224260045	HBS1L;IFITM2;DOCK8;SPPL2A;PTPN22;THADA;ETS1;RCBTB1;ABO;ATXN1;CHSY1;NLRP3;PMPCA;S1PR4;SH2B3;LYN;BRD3;TRAP1;PCGF3;PLAUR;TADA2B;NPC1;RAB37;RASA2;DRG1;IRF8;RIN3;PIGL;CRK;SPC25
BRCA1/2-negative high-risk breast cancer	4/16	0.419275758741734	0.999994527882068	0	0	1.29814678749286	1.12838351083828	SIAH2;SLC39A11;ITPR2;DCAF12
Eating disorders (purging via substances)	4/16	0.419275758741734	0.999994527882068	0	0	1.29814678749286	1.12838351083828	NCL;PDE6D;FLNB;DNASE1L3
Esophageal squamous cell carcinoma	4/16	0.419275758741734	0.999994527882068	0	0	1.29814678749286	1.12838351083828	CASP8;CDKN2A;CCDC117;RUNX1
Glioblastoma	4/16	0.419275758741734	0.999994527882068	0	0	1.29814678749286	1.12838351083828	RTEL1;POLR3B;CDKN2A;LMF1
Progressive supranuclear palsy	4/16	0.419275758741734	0.999994527882068	0	0	1.29814678749286	1.12838351083828	SP1;BMS1;STX6;RUNX2
Stearic acid (18:0) levels	4/16	0.419275758741734	0.999994527882068	0	0	1.29814678749286	1.12838351083828	LPGAT1;ALG14;MCTP2;FADS1
White blood cell count	48/227	0.420925040027366	0.999994527882068	0	0	1.04460836453517	0.903900154076197	RERE;HBS1L;IFITM2;NUP107;WDR26;CSF1;BCL2A1;PVT1;DOCK8;CCDC69;LY75;PTPN22;ARHGAP15;ETS1;BACH2;ABO;CNN2;SBNO2;ATXN1;MXI1;FAM53B;NLRP3;PMPCA;CCDC92;PAK2;S1PR4;SH2B3;FADS1;LYN;TRAP1;CCDC12;ITGA4;CDKN2A;PCGF3;HLA-B;PLAUR;EPS15L1;LSS;RABEP1;ARPC2;NPC1;RAB37;RASA2;FAM76B;RIN3;PIGL;SPC25;FKBP5
Pulmonary function (smoking interaction)	12/54	0.424853076073707	0.999994527882068	0	0	1.11277826468011	0.952551406786016	ADAM19;HDAC4;CDC123;CFDP1;VAPA;GSTCD;FAM13A;ITGA1;AGER;KCNJ2;HLA-DQB1;PPARD
Adult asthma	5/21	0.433925170711199	0.999994527882068	0	0	1.21700453209211	1.01605661074055	OAS2;CLEC16A;TMTC2;MOB3B;SEC31A
DNA methylation (variation)	5/21	0.433925170711199	0.999994527882068	0	0	1.21700453209211	1.01605661074055	FIP1L1;SLCO3A1;TRIM5;THADA;MRPL23
Heart rate response to exercise	5/21	0.433925170711199	0.999994527882068	0	0	1.21700453209211	1.01605661074055	PPIL1;HLA-DRB5;NDUFA11;MCTP2;HLA-DRB1
Obesity (early onset extreme)	5/21	0.433925170711199	0.999994527882068	0	0	1.21700453209211	1.01605661074055	PRKCH;TNKS;PACS1;FARS2;SDCCAG8
Selective IgA deficiency	9/40	0.43406016896537	0.999994527882068	0	0	1.13067759338069	0.943631991985656	CD86;PFKFB3;MAST4;PVT1;IL2RA;CLEC16A;MYO9B;GATA3;HLA-DQA1
Asthma (sex interaction)	2/7	0.435237651541832	0.999994527882068	0	0	1.55769889840881	1.29579219040053	RAP1GAP2;IRF1
Birth length	2/7	0.435237651541832	0.999994527882068	0	0	1.55769889840881	1.29579219040053	HSD17B12;LCORL
Childhood and early adolescence aggressive behavior	2/7	0.435237651541832	0.999994527882068	0	0	1.55769889840881	1.29579219040053	PDSS2;TRIM27
Childhood steroid-sensitive nephrotic syndrome	2/7	0.435237651541832	0.999994527882068	0	0	1.55769889840881	1.29579219040053	HLA-DRB1;HLA-DQB1
Cholesterol efflux capacity	2/7	0.435237651541832	0.999994527882068	0	0	1.55769889840881	1.29579219040053	PPP1CB;CDKAL1
Clinical laboratory measurements	2/7	0.435237651541832	0.999994527882068	0	0	1.55769889840881	1.29579219040053	TCF7L2;ABO
Cystic fibrosis severity	2/7	0.435237651541832	0.999994527882068	0	0	1.55769889840881	1.29579219040053	APIP;HLA-DRA
Depressive and manic episodes in bipolar disorder	2/7	0.435237651541832	0.999994527882068	0	0	1.55769889840881	1.29579219040053	NFYC;ETS1
Depressive episodes in bipolar disorder	2/7	0.435237651541832	0.999994527882068	0	0	1.55769889840881	1.29579219040053	ETS1;KCNJ2
Exhaled carbon monoxide levels in smokers with chronic obstructive pulmonary disease	2/7	0.435237651541832	0.999994527882068	0	0	1.55769889840881	1.29579219040053	CEP70;MNAT1
Exploratory eye movement dysfunction in schizophrenia (responsive search score)	2/7	0.435237651541832	0.999994527882068	0	0	1.55769889840881	1.29579219040053	MAN2A1;TAF8
Influenza A (H1N1) severity	2/7	0.435237651541832	0.999994527882068	0	0	1.55769889840881	1.29579219040053	ZFYVE28;MAML2
Lean body mass	2/7	0.435237651541832	0.999994527882068	0	0	1.55769889840881	1.29579219040053	KLF12;VCAN
Lung function (forced vital capacity)	2/7	0.435237651541832	0.999994527882068	0	0	1.55769889840881	1.29579219040053	HSD17B12;KCNJ2
Menarche and menopause (age at onset)	2/7	0.435237651541832	0.999994527882068	0	0	1.55769889840881	1.29579219040053	TRMT6;UIMC1
Number of children ever born	2/7	0.435237651541832	0.999994527882068	0	0	1.55769889840881	1.29579219040053	FBXL17;AFF3
Perioperative myocardial infarction in coronary artery bypass surgery	2/7	0.435237651541832	0.999994527882068	0	0	1.55769889840881	1.29579219040053	HDAC4;RFXAP
Plasma androstenedione levels in resected early stage-receptor positive breast cancer	2/7	0.435237651541832	0.999994527882068	0	0	1.55769889840881	1.29579219040053	ADGRE2;ELMO1
Pulmonary function in asthmatics	2/7	0.435237651541832	0.999994527882068	0	0	1.55769889840881	1.29579219040053	YES1;DGKH
Response to antipsychotic therapy (extrapyramidal side effects)	2/7	0.435237651541832	0.999994527882068	0	0	1.55769889840881	1.29579219040053	FGGY;TRIM44
Serum urate levels in chronic kidney disease	2/7	0.435237651541832	0.999994527882068	0	0	1.55769889840881	1.29579219040053	SLC2A9;BACH2
Stroke (ischemic)	2/7	0.435237651541832	0.999994527882068	0	0	1.55769889840881	1.29579219040053	CDC5L;HDAC9
Systolic blood pressure change trajectories	2/7	0.435237651541832	0.999994527882068	0	0	1.55769889840881	1.29579219040053	PDXK;OGDH
Ulna and radius bone mineral density	2/7	0.435237651541832	0.999994527882068	0	0	1.55769889840881	1.29579219040053	SLC9A9;FAM3C
Psoriasis	27/127	0.443525631273624	0.999994527882068	0	0	1.05160344827586	0.854953272956981	ETS1;UBE2L3;AKAP13;PRDX5;RNF114;ZMIZ1;TAGAP;ANXA6;TRIM65;IKBKE;CAMK2G;MICA;TCF19;STAT5B;PLCL2;STAT3;ERAP1;HLA-B;TYK2;RUNX3;PSMA6;ILF3;SLC9A8;FUBP1;ELMO1;SNAI1;EXOC2
Periodontitis (CDC/AAP)	6/26	0.444684693179851	0.999994527882068	0	0	1.16831658907131	0.946791850005125	KDM4B;ETNK2;HLA-DOA;GPN1;PARP15;ERGIC1
Visceral adipose tissue adjusted for BMI	12/55	0.45221512020477	0.999994527882068	0	0	1.08683121700671	0.862506300583024	TLE1;PDCD6IP;SUCLA2;OAS2;TAF1C;C1GALT1;SLC39A11;HLA-B;TAF4B;SDHC;ZDHHC21;LPP
Response to amphetamines	7/31	0.453124032227015	0.999994527882068	0	0	1.13585580065359	0.899131399402252	MAP2K4;PTPRE;FBXL17;TMEM106B;THADA;TRAPPC9;CNTLN
Bipolar disorder (body mass index interaction)	3/12	0.457043813262788	0.999994527882068	0	0	1.29807378387202	1.01636064653458	TCF7L2;FBXL17;MCTP2
Dimensional psychopathology (Cognitive)	3/12	0.457043813262788	0.999994527882068	0	0	1.29807378387202	1.01636064653458	RPH3AL;PLEKHB1;RAB6A
Ewing sarcoma	3/12	0.457043813262788	0.999994527882068	0	0	1.29807378387202	1.01636064653458	SSR1;SRP14;TARDBP
Osteoarthritis	3/12	0.457043813262788	0.999994527882068	0	0	1.29807378387202	1.01636064653458	MCF2L;CDC5L;DUS4L
Peak insulin response	3/12	0.457043813262788	0.999994527882068	0	0	1.29807378387202	1.01636064653458	TCF7L2;URGCP;CDKAL1
Response to anti-retroviral therapy (ddI/d4T) in HIV-1 (Grade 3 peripheral neuropathy)	3/12	0.457043813262788	0.999994527882068	0	0	1.29807378387202	1.01636064653458	IL2RA;LRIG1;HDAC9
Serum bilirubin levels in metabolic syndrome	3/12	0.457043813262788	0.999994527882068	0	0	1.29807378387202	1.01636064653458	KANK1;ROM1;SSBP3
Total ventricular volume (Alzheimer's disease interaction)	3/12	0.457043813262788	0.999994527882068	0	0	1.29807378387202	1.01636064653458	PDS5B;PAK2;PCSK5
Lumbar spine bone mineral density	8/36	0.460041524596952	0.999994527882068	0	0	1.11266767064757	0.863918042465025	CYLD;RPS6KA5;SMAD3;CTNNB1;CDKAL1;TNFRSF11A;SPTBN1;MPP7
Cough in response to angiotensin-converting enzyme inhibitor drugs	4/17	0.469309130270144	0.999994527882068	0	0	1.1982139829311	0.906441211061989	VPS13B;DNAJC16;TGFBR1;CLASP1
Heart failure	4/17	0.469309130270144	0.999994527882068	0	0	1.1982139829311	0.906441211061989	RPUSD4;GNA15;TBC1D4;TMTC1
Plasma omega-6 polyunsaturated fatty acid levels (adrenic acid)	4/17	0.469309130270144	0.999994527882068	0	0	1.1982139829311	0.906441211061989	REEP3;PPT2;FADS1;BEST1
Sphingolipid levels	4/17	0.469309130270144	0.999994527882068	0	0	1.1982139829311	0.906441211061989	CERS4;ATP10D;LPAR2;FADS1
Systolic blood pressure x smoking status (current vs non-current) interaction (1df test)	4/17	0.469309130270144	0.999994527882068	0	0	1.1982139829311	0.906441211061989	EXT1;ACAA2;MED30;DYM
Neutrophil count	39/187	0.472169433764202	0.999994527882068	0	0	1.02625754459994	0.770121506004657	HBS1L;IFITM2;DOCK8;SPPL2A;LY75;PTPN22;THADA;ETS1;RCBTB1;ABO;BCL2L13;FGGY;ATXN1;NCLN;CHSY1;MXI1;NLRP3;PMPCA;S1PR4;SH2B3;LYN;BRD3;TRAP1;KIDINS220;PCGF3;HLA-B;PLAUR;VRK1;TADA2B;NEIL2;ARPC2;NPC1;RAB37;DRG1;IRF8;RIN3;PIGL;CRK;SPC25
Eyebrow thickness	17/80	0.472293361926742	0.999994527882068	0	0	1.05085605085605	0.788304875601329	KCNH2;MEAF6;HSPA4;NOS3;CDCA8;GCC2;TBC1D2B;ABCB8;WDR61;EDAR;INPP5B;NUB1;MTF1;ZC3H12A;ABCF2;IDH3A;LIMS1
Mitochondrial DNA levels	5/22	0.477723113971943	0.999994527882068	0	0	1.14534397786552	0.846093054695789	ZBTB20;RRAS2;UBE2O;THADA;MRPL37
Mortality in sepsis	5/22	0.477723113971943	0.999994527882068	0	0	1.14534397786552	0.846093054695789	ETNK1;USP12;HLA-DOA;LPP;HLA-DPA1
Pyoderma gangrenosum in inflammatory bowel disease	5/22	0.477723113971943	0.999994527882068	0	0	1.14534397786552	0.846093054695789	USP15;MON2;TNFAIP8;BCL2;HSD17B4
Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis	5/22	0.477723113971943	0.999994527882068	0	0	1.14534397786552	0.846093054695789	FCGR3B;TMX1;EPHX1;ATG4C;DDHD1
Response to platinum-based neoadjuvant chemotherapy in cervical cancer	5/22	0.477723113971943	0.999994527882068	0	0	1.14534397786552	0.846093054695789	MBTPS1;HSDL1;RPS6KA5;TAF1C;NRDE2
Red blood cell count	51/246	0.479312236742758	0.999994527882068	0	0	1.01854844857818	0.749043628218161	PRDM8;HBS1L;BTG2;POP7;TRAF3IP3;PRKAG2;IKZF1;AFF3;HK1;CCND2;ZMIZ2;PSD4;FNTB;PIEZO1;CD36;FBXO7;SBF2;ZNF641;BCAS3;HLA-A;TMC6;BET1L;FAM234A;PRKAR1B;TBC1D4;GAS6;HLA-DQB1;GCDH;ABO;ZFP36L2;TIMM23B;DPP8;FIP1L1;LMAN2;MICALL2;SH2B3;HLA-DQA1;EGLN1;CD164;PLCL2;AP3D1;RAB11A;QKI;RCL1;NPLOC4;KANSL1;SP1;BCL2;ANP32B;FARSA;ATR
Hair color	13/61	0.483051339067765	0.999994527882068	0	0	1.05468110783832	0.767420081303122	TRAPPC2L;SNAI3;CYBA;GAB2;PLXDC2;CBFA2T3;APRT;CTU2;DSTYK;PPFIBP2;PIEZO1;ZC3H18;RNF166
White matter hyperintensity burden	6/27	0.484112372004394	0.999994527882068	0	0	1.11261245493051	0.807131605141793	AHCYL2;EVL;MCTP2;PMF1;TRIM65;UNC13D
Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes	7/32	0.489270733557781	0.999994527882068	0	0	1.09035294117647	0.779427128159922	ATXN1;POU2F1;ARHGEF3;PTPRM;PDSS2;FRY;CNTLN
Educational attainment	15/71	0.489415574384509	0.999994527882068	0	0	1.04307728739826	0.745323892364605	IFNGR2;CYHR1;TUFM;MPHOSPH9;RILPL2;STK24;RILPL1;REEP3;AKT3;CRYZL1;GART;FNIP2;VPS28;LAT;SDCCAG8
Loneliness (MTAG)	15/71	0.489415574384509	0.999994527882068	0	0	1.04307728739826	0.745323892364605	ARFGEF2;MTCH2;CSE1L;AKAP7;SLC39A13;PREX1;ORC4;ZNFX1;NMRK1;EPB41L2;FAM120A;AMZ2;OSTF1;ARSG;BPTF
Aspartate aminotransferase levels	8/37	0.49360821801745	0.999994527882068	0	0	1.07423219010745	0.758422060303019	PANX1;HBS1L;B4GALT1;CSF1;FCGRT;GOT2;IKZF1;CD36
Feeling nervous	8/37	0.49360821801745	0.999994527882068	0	0	1.07423219010745	0.758422060303019	TRIM8;NFIA;DENND1A;MGA;NF1;TSNARE1;LIN7C;FBXO31
Polycystic ovary syndrome	10/47	0.500680418280361	0.999994527882068	0	0	1.05244317164847	0.728066787595658	ARL14EP;NEIL2;DENND1A;IRF1;FANCC;THADA;MAPRE1;ZFP36L2;LMF1;FDFT1
Urate levels in obese individuals	10/47	0.500680418280361	0.999994527882068	0	0	1.05244317164847	0.728066787595658	EXT1;SLC2A9;ANXA1;MED30;UBE2Q2;CDCA7L;ZBTB20;ME3;GRAMD4;CLK4
Asthma	42/204	0.506298138365013	0.999994527882068	0	0	1.00954081399075	0.687123337143874	ITSN2;DENND1B;CELF2;CLEC16A;GATA3;PDS5B;LPP;BACH2;GLT1D1;BBS9;STAT6;D2HGDH;TRIM27;HLA-DOA;IL6R;HLA-DQA1;MICA;LHPP;HLA-DRB5;NDFIP1;SMAD3;PYHIN1;PBX2;C20ORF194;DEXI;EMSY;MOB3B;ETV6;BCR;TLR1;GNPDA1;REEP3;IRF1;IL2RB;HLA-DRA;BAX;AAGAB;COPS8;HLA-DRB1;IL18R1;ZNF652;HLA-DQB1
Adiposity	2/8	0.5094150560593	0.999994527882068	0	0	1.29800081599347	0.875491374601634	TBCE;LRRFIP1
Aging (time to event)	2/8	0.5094150560593	0.999994527882068	0	0	1.29800081599347	0.875491374601634	SUCLA2;ST3GAL3
Alzheimer's disease (APOE e4 interaction)	2/8	0.5094150560593	0.999994527882068	0	0	1.29800081599347	0.875491374601634	PMS2CL;TMEM106B
Alzheimer's disease (survival time)	2/8	0.5094150560593	0.999994527882068	0	0	1.29800081599347	0.875491374601634	NARS2;GAB2
Antibody level in response to infection	2/8	0.5094150560593	0.999994527882068	0	0	1.29800081599347	0.875491374601634	L3MBTL1;SRSF6
Arthritis (juvenile idiopathic)	2/8	0.5094150560593	0.999994527882068	0	0	1.29800081599347	0.875491374601634	REEP3;HLA-DRB1
Body mass index and waist-hip ratio (pleiotropy)	2/8	0.5094150560593	0.999994527882068	0	0	1.29800081599347	0.875491374601634	KEAP1;DOCK2
Breast Cancer in BRCA1 mutation carriers	2/8	0.5094150560593	0.999994527882068	0	0	1.29800081599347	0.875491374601634	TCF7L2;MDM4
Capecitabine sensitivity	2/8	0.5094150560593	0.999994527882068	0	0	1.29800081599347	0.875491374601634	MTRR;SMARCAD1
Emphysema distribution in smoking	2/8	0.5094150560593	0.999994527882068	0	0	1.29800081599347	0.875491374601634	IREB2;TRAPPC9
Functional impairment in major depressive disorder, bipolar disorder and schizophrenia	2/8	0.5094150560593	0.999994527882068	0	0	1.29800081599347	0.875491374601634	FCGR2A;ZZEF1
Heart rate variability traits (pvRSA/HF)	2/8	0.5094150560593	0.999994527882068	0	0	1.29800081599347	0.875491374601634	PPIL1;NDUFA11
Insulin-like growth factors	2/8	0.5094150560593	0.999994527882068	0	0	1.29800081599347	0.875491374601634	SPOCK2;NUBP2
Lentiform nucleus volume	2/8	0.5094150560593	0.999994527882068	0	0	1.29800081599347	0.875491374601634	EPB41L2;SLC39A1
Lower body strength	2/8	0.5094150560593	0.999994527882068	0	0	1.29800081599347	0.875491374601634	ASB7;ACADSB
Major depressive disorder (broad)	2/8	0.5094150560593	0.999994527882068	0	0	1.29800081599347	0.875491374601634	SP4;ATP6V1B2
Non-response to selective serotonin reuptake inhibitors and depression	2/8	0.5094150560593	0.999994527882068	0	0	1.29800081599347	0.875491374601634	YWHAQ;TAF1B
Osteoporosis-related phenotypes	2/8	0.5094150560593	0.999994527882068	0	0	1.29800081599347	0.875491374601634	TBC1D8;OSBPL1A
Renal sinus fat	2/8	0.5094150560593	0.999994527882068	0	0	1.29800081599347	0.875491374601634	TIAM1;GLT1D1
Response to bupropion and depression	2/8	0.5094150560593	0.999994527882068	0	0	1.29800081599347	0.875491374601634	DOCK10;CUL3
Serum 25-Hydroxyvitamin D levels	2/8	0.5094150560593	0.999994527882068	0	0	1.29800081599347	0.875491374601634	NADSYN1;ARID2
Uterine fibroid size (maximum volume)	2/8	0.5094150560593	0.999994527882068	0	0	1.29800081599347	0.875491374601634	CUL1;BCAT1
Vigorous physical activity	2/8	0.5094150560593	0.999994527882068	0	0	1.29800081599347	0.875491374601634	DPY19L1;EXOC4
White matter growth	2/8	0.5094150560593	0.999994527882068	0	0	1.29800081599347	0.875491374601634	PRPF4;AKR1B1
White matter integrity (bipolar disorder risk interaction)	2/8	0.5094150560593	0.999994527882068	0	0	1.29800081599347	0.875491374601634	CAMK2D;LPP
Biochemical measures	3/13	0.51432801003298	0.999994527882068	0	0	1.16819294809011	0.776724558245145	SLC2A9;RAP1GDS1;NR3C2
Eye morphology	3/13	0.51432801003298	0.999994527882068	0	0	1.16819294809011	0.776724558245145	KANK1;PSMG1;CLN8
Hematological parameters	3/13	0.51432801003298	0.999994527882068	0	0	1.16819294809011	0.776724558245145	HBS1L;PTPN11;BAK1
Multiple myeloma and monoclonal gammopathy	3/13	0.51432801003298	0.999994527882068	0	0	1.16819294809011	0.776724558245145	DTNB;CDCA7L;TOM1
Nonalcoholic fatty liver disease	3/13	0.51432801003298	0.999994527882068	0	0	1.16819294809011	0.776724558245145	YIPF1;GPN1;GATAD2A
Oral cavity cancer	3/13	0.51432801003298	0.999994527882068	0	0	1.16819294809011	0.776724558245145	CLPTM1L;GPN1;AIF1
Prothrombin time	3/13	0.51432801003298	0.999994527882068	0	0	1.16819294809011	0.776724558245145	EDEM2;PLXDC2;TRPC4AP
QT interval (sulfonylurea treatment interaction)	3/13	0.51432801003298	0.999994527882068	0	0	1.16819294809011	0.776724558245145	NFIA;HSD17B4;SPATS2L
Reading disability or specific language impairment (pleiotropy)	3/13	0.51432801003298	0.999994527882068	0	0	1.16819294809011	0.776724558245145	STK24;ZFP64;COX6A1
Severity of nausea and vomiting of pregnancy	3/13	0.51432801003298	0.999994527882068	0	0	1.16819294809011	0.776724558245145	LRRC25;INPP4B;SPECC1L
Wegener's granulomatosis	3/13	0.51432801003298	0.999994527882068	0	0	1.16819294809011	0.776724558245145	HLA-DPB1;HLA-DOA;HLA-DPB2
Bone mineral density (Ward's triangle area)	4/18	0.517650290884099	0.999994527882068	0	0	1.11255729330674	0.732569334043465	DUSP23;TNKS;NAB1;PLXDC2
Global electrical heterogeneity phenotypes	4/18	0.517650290884099	0.999994527882068	0	0	1.11255729330674	0.732569334043465	KDM1A;NFIA;SLC39A13;ACTB
Idiopathic pulmonary fibrosis	4/18	0.517650290884099	0.999994527882068	0	0	1.11255729330674	0.732569334043465	AKAP13;KANSL1;GOSR2;TOLLIP
Influenza A (H1N1) infection	4/18	0.517650290884099	0.999994527882068	0	0	1.11255729330674	0.732569334043465	L3MBTL3;B4GALT1;GHITM;TMCO3
Logical memory (immediate recall) in mild cognitive impairment	4/18	0.517650290884099	0.999994527882068	0	0	1.11255729330674	0.732569334043465	HNRNPL;ECH1;ACTN4;ADARB1
Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	5/23	0.520316260185557	0.999994527882068	0	0	1.08164570744189	0.706659107436552	PRIM2;PDXDC1;NTAN1;FADS1;BEST1
Cobalt levels	6/28	0.522613861652599	0.999994527882068	0	0	1.06197233298434	0.68912701728999	ASAH2B;ADAMTS13;NFIA;ZMIZ1;TMTC2;TOMM20
Loneliness (linear analysis)	6/28	0.522613861652599	0.999994527882068	0	0	1.06197233298434	0.68912701728999	CCDC69;GNA12;LAPTM5;ATP11B;BUD13;DCAF10
Thyroid hormone levels	6/28	0.522613861652599	0.999994527882068	0	0	1.06197233298434	0.68912701728999	CAPZB;NFIA;ITPK1;LPCAT2;ABO;NR3C2
Vitamin D levels	6/28	0.522613861652599	0.999994527882068	0	0	1.06197233298434	0.68912701728999	MKLN1;GEMIN2;PDE3B;RRAS2;HSF5;NADSYN1
Alanine transaminase levels	8/38	0.526548179681294	0.999994527882068	0	0	1.03835907493667	0.666016430165412	N6AMT1;PANX1;KDM4C;MAP3K1;ZNF713;STRN;PIK3AP1;FADS1
Experiencing mood swings	8/38	0.526548179681294	0.999994527882068	0	0	1.03835907493667	0.666016430165412	RFWD3;FBXL17;ORAI1;TMEM106B;HOXB2;TRIM27;ARHGAP15;FBXO31
Familial squamous cell lung carcinoma	9/43	0.528292434321558	0.999994527882068	0	0	1.03071719124138	0.657706098114621	IPPK;TMEM221;NBAS;GPD2;ZSCAN9;NF1;BTBD9;LCORL;HS2ST1
Itch intensity from mosquito bite adjusted by bite size	24/117	0.528533020639987	0.999994527882068	0	0	1.00481925797718	0.640722995527768	HLA-DRB5;CHURC1;PCGF3;STAT3;HTT;IKZF1;TXN;ARID3B;RUNX3;RNF144A;FPGT;DHX35;IRF1;FNTB;HLA-DRA;STAT6;LTBR;IL6R;LMCD1;CAMK2G;HLA-DQA1;MICA;TMEM14C;HLA-DQB1
Extremely high intelligence	16/78	0.538249197332019	0.999994527882068	0	0	1.00480978756111	0.622412978181451	ARFGEF2;CSE1L;TET2;AFF3;ARHGAP15;TUFM;CDC42;PREX1;CLN3;PAIP2B;ZNFX1;ZNF638;GRK6;EXOC4;RPL15;AVL9
Major depressive disorder	43/212	0.549518821448477	0.999994527882068	0	0	0.990571172721367	0.593067099341081	RERE;DENND1B;FH;TRIO;WDR26;NVL;DENND1A;PDCD5;GNAI3;GMPR;ITPR2;FMN1;CALML4;SPPL3;SLC2A8;MAP1LC3B;LAPTM4A;CCND2;ATXN1;OPA1;RSRC1;VPS8;NUDT19;PLXNC1;SF3B1;ABCF3;AP2M1;ANKRD27;RFX3;ALG3;TSC2;PAX5;TRAPPC9;PARP15;UNC13D;FBXO31;VCAN;RCN1;OSTM1;SP4;ORAI1;IRF8;KCTD15
Blood metabolite levels	32/158	0.554474262924179	0.999994527882068	0	0	0.988753841034975	0.583102635893908	GCDH;PDXDC1;ECI2;AMD1;GMPR;RPF2;ABO;DDO;NUBP2;LACTB;THEM4;SMYD3;ACADM;SH2B3;PSPH;FADS1;ARSA;ABCC4;ABCC1;MBOAT7;GOT2;CYHR1;SLC2A9;RNF167;SLC7A5;SLC7A6;IVD;ALMS1;SKIV2L;STAMBP;TKT;VPS28
Intelligence	12/59	0.559031876382294	0.999994527882068	0	0	0.994084323195405	0.578108528863769	RXRA;CSE1L;ZNF638;PLCL2;EXOC4;NAGA;TCF20;PAX5;AFF3;DEPDC5;ARHGAP15;TUFM
Immune reponse to smallpox (secreted IFN-alpha)	7/34	0.559092662911482	0.999994527882068	0	0	1.00945896877269	0.586939877384659	ATP8A1;WDR92;RAB14;ATP10A;MNAT1;SGK1;LPP
C-reactive protein	6/29	0.559907724956298	0.999994527882068	0	0	1.01573569990305	0.589109728626358	DUSP23;TOMM40;IFI16;IL6R;C12ORF43;OASL
Feeling fed-up	6/29	0.559907724956298	0.999994527882068	0	0	1.01573569990305	0.589109728626358	ITSN2;NEK9;KIAA1109;ACBD4;ACTN1;PABPC1L
Quantitative traits	6/29	0.559907724956298	0.999994527882068	0	0	1.01573569990305	0.589109728626358	TOMM40;UBE3C;FKBP1B;ARHGAP15;FKBP4;SPPL3
Urate levels	15/74	0.560272320159996	0.999994527882068	0	0	0.989852152775465	0.573453351500455	BCAS3;B4GALT1;BMPR2;WDR1;ADPGK;SFMBT1;ZNF160;PRKAG2;PTPN11;RASGRP2;PRPSAP1;SLC2A9;ATXN2;UBE2Q2;SF1
Cerebrospinal fluid clusterin levels	5/24	0.561340844867846	0.999994527882068	0	0	1.02465251811547	0.591662020708429	SETD5;SEC23IP;IDH2;FOXN3;ZC3H13
Logical memory (delayed recall)	5/24	0.561340844867846	0.999994527882068	0	0	1.02465251811547	0.591662020708429	TOMM40;CLPTM1;TRIB3;PDS5B;N4BP2L2
Waist-to-hip ratio adjusted for BMI x sex interaction	5/24	0.561340844867846	0.999994527882068	0	0	1.02465251811547	0.591662020708429	PIGU;TNFAIP8;RXRA;SLC2A3;IQGAP2
HIV-1 control	4/19	0.563806395021028	0.999994527882068	0	0	1.0383214956323	0.595004274503416	DDR1;HLA-B;HLA-A;MICA
Colorectal cancer	25/124	0.566002573777626	0.999994527882068	0	0	0.983120222411212	0.559549415755096	MACF1;CRTC3;COX15;GPATCH1;GATA3;RAD51AP1;CDC42;PREX1;SLC25A26;CCND2;ZMIZ1;VTI1A;LRIG1;SYMPK;DIP2B;SH2B3;FADS1;TCF7L2;ERAP1;ENTPD7;BTBD9;ETV6;CTNNB1;NAF1;B9D2
Asthma exacerbations in inhaled corticosteroid treatment	3/14	0.56819428045228	0.999994527882068	0	0	1.06192680972309	0.600298598118731	ACOT7;DTNBP1;ME3
Dimensional psychopathology (Social)	3/14	0.56819428045228	0.999994527882068	0	0	1.06192680972309	0.600298598118731	MED21;NUDT1;TM7SF3
Glycemic traits (pregnancy)	3/14	0.56819428045228	0.999994527882068	0	0	1.06192680972309	0.600298598118731	HKDC1;VPS26A;HK1
Homocysteine levels	3/14	0.56819428045228	0.999994527882068	0	0	1.06192680972309	0.600298598118731	FANCA;MTHFR;MTR
Immune response to anthrax vaccine	3/14	0.56819428045228	0.999994527882068	0	0	1.06192680972309	0.600298598118731	TET2;HLA-DQA1;HLA-DRB1
Immunoglobulin light chain (AL) amyloidosis	3/14	0.56819428045228	0.999994527882068	0	0	1.06192680972309	0.600298598118731	BCL7C;SRP54;PRR14
Right lateral prefrontal cortical growth	3/14	0.56819428045228	0.999994527882068	0	0	1.06192680972309	0.600298598118731	ARL15;BUB3;PDE7A
Upper eyelid morphology	3/14	0.56819428045228	0.999994527882068	0	0	1.06192680972309	0.600298598118731	RERE;FAM120A;PLCG2
Attention deficit hyperactivity disorder symptom score	2/9	0.576867171438377	0.999994527882068	0	0	1.1125021856968	0.612035561902297	CUX1;FOXN3
Bipolar disorder lithium response (continuous) or schizophrenia	2/9	0.576867171438377	0.999994527882068	0	0	1.1125021856968	0.612035561902297	FAM177A1;MAIP1
Bone fracture in osteoporosis	2/9	0.576867171438377	0.999994527882068	0	0	1.1125021856968	0.612035561902297	RAB31;PTER
Cardiovascular risk factors (age interaction)	2/9	0.576867171438377	0.999994527882068	0	0	1.1125021856968	0.612035561902297	BUD13;SORL1
Chronic myeloid leukemia	2/9	0.576867171438377	0.999994527882068	0	0	1.1125021856968	0.612035561902297	MTHFD1L;RMND1
Chronic periodontitis (mean interproximal clinical attachment level)	2/9	0.576867171438377	0.999994527882068	0	0	1.1125021856968	0.612035561902297	TSNAX;DISC1
Coenzyme Q10 levels	2/9	0.576867171438377	0.999994527882068	0	0	1.1125021856968	0.612035561902297	BCR;TTC39B
Forehead morphology	2/9	0.576867171438377	0.999994527882068	0	0	1.1125021856968	0.612035561902297	TLE1;FBXL14
Hippocampal subfield CA3 volume	2/9	0.576867171438377	0.999994527882068	0	0	1.1125021856968	0.612035561902297	FBXW8;FAM53B
Immunoglobulin A vasculitis	2/9	0.576867171438377	0.999994527882068	0	0	1.1125021856968	0.612035561902297	HLA-DQA1;HLA-DQB1
Iron status biomarkers (transferrin levels)	2/9	0.576867171438377	0.999994527882068	0	0	1.1125021856968	0.612035561902297	TFRC;ARNTL
Large HDL particle concentration	2/9	0.576867171438377	0.999994527882068	0	0	1.1125021856968	0.612035561902297	SYS1;ACAA2
Lung disease severity in cystic fibrosis	2/9	0.576867171438377	0.999994527882068	0	0	1.1125021856968	0.612035561902297	APIP;HLA-DRA
Metabolite levels (HVA/5-HIAA ratio)	2/9	0.576867171438377	0.999994527882068	0	0	1.1125021856968	0.612035561902297	TRAP1;RCN1
Molar-incisor hypomineralization	2/9	0.576867171438377	0.999994527882068	0	0	1.1125021856968	0.612035561902297	NFATC2;TTLL12
Plasma amyloid beta peptide concentrations (ABx-40)	2/9	0.576867171438377	0.999994527882068	0	0	1.1125021856968	0.612035561902297	KCNQ1;SAV1
Recurrent major depressive disorder	2/9	0.576867171438377	0.999994527882068	0	0	1.1125021856968	0.612035561902297	RASGEF1A;RNF19A
Response to anti-retroviral therapy (ddI/d4T) in HIV-1 (Grade 1 peripheral neuropathy)	2/9	0.576867171438377	0.999994527882068	0	0	1.1125021856968	0.612035561902297	ADCK1;NFE2L3
Response to antipsychotic treatment in schizophrenia (working memory)	2/9	0.576867171438377	0.999994527882068	0	0	1.1125021856968	0.612035561902297	ITSN2;GPR137B
Serum sulfate level	2/9	0.576867171438377	0.999994527882068	0	0	1.1125021856968	0.612035561902297	UBLCP1;HTT
Type 2 diabetes and other traits	2/9	0.576867171438377	0.999994527882068	0	0	1.1125021856968	0.612035561902297	TCF7L2;CDKAL1
Reaction time	13/65	0.583911891157528	0.999994527882068	0	0	0.973306332842415	0.523643847668675	METAP1D;OLA1;PTPN11;KIF27;ARL17A;ATXN2;KIAA1328;APC;REEP5;KANSL1;ZNF638;SPATS2L;SH2B3
Alzheimer's disease (cognitive decline)	10/50	0.586486259700219	0.999994527882068	0	0	0.973325974981604	0.519372617955652	BCAS3;OSBPL7;CRADD;CLMN;MAN2A1;ELMO1;EXOC4;RRAS2;MRPL10;LIMS2
Femoral neck bone mineral density	9/45	0.587930535515208	0.999994527882068	0	0	0.973332515939186	0.516982134786669	CYLD;RPS6KA5;SMAD3;PLEKHA1;FUBP3;CTNNB1;CDKAL1;TNFRSF11A;FGFRL1
Carotid plaque burden	8/40	0.589829217440705	0.999994527882068	0	0	0.97333905368963	0.51384733929417	SYNM;NUB1;SERBP1;TNFSF10;MRPL37;HMGB1;ANTXR2;C12ORF75
Erosive tooth wear (severe vs non-severe)	8/40	0.589829217440705	0.999994527882068	0	0	0.97333905368963	0.51384733929417	CEP57;PTP4A3;GNPDA1;WTAP;RBM19;C1GALT1;ING1;SKAP2
Bulimia nervosa	6/30	0.595762597728118	0.999994527882068	0	0	0.973352119578535	0.504111733077335	CDV3;GM2A;CCDC69;PERP;PDE8A;PHTF1
Glioma	5/25	0.600510530302046	0.999994527882068	0	0	0.973358647721705	0.496388675387449	RTEL1;POLR3B;CDKN2A;MDM4;LMF1
Inflammatory biomarkers	5/25	0.600510530302046	0.999994527882068	0	0	0.973358647721705	0.496388675387449	APBB1IP;AHCYL2;COMMD10;IL2RA;ABO
Monobrow thickness	5/25	0.600510530302046	0.999994527882068	0	0	0.973358647721705	0.496388675387449	RANBP2;EDAR;CNIH1;RFX3;LIMS1
LDL cholesterol	36/181	0.602024133689183	0.999994527882068	0	0	0.966382076796704	0.490398069782026	LRPAP1;HBS1L;ZNF274;TOMM40;HP;GMPR;C10ORF88;TOMM20;N4BP2L2;ABO;PGS1;C7ORF50;ATXN2;UNK;PPP6R2;DHX38;DIP2B;LDLRAP1;JAK2;LDLR;RNF130;FADS1;SNX5;KPNA1;OSBPL7;DTNB;ITGA1;IRF2BP2;GAB2;FAM136A;DNM2;PPARG;BUD13;GAS6;PPARA;LIMS1
Chronic kidney disease	16/81	0.604551111092239	0.999994527882068	0	0	0.958252555599645	0.482258864317879	RB1;PHTF2;BCAS3;WDR37;SETDB1;PRKAG2;PSMA5;TMX4;ATXN2;GATM;SPATA5L1;UBE2Q2;LMAN2;RSBN1L;GRK6;ALMS1
Male-pattern baldness	50/251	0.605705888509916	0.999994527882068	0	0	0.968158957503786	0.48539689448595	PRDM8;C2ORF42;CRTC3;CD82;CHD6;TTC27;FAM53B;DIP2B;FADS1;DFFA;TCF12;RUNX3;RUNX1;SRRM1;EDAR;KATNAL1;RASA2;C1D;SNRPE;BIRC6;EXOC2;HDAC4;ITPR2;THADA;HDAC9;AKAP1;ARL17A;CEP70;EMC2;ATG7;LHPP;ZNF142;ACBD4;RNF25;YIPF4;CDC5L;MEMO1;ARHGAP27;FAM136A;WARS2;MKLN1;EHD3;UBLCP1;KANSL1;RCAN3;SP3;BCL2;EIF3E;TARDBP;MAP3K14
Feeling guilty	4/20	0.607416586697815	0.999994527882068	0	0	0.973365172667156	0.485261881062337	ACBD4;GOSR2;PRKCA;ARNTL
Immunoglobulin A	4/20	0.607416586697815	0.999994527882068	0	0	0.973365172667156	0.485261881062337	PVT1;CLEC16A;L3MBTL4;HLA-DRB1
Primary tooth development (number of teeth)	4/20	0.607416586697815	0.999994527882068	0	0	0.973365172667156	0.485261881062337	ADK;HOXB2;C14ORF93;KCNJ2
Primary tooth development (time to first tooth eruption)	4/20	0.607416586697815	0.999994527882068	0	0	0.973365172667156	0.485261881062337	RAD51C;ADK;C14ORF93;KCNJ2
Red vs. brown/black hair color	4/20	0.607416586697815	0.999994527882068	0	0	0.973365172667156	0.485261881062337	AFG3L1P;TCF25;FANCA;CBFA2T3
Response to angiotensin II receptor blocker therapy	4/20	0.607416586697815	0.999994527882068	0	0	0.973365172667156	0.485261881062337	APBB1IP;SYNRG;SLC9A9;DNAJC21
Subcutaneous adipose tissue	12/61	0.609399611752351	0.999994527882068	0	0	0.953389257543508	0.472195632085767	ITPKB;MLLT10;RNGTT;SP110;QPCTL;ZFP64;CD28;CTLA4;EML2;PMS1;NR3C2;LHPP
Cadmium levels	9/46	0.616382691484724	0.999994527882068	0	0	0.946966584043583	0.458225061815692	CD82;PRKCB;SEL1L;SEC62;SORL1;TAF3;SND1;HOPX;CARD11
Metabolic traits	9/46	0.616382691484724	0.999994527882068	0	0	0.946966584043583	0.458225061815692	SLC2A9;LACTB;SLC7A6;PDXDC1;IVD;LEF1;ACADM;ABO;FADS1
Waist-to-hip ratio adjusted for BMI in active individuals	9/46	0.616382691484724	0.999994527882068	0	0	0.946966584043583	0.458225061815692	TCF19;MAP3K1;NFE2L3;ITPR2;PPARG;PEPD;CCDC92;KCNJ2;WARS2
Breast cancer and/or colorectal cancer	3/15	0.618196526636005	0.999994527882068	0	0	0.973371694417238	0.468142014389931	ZNF808;CD83;DHX35
Eosinophilic esophagitis	3/15	0.618196526636005	0.999994527882068	0	0	0.973371694417238	0.468142014389931	ANKRD27;STAT6;XKR6
Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	3/15	0.618196526636005	0.999994527882068	0	0	0.973371694417238	0.468142014389931	PRDM8;MAN2A1;TAF8
Glycerophospholipid levels	3/15	0.618196526636005	0.999994527882068	0	0	0.973371694417238	0.468142014389931	PDXDC1;NTAN1;FADS1
Hirschsprung disease	3/15	0.618196526636005	0.999994527882068	0	0	0.973371694417238	0.468142014389931	RASGEF1A;STIM2;CSGALNACT2
Idiopathic membranous nephropathy	3/15	0.618196526636005	0.999994527882068	0	0	0.973371694417238	0.468142014389931	TCF19;LY75;HLA-DQA1
Midgestational circulating levels of PCBs	3/15	0.618196526636005	0.999994527882068	0	0	0.973371694417238	0.468142014389931	CD164;FMN1;SUMF1
PR interval in Tripanosoma cruzi seropositivity	3/15	0.618196526636005	0.999994527882068	0	0	0.973371694417238	0.468142014389931	RAP1GAP2;YES1;WIPF2
Post-traumatic stress disorder (asjusted for relatedness)	3/15	0.618196526636005	0.999994527882068	0	0	0.973371694417238	0.468142014389931	AKT3;PRKCA;NDRG1
Prostate cancer (early onset)	3/15	0.618196526636005	0.999994527882068	0	0	0.973371694417238	0.468142014389931	TOR1A;MYO9B;LARP4B
Smoking initiation	3/15	0.618196526636005	0.999994527882068	0	0	0.973371694417238	0.468142014389931	SLCO3A1;SLC39A11;MAT2B
Uterine fibroid number (single vs multiple)	3/15	0.618196526636005	0.999994527882068	0	0	0.973371694417238	0.468142014389931	GOT2;GPCPD1;LMCD1
BMI (adjusted for smoking behaviour)	15/77	0.627247368965264	0.999994527882068	0	0	0.941777837632296	0.439258639875586	SCARB2;TCF7L2;MTCH2;TOMM40;ADPGK;QPCTL;MTIF3;GALNT10;GNPDA2;FUBP1;RASA2;ZFP64;PGPEP1;KCTD15;MAP2K5
Body mass index (joint analysis main effects and smoking interaction)	15/77	0.627247368965264	0.999994527882068	0	0	0.941777837632296	0.439258639875586	SCARB2;TCF7L2;MTCH2;TOMM40;ADPGK;QPCTL;MTIF3;GALNT10;GNPDA2;FUBP1;RASA2;ZFP64;PGPEP1;KCTD15;MAP2K5
Copper levels	13/67	0.631106481697677	0.999994527882068	0	0	0.937139766177567	0.431347328801499	CMTM7;FARP2;PDXDC1;USP10;GSTCD;PRDM2;VRK1;FOXN3;NFKB1;FARS2;VOPP1;MCTP2;LLGL2
Lung cancer in ever smokers	30/153	0.632284548371592	0.999994527882068	0	0	0.9492776712337	0.435163836941437	ITSN2;DDR1;SLC44A1;FHL2;LPCAT1;HAPLN3;MRPL32;LMNA;CEP170;TRIM27;HLA-DOB;MICA;HLA-DPA1;ABT1;SMAD2;DAXX;HLA-B;HLA-A;BTN3A2;FAM86EP;HLA-E;MORF4L1;DEPDC7;WNK1;HLA-DRA;PLIN3;CLPTM1L;GALK2;EXOC2;HLA-DQB1
Mean corpuscular hemoglobin concentration	26/133	0.634388331217426	0.999994527882068	0	0	0.945754809252359	0.430407341285882	GCDH;MACF1;HBS1L;TFRC;PIGQ;GMPR;ABO;SMG5;UBE2L3;NDOR1;FNTB;UBTF;LUC7L;PIEZO1;CD36;KCNN4;SH2B3;HSPA8;SWAP70;ATP2B4;MYO9B;BET1L;RAB11A;FAM234A;ARL2BP;TMEM79
Blood urea nitrogen levels	11/57	0.636369763351859	0.999994527882068	0	0	0.930883858855656	0.420736693512886	PRDM8;BCAS3;RASGEF1A;GOSR2;MICALL2;LRIG1;NFATC1;SSBP3;PITPNC1;ABO;DGKH
Accelerated cognitive decline after conversion of MCI to Alzheimer's disease	2/10	0.637244583295273	0.999994527882068	0	0	0.973378212974296	0.438605912440949	ST6GAL1;PDS5B
Acylcarnitine levels	2/10	0.637244583295273	0.999994527882068	0	0	0.973378212974296	0.438605912440949	THEM4;ACADM
Age at smoking initiation in chronic obstructive pulmonary disease	2/10	0.637244583295273	0.999994527882068	0	0	0.973378212974296	0.438605912440949	ZBTB9;GIMAP2
Complement C3 and C4 levels	2/10	0.637244583295273	0.999994527882068	0	0	0.973378212974296	0.438605912440949	HLA-DRA;HLA-A
Cortisol levels (saliva)	2/10	0.637244583295273	0.999994527882068	0	0	0.973378212974296	0.438605912440949	LDLR;DGKH
Diastolic blood pressure response to hydrochlorothiazide in hypertension	2/10	0.637244583295273	0.999994527882068	0	0	0.973378212974296	0.438605912440949	MTAP;ZDHHC2
Dimensional psychopathology (Negative)	2/10	0.637244583295273	0.999994527882068	0	0	0.973378212974296	0.438605912440949	RTCB;TFB1M
Hippocampal subfield CA1 volume	2/10	0.637244583295273	0.999994527882068	0	0	0.973378212974296	0.438605912440949	FBXW8;FAM53B
Lobe attachment (rater scored)	2/10	0.637244583295273	0.999994527882068	0	0	0.973378212974296	0.438605912440949	EDAR;ARHGAP21
Local histogram emphysema pattern	2/10	0.637244583295273	0.999994527882068	0	0	0.973378212974296	0.438605912440949	VWA8;RIN3
Low vWF levels	2/10	0.637244583295273	0.999994527882068	0	0	0.973378212974296	0.438605912440949	STXBP5;ABO
Parkinson disease and lewy body pathology	2/10	0.637244583295273	0.999994527882068	0	0	0.973378212974296	0.438605912440949	MX2;TCEANC2
Phospholipid levels in large HDL	2/10	0.637244583295273	0.999994527882068	0	0	0.973378212974296	0.438605912440949	SYS1;ACAA2
Plasma omega-3 polyunsaturated fatty acid levels (alphalinolenic acid)	2/10	0.637244583295273	0.999994527882068	0	0	0.973378212974296	0.438605912440949	PDXDC1;FADS1
Response to platinum-based chemotherapy in non-small-cell lung cancer	2/10	0.637244583295273	0.999994527882068	0	0	0.973378212974296	0.438605912440949	SNW1;ALKBH1
Seborrheic dermatitis	2/10	0.637244583295273	0.999994527882068	0	0	0.973378212974296	0.438605912440949	MAST4;SENP2
Sporadic neuroblastoma	2/10	0.637244583295273	0.999994527882068	0	0	0.973378212974296	0.438605912440949	RSRC1;HSD17B12
Tourette syndrome	2/10	0.637244583295273	0.999994527882068	0	0	0.973378212974296	0.438605912440949	POLR3B;TMEM106B
Urinary bladder cancer	2/10	0.637244583295273	0.999994527882068	0	0	0.973378212974296	0.438605912440949	SLBP;PVT1
Urinary metabolites (H-NMR features)	2/10	0.637244583295273	0.999994527882068	0	0	0.973378212974296	0.438605912440949	ALMS1;ABO
Aortic root size	5/26	0.637611892012376	0.999994527882068	0	0	0.926949907841628	0.417151096185828	RABGEF1;FGGY;CFDP1;GOSR2;GOT2
Cancer	5/26	0.637611892012376	0.999994527882068	0	0	0.926949907841628	0.417151096185828	TMX1;FRY;SH2B3;ZNF652;GLYR1
Response to fenofibrate (total cholesterol levels)	5/26	0.637611892012376	0.999994527882068	0	0	0.926949907841628	0.417151096185828	BCAS4;GALC;SLC44A1;RAP1GDS1;CARD11
Immune response to smallpox vaccine (IL-6)	9/47	0.64378584237465	0.999994527882068	0	0	0.921988332774064	0.406033659175057	CDC42;BCR;RAB10;GOLGA3;ZHX2;CRBN;TMTC2;PRKCQ;RUNX1
Intracranial aneurysm	9/47	0.64378584237465	0.999994527882068	0	0	0.921988332774064	0.406033659175057	CARHSP1;DTNB;CDKN2A;SIRPG;GATA3;SYN3;BET1L;CARD11;XKR6
Age-related hearing impairment	4/21	0.648238063271047	0.999994527882068	0	0	0.916050770050856	0.397105506630627	ISG20;DEPDC5;SFI1;TRIOBP
Fasting blood insulin (BMI interaction)	4/21	0.648238063271047	0.999994527882068	0	0	0.916050770050856	0.397105506630627	TCF7L2;SFMBT2;PPARG;PEPD
Kawasaki disease	4/21	0.648238063271047	0.999994527882068	0	0	0.916050770050856	0.397105506630627	FCGR2A;MED30;PELI1;HLA-DOB
Narcolepsy	4/21	0.648238063271047	0.999994527882068	0	0	0.916050770050856	0.397105506630627	DNMT1;IL10RB;CTSH;LMCD1
Plasma omega-3 polyunsaturated fatty acid levels (docosapentaenoic acid)	4/21	0.648238063271047	0.999994527882068	0	0	0.916050770050856	0.397105506630627	STIM2;AGPAT3;FADS1;BEST1
Plasma parathyroid hormone levels	4/21	0.648238063271047	0.999994527882068	0	0	0.916050770050856	0.397105506630627	MTHFSD;CD82;FMN1;GATA3
Worry too long after an embarrassing experience	4/21	0.648238063271047	0.999994527882068	0	0	0.916050770050856	0.397105506630627	TRAF3IP3;ACBD4;HTT;ARNTL
Atrial fibrillation	47/240	0.654165243790064	0.999994527882068	0	0	0.947570922895398	0.402144639549583	PRDM8;USP36;ASAH1;CAMK2D;WDR1;KDM1B;GOSR2;SLC41A1;NUCKS1;NR3C1;MLLT3;SYNE2;PSMB7;SLC25A26;PCM1;FXR2;XPO1;ATXN1;POLR2A;LRIG1;CCDC92;KIFAP3;PAK2;IL6R;KCNJ2;CYTH1;GTF2I;KCNH2;SUN1;SYK;HIP1R;MTHFR;FRMD4B;ARHGAP26;SIRT1;SORL1;PTK2;CUL4A;MYO1C;MTHFD1;NACA;REEP3;SPATS2L;PI16;BCAT1;PHLDB2;CRK
Hip circumference adjusted for BMI	19/99	0.659817581626195	0.999994527882068	0	0	0.924370083579154	0.384345568988409	SUZ12;SLBP;L3MBTL3;CRADD;FNDC3B;TUFM;CCDC91;RFT1;GNA12;CDK5RAP1;DYM;INTS7;PPARG;ATP13A2;CORO7;CCDC66;LCORL;MICA;KCNJ2
BMI in non-smokers	11/58	0.660575501194976	0.999994527882068	0	0	0.911020399640866	0.377749008122468	TCF7L2;MTCH2;TOMM40;GNPDA2;ADPGK;QPCTL;FUBP1;RASA2;ZFP64;KCTD15;MAP2K5
Motion sickness	6/32	0.662470824953792	0.999994527882068	0	0	0.898365785158238	0.369927948946399	CELF2;GPD2;UBE2E2;COPS8;MCTP2;MAP2K5
Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction)	6/32	0.662470824953792	0.999994527882068	0	0	0.898365785158238	0.369927948946399	MAP3K1;FAM13A;ITPR2;PPARG;CCDC92;WARS2
Waist-to-hip ratio adjusted for BMI in non-smokers	6/32	0.662470824953792	0.999994527882068	0	0	0.898365785158238	0.369927948946399	MAP3K1;FAM13A;ITPR2;PPARG;CCDC92;WARS2
AIDS progression	3/16	0.664101278561717	0.999994527882068	0	0	0.898440443004596	0.367750193038612	RPH3AL;LTB;TNF
Autism	3/16	0.664101278561717	0.999994527882068	0	0	0.898440443004596	0.367750193038612	NEDD1;TAF1C;CSDE1
Cancer (pleiotropy)	3/16	0.664101278561717	0.999994527882068	0	0	0.898440443004596	0.367750193038612	TUBA1C;FRY;SH2B3
Electroencephalogram traits	3/16	0.664101278561717	0.999994527882068	0	0	0.898440443004596	0.367750193038612	TRIO;MSH2;PACS1
Hippocampal volume in mild cognitive impairment	3/16	0.664101278561717	0.999994527882068	0	0	0.898440443004596	0.367750193038612	KLHDC4;TOM1;PFKP
Mitral valve prolapse	3/16	0.664101278561717	0.999994527882068	0	0	0.898440443004596	0.367750193038612	CBR1;PITPNB;LMCD1
Systolic blood pressure response to hydrochlorothiazide in hypertension	3/16	0.664101278561717	0.999994527882068	0	0	0.898440443004596	0.367750193038612	TAF1C;C1D;ZDHHC2
Severe influenza A (H1N1) infection	9/48	0.670060631832114	0.999994527882068	0	0	0.898291017467084	0.35966411335949	DDX18;TBC1D2;B4GALT1;PDCD6IP;FANCM;SNX13;PIP4K2A;BUD13;CLEC4F
Longevity	14/74	0.672013016196961	0.999994527882068	0	0	0.908183975775432	0.360982759173746	ABCC4;TOMM40;FAM13A;SLC39A11;AKR1C2;SYDE2;ZFYVE28;STK10;C7ORF50;MTHFD1;STK24;NTHL1;LRRFIP1;TBC1D22A
Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia	5/27	0.672498116804908	0.999994527882068	0	0	0.884760144314284	0.351033867328426	LST1;MSH5;PBX2;GSAP;MICA
Phospholipid levels (plasma)	5/27	0.672498116804908	0.999994527882068	0	0	0.884760144314284	0.351033867328426	KLF12;PDXDC1;ALG14;FADS1;ILKAP
Cognitive decline (age-related)	8/43	0.676222682957156	0.999994527882068	0	0	0.889741883514867	0.348096247980638	ARL4C;TCF7L2;GRAMD1A;SCFD1;TOMM40;VTI1A;G2E3;STRN
Feeling worry	8/43	0.676222682957156	0.999994527882068	0	0	0.889741883514867	0.348096247980638	CEP57;GOSR2;RFT1;MED8;HLA-DRA;ECE1;FAM76B;PAM
Serum metabolite levels	19/100	0.677887136204613	0.999994527882068	0	0	0.912900445512704	0.354912387481908	PRMT7;GPAA1;ARPC1B;RPS27L;GTF2H1;SPPL3;OASL;SLC2A9;LACTB;SLC7A6;GATM;TRIM4;ALMS1;THEM4;MLEC;STAMBP;ACADM;FADS1;RAB8B
Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	TMEM106B
Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin)	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	LHPP
Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	TRIO
Amyotrophic lateral sclerosis in C9orf72 mutation negative individuals	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	TBC1D1
Apolipoprotein A1 levels	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	ACAA2
Appendicular lean mass	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	VCAN
Autism spectrum disorder	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	EXT1
Binge eating behaviour and bipolar disorder	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	SLC25A26
Body mass index (alcohol intake interaction)	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	LRP8
Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	HHAT
Branched-chain amino acid levels (Isoleucine)	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	DDX19A
Caffeine metabolism (plasma caffeine) level)	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	ARID3B
Callous-unemotional behaviour	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	TGFBR1
Cannabis dependence	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	UCHL5
Cerebral amyloid deposition positivity (PET imaging)	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	TOMM40
Cervical artery dissection	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	FGGY
Cingulate cortical amyloid beta load	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	TOMM40
Cognitive flexibility	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	CPEB2
Colorectal cancer (calcium intake interaction)	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	EPB41L2
Dermatomyositis	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	HLA-DPB1
Discordance in emotional problems in monozygotic twins	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	UHMK1
Echocardiographic traits	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	PDE4B
Electrodermal activity	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	ARHGAP15
Electroencephalographic traits in alcoholism	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	PRR5
Elevated fasting plasma glucose	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	SNX30
Entorhinal cortical thickness	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	ME2
Erythrocyte cadmium concentration	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	BCAT1
Extraversion	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	MTMR9
GLP-1 levels in response to oral glucose tolerance test (fasting)	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	ZFAND2A
Glomerular filtration rate (cystatin C)	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	ATXN2
HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	STX8
Iris color (a* coordinate)	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	HK1
Longitudinal change in brain amyloid plaque burden	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	APP
Lung cancer (smoking interaction)	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	SMAD3
Male infertility	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	ARL6
Manic episodes in bipolar disorder	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	RNF144A
Mean arterial pressure (long-term average)	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	ARL3
Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event)	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	GLCCI1
Multiple keratinocyte cancers	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	HAPLN3
Multiple sclerosis--Brain Glutamate Levels	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	SUMF1
Mumps	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	HLA-A
Normalized brain volume	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	MXI1
Obesity in adult survivors of childhood cancer exposed to cranial radiation	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	BASP1
Opioid sensitivity	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	METTL21A
Optic disc parameters	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	CDC7
Orthostatic hypotension	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	PIK3AP1
Plasma homocysteine levels (post-methionine load test)	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	PSPH
Posterior cortical atrophy and Alzheimer's disease	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	TOMM40
Problematic alcohol use in trauma-exposed individuals	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	SCLT1
Pulmonary artery enlargement and chronic obstructive pulmonary disease	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	IREB2
Renal overload gout	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	SLC2A9
Resistance to Mycobacterium tuberculosis in HIV+ individuals measured by a negative TST (continuous)	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	FRY
Response to acetaminophen (hepatotoxicity)	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	ETNK2
Response to antidepressants	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	CUX1
Response to platinum-based agents	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	ITGA1
Schizophrenia (treatment resistant)	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	NFKB1
Schizophrenia, schizoaffective disorder or bipolar disorder	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	SDCCAG8
Suicide risk	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	PDLIM1
Survival in sporadic amyotrophic lateral sclerosis	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	SLC9A9
Tooth agenesis	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	ARHGAP15
Two-hour glucose challenge	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	TCF7L2
Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	NDUFAF6
Vitamin E levels	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	BUD13
Waist-to-hip circumference ratio (dietary energy interaction)	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	DNAJC10
facial morphology traits (multivariate analysis)	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	RUNX2
middle facial morphology traits (quantitative measurement)	1/5	0.681172683373609	0.999994527882068	0	0	0.973384728340675	0.373720779464526	RUNX1
Attention deficit hyperactivity disorder	17/90	0.682803905316994	0.999994527882068	0	0	0.906330988522769	0.345808384941674	IFNAR2;RANBP2;PI4K2B;ITGA1;TNFRSF10A;ITGAE;CLYBL;PPM1F;STIP1;TMX3;MAN2A2;REEP5;NCL;MAP1B;SLC9A9;ARSB;ST3GAL3
Anti-saccade response	7/38	0.683735507872099	0.999994527882068	0	0	0.878984819734345	0.334176070657652	TPST2;HNRNPL;SYK;USP12;DIP2A;STAMBP;ZZEF1
Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes	7/38	0.683735507872099	0.999994527882068	0	0	0.878984819734345	0.334176070657652	GIMAP1-GIMAP5;MTAP;NAAA;OLA1;ZNF587;FLI1;ST3GAL3
Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)	7/38	0.683735507872099	0.999994527882068	0	0	0.878984819734345	0.334176070657652	PCM1;INPP5D;PITPNA;ATP6V1H;LCP2;MLYCD;KCNJ2
Urate levels in lean individuals	7/38	0.683735507872099	0.999994527882068	0	0	0.878984819734345	0.334176070657652	SLC2A9;ASAH2B;NSD1;APLF;TAP2;SPATS2L;CACNA2D4
C-reactive protein levels or triglyceride levels (pleiotropy)	4/22	0.686130239165301	0.999994527882068	0	0	0.865104634391923	0.32587437557018	PLA2G6;FADS1;ARNTL;CTSB
Cutaneous malignant melanoma	4/22	0.686130239165301	0.999994527882068	0	0	0.865104634391923	0.32587437557018	RTEL1;CDKAL1;TMEM38B;RAD23B
Hemostatic factors and hematological phenotypes	4/22	0.686130239165301	0.999994527882068	0	0	0.865104634391923	0.32587437557018	CD82;EDEM2;PCGF3;LHPP
Cholesterol, total	23/121	0.686700363802175	0.999994527882068	0	0	0.913307990519042	0.343273414716029	LRPAP1;HBS1L;ZNF274;OSBPL7;TOMM40;HP;IRF2BP2;TOMM20;ABO;TTC39B;UBASH3B;ALOX5;TOM1;DHX38;PPARG;VIM;LDLRAP1;ERGIC3;PPARA;LDLR;FADS1;SNX5;GPR146
Depression in smokers	10/54	0.689050561179663	0.999994527882068	0	0	0.884618815082391	0.329467986354182	FIG4;EXT1;DFFA;RNGTT;ZBTB24;ZNF506;CDKAL1;MBP;GALM;KLF2
Serum total protein level	10/54	0.689050561179663	0.999994527882068	0	0	0.884618815082391	0.329467986354182	SPCS3;ATXN2;CSF1;FCGRT;ITGA1;BCL2;PMPCA;IKZF1;AFF3;NFKB1
Bone properties (heel)	2/11	0.690621413721338	0.999994527882068	0	0	0.865170678634571	0.320254595332419	GPATCH1;SPTBN1
Dehydroepiandrosterone sulphate levels	2/11	0.690621413721338	0.999994527882068	0	0	0.865170678634571	0.320254595332419	BCL2L11;TRIM4
Dentate gyrus granule cell layer volume	2/11	0.690621413721338	0.999994527882068	0	0	0.865170678634571	0.320254595332419	FBXW8;FAM53B
Glucocorticoid-induced osteonecrosis (age 10 years and older)	2/11	0.690621413721338	0.999994527882068	0	0	0.865170678634571	0.320254595332419	CSGALNACT1;CWC27
Hair shape	2/11	0.690621413721338	0.999994527882068	0	0	0.865170678634571	0.320254595332419	ERRFI1;GATA3
Hippocampal subfield CA4 volume	2/11	0.690621413721338	0.999994527882068	0	0	0.865170678634571	0.320254595332419	FBXW8;FAM53B
Inflammatory bowel disease (early onset)	2/11	0.690621413721338	0.999994527882068	0	0	0.865170678634571	0.320254595332419	CLN3;ZMIZ1
Low high density lipoprotein cholesterol levels	2/11	0.690621413721338	0.999994527882068	0	0	0.865170678634571	0.320254595332419	SYNM;LMCD1
Mortality in heart failure	2/11	0.690621413721338	0.999994527882068	0	0	0.865170678634571	0.320254595332419	CMTM7;IFRD1
Oropharynx cancer	2/11	0.690621413721338	0.999994527882068	0	0	0.865170678634571	0.320254595332419	CSGALNACT1;HLA-DQB1
Proteinuria and chronic kidney disease	2/11	0.690621413721338	0.999994527882068	0	0	0.865170678634571	0.320254595332419	PLXDC2;GAS7
Psychosis and Alzheimer's disease	2/11	0.690621413721338	0.999994527882068	0	0	0.865170678634571	0.320254595332419	SLC2A9;MPP7
Response to antidepressants in depression	2/11	0.690621413721338	0.999994527882068	0	0	0.865170678634571	0.320254595332419	PPP5C;RNF24
Retinopathy in non-diabetics	2/11	0.690621413721338	0.999994527882068	0	0	0.865170678634571	0.320254595332419	KLHL22;HDAC9
Select biomarker traits	2/11	0.690621413721338	0.999994527882068	0	0	0.865170678634571	0.320254595332419	PTPRE;MKI67
Thiopurine-induced alopecia in inflammatory bowel disease	2/11	0.690621413721338	0.999994527882068	0	0	0.865170678634571	0.320254595332419	SUCLA2;MED4
Glomerular filtration rate	21/111	0.690686435939049	0.999994527882068	0	0	0.908025905886211	0.336032548798955	PRDM8;MED1;PHTF2;BCAS3;SPPL2A;PRKAG2;AKAP7;NFATC1;GAB2;GATM;SPATA5L1;PAX8;UBE2Q2;TMEM128;PSD4;ALMS1;MICALL2;CDK12;HLA-DQA1;HLA-DRB1;DGKH
Waist-to-hip ratio adjusted for body mass index	21/111	0.690686435939049	0.999994527882068	0	0	0.908025905886211	0.336032548798955	TCF19;TCF7L2;HLA-DRB5;TNFAIP8;KLF12;MAP3K1;FAM13A;PDE3B;SPRYD7;ITPR2;HSD17B4;PEPD;WARS2;BCL2;NFE2L3;PEMT;HLA-DRA;PPARG;DLEU2;CCDC92;KCNJ2
Blood pressure (smoking interaction)	6/33	0.693093462521849	0.999994527882068	0	0	0.865038525415884	0.317114838365672	CYB5B;RPS6KA2;SACS;CACNA2D4;TRAPPC9;FRY
Hemoglobin	6/33	0.693093462521849	0.999994527882068	0	0	0.865038525415884	0.317114838365672	HBS1L;MICALL2;PRKAG2;ATXN10;ABO;HK1
Irritable mood	6/33	0.693093462521849	0.999994527882068	0	0	0.865038525415884	0.317114838365672	ACBD4;FBXL17;LGALS9;PRR14;LRP12;CAMKMT
Myopia	13/70	0.696425780046444	0.999994527882068	0	0	0.887648674951985	0.321146011530799	TCF7L2;METAP1D;CPSF2;ANTXR2;CAMKMT;APH1B;NPLOC4;PCCA;POLR2A;NFIA;GPD2;HAT1;FXN
Angiotensin-converting enzyme inhibitor intolerance	8/44	0.702377078174885	0.999994527882068	0	0	0.864972351611234	0.305581645459994	C2ORF27A;PNP;APC;STIM2;LPCAT2;STXBP5;PSMF1;ATP6V0E2
Circulating fibroblast growth factor 23 levels	5/28	0.705081619395583	0.999994527882068	0	0	0.846239055876275	0.295711223328479	ADAMTS13;NSD1;FAM177A1;PDS5B;ABO
Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	5/28	0.705081619395583	0.999994527882068	0	0	0.846239055876275	0.295711223328479	PDXDC1;REEP3;NTAN1;FADS1;BEST1
Cerebrospinal fluid t-tau levels in mild cognitive impairment	3/17	0.7058424101054	0.999994527882068	0	0	0.834213656079474	0.29060940674839	TOMM40;CLPTM1;ARSB
Liver enzyme levels (alanine transaminase)	3/17	0.7058424101054	0.999994527882068	0	0	0.834213656079474	0.29060940674839	CELF2;SLC39A11;BRD7
Total hippocampal volume	3/17	0.7058424101054	0.999994527882068	0	0	0.834213656079474	0.29060940674839	FBXW8;MAST4;FAM53B
Fasting blood glucose	7/39	0.711092376237167	0.999994527882068	0	0	0.851462928921569	0.290308783155938	TCF7L2;MED30;CRY2;FOXN3;FADS1;SERINC5;SPC25
Iron status biomarkers (transferrin saturation)	7/39	0.711092376237167	0.999994527882068	0	0	0.851462928921569	0.290308783155938	FIG4;TFRC;SLC3A2;MALSU1;POLK;MAPRE1;HLA-DQB1
Monobrow	14/76	0.712052455531538	0.999994527882068	0	0	0.878776838820557	0.298435863112119	TCF25;ARL15;ERCC6L2;CPSF2;HTT;CDC5L;ATP11B;PRDM1;HDAC9;SMARCA2;WARS2;EDAR;PPP6R3;ATG5
Systolic blood pressure	129/657	0.712346379408035	0.999994527882068	0	0	0.949680451559557	0.322123060083294	PRDM8;MTCH2;NAB1;CTNND1;FAM13A;ZBTB20;CALML4;CWC27;DIP2B;PDE8A;MEF2A;EOMES;SZT2;ARL15;SWAP70;SLC30A5;HLA-B;CDKAL1;SRRM1;ST7L;CFDP1;PRKD3;MSH5;GUF1;SRFBP1;PHIP;TSNARE1;XPR1;DGKH;RNASEH2B;TNKS;ITPR1;THADA;ZFP36L2;RTN4;ARHGAP12;INPP5A;EPB41L2;STXBP5;ATG7;MARK3;NADK;BANP;PPP4R1L;ARL14EP;YES1;PNPT1;ACBD4;PBX3;MTHFR;NFATC2;INO80;TRAPPC9;C12ORF75;SMARCA2;GPR137B;CCT6A;LRCH1;YEATS2;BCL2;PLXNB2;SPATS2L;MDM4;PAM;ZNF652;LRP12;USP36;PHTF2;OLA1;CHD6;PRKAG2;LSP1;PEPD;TCHP;PPP6C;UFL1;SNRNP70;MCF2L;WDR7;METTL15;BCAS3;CERS5;AGTRAP;SLC39A13;SENP2;TGFBR2;TBC1D1;PTP4A3;CREB1;RNF207;PECAM1;NCOA7;LCORL;CRK;KANK1;CDC123;GOSR2;LEF1;METTL21A;CLN8;HDAC9;AMN1;CAND1;LRIG1;RNF130;SH2B3;CYTH1;FARP2;PTCD3;TCF7L2;KDM4B;YTHDF3;NOS3;C1GALT1;TTC1;PTPN11;MYO9B;RRP1B;SLC4A7;MKLN1;CLCN6;GNPDA2;KANSL1;CAPZA1;PPP2R2D;CCDC6;CTNNB1;SIPA1;TNRC6B
Lung cancer	43/225	0.714820076899861	0.999994527882068	0	0	0.919056586341453	0.308549728969469	ITSN2;DDR1;RIF1;PVT1;PDS5B;FRY;SYNGR2;SLK;KATNA1;VTI1A;METTL4;BAK1;HLA-DOA;TRIM21;HLA-DOB;HLA-DQA1;HLA-DPA1;BPTF;ABT1;CD164;ACTR2;DAXX;SLF2;BTN3A1;RNASET2;PLCL2;HLA-E;ZBTB9;MORF4L1;MTAP;WNK1;COPS2;MSH5;SP3;HLA-DRA;NAF1;SNRPA1;BUD13;CLPTM1L;COPS8;GALK2;MEGF9;HLA-DPB2
Cognitive function	17/92	0.7187580783759	0.999994527882068	0	0	0.882050778050778	0.291280023113057	TOMM40;RALGAPA2;WDR19;KLHL2;TCF20;VRK1;CDKAL1;ARHGAP27;TMEM251;CHFR;LRRC37A4P;RAD51C;KANSL1;GLCCI1;HSF5;MAP3K14;WRAP53
Basophil percentage of white cells	9/50	0.718998109782383	0.999994527882068	0	0	0.854364286654147	0.281851830796765	SLC36A1;DSTYK;PPP5C;FCGR3B;CRBN;BCL2;LARP4B;MICA;RUNX1
Delirium	9/50	0.718998109782383	0.999994527882068	0	0	0.854364286654147	0.281851830796765	AFTPH;SUMO3;SIK3;BUD13;LBR;TBC1D10A;MOB3B;IL18R1;FAM217B
Attention function in attention deficit hyperactive disorder	4/23	0.721038408587041	0.999994527882068	0	0	0.819521249854983	0.268034973514878	ARHGEF3;CAAP1;ZNF622;BTBD9
Non-melanoma skin cancer	4/23	0.721038408587041	0.999994527882068	0	0	0.819521249854983	0.268034973514878	RCC2;CLPTM1L;THNSL2;EXOC2
Western dietary pattern	4/23	0.721038408587041	0.999994527882068	0	0	0.819521249854983	0.268034973514878	PFKFB3;TET2;ITPR1;ARID1B
Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)	16/87	0.722411263884862	0.999994527882068	0	0	0.876941333582433	0.28514684446129	MAP3K1;BCKDHB;FNDC3B;ITPR2;PEPD;CCDC91;ZMIZ1;KCNQ1;NSD1;VPS53;ATP13A2;CCDC92;TMEM38B;ZSCAN2;MYO1F;HLA-DRB1
Hippocampal volume	10/56	0.734001578908536	0.999994527882068	0	0	0.846050484691429	0.261636120073984	SCARB2;TOMM40;NAAA;CLPTM1;PTPRM;NUP54;TMTC1;HMGB1;MCTP2;MPP7
Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)	10/56	0.734001578908536	0.999994527882068	0	0	0.846050484691429	0.261636120073984	TCF19;MAP3K1;NFE2L3;ITPR2;HLA-DRA;PPARG;PEPD;CCDC92;KCNJ2;WARS2
Colorectal or endometrial cancer	5/29	0.735326148266008	0.999994527882068	0	0	0.810928058141434	0.249312645886638	ARL5B;RNGTT;TET2;TMTC1;SH2B3
Birth weight	13/72	0.735860772624426	0.999994527882068	0	0	0.857450720983833	0.262992436923061	RB1;L3MBTL3;PLEKHA1;STRBP;ITPR2;CDKAL1;PEPD;SREBF2;GNA12;LCORL;CRLF3;DTL;YKT6
Blood and toenail selenium levels	2/12	0.737336877397917	0.999994527882068	0	0	0.778604651162791	0.237248933469064	U2AF1;ARSB
Brain volume in infants (grey matter)	2/12	0.737336877397917	0.999994527882068	0	0	0.778604651162791	0.237248933469064	OPA1;CAAP1
Cannabis dependence symptom count	2/12	0.737336877397917	0.999994527882068	0	0	0.778604651162791	0.237248933469064	PI4K2B;AFF3
Dentate gyrus molecular layer volume	2/12	0.737336877397917	0.999994527882068	0	0	0.778604651162791	0.237248933469064	FBXW8;FAM53B
GIP levels in response to oral glucose tolerance test (120 minutes)	2/12	0.737336877397917	0.999994527882068	0	0	0.778604651162791	0.237248933469064	CLEC10A;ABO
Gastric cancer	2/12	0.737336877397917	0.999994527882068	0	0	0.778604651162791	0.237248933469064	TTC33;ZBTB20
Gastroesophageal reflux disease	2/12	0.737336877397917	0.999994527882068	0	0	0.778604651162791	0.237248933469064	CRTC3;SLCO3A1
Ischemic stroke (cardioembolic)	2/12	0.737336877397917	0.999994527882068	0	0	0.778604651162791	0.237248933469064	ABO;HK1
Metabolite levels (5-HIAA)	2/12	0.737336877397917	0.999994527882068	0	0	0.778604651162791	0.237248933469064	ARHGAP32;PCSK5
Metabolite levels (HVA)	2/12	0.737336877397917	0.999994527882068	0	0	0.778604651162791	0.237248933469064	RAB10;SLC2A8
Peripheral arterial disease (traffic-related air pollution interaction)	2/12	0.737336877397917	0.999994527882068	0	0	0.778604651162791	0.237248933469064	MACF1;MTHFD1L
Preterm birth (maternal effect)	2/12	0.737336877397917	0.999994527882068	0	0	0.778604651162791	0.237248933469064	EEFSEC;B9D2
Reading disability or specific language impairment adjusted for IQ (pleiotropy)	2/12	0.737336877397917	0.999994527882068	0	0	0.778604651162791	0.237248933469064	COX6A1;INIP
Response to antidepressants (symptom remission)	2/12	0.737336877397917	0.999994527882068	0	0	0.778604651162791	0.237248933469064	TBC1D1;KCTD15
Triptolide cytotoxicity	2/12	0.737336877397917	0.999994527882068	0	0	0.778604651162791	0.237248933469064	FNDC3B;CFLAR
Waist circumference adjusted for BMI in smokers	2/12	0.737336877397917	0.999994527882068	0	0	0.778604651162791	0.237248933469064	FNDC3B;LCORL
Ischemic stroke	12/67	0.741415159536161	0.999994527882068	0	0	0.849061907417736	0.254034687924061	ERRFI1;TCF7L2;ILF3;LRCH1;SWAP70;CDC5L;PMF1;PRPF8;HDAC9;SH2B3;LDLR;ABO
Basophil percentage of granulocytes	9/51	0.74158915423238	0.999994527882068	0	0	0.833969733062426	0.24932349937523	SLC36A1;FCGR3B;CRBN;RBBP5;BCL2;LARP4B;S1PR4;RUNX1;CDC25B
Alzheimer's disease (age of onset)	3/18	0.743480789204514	0.999994527882068	0	0	0.778550440744368	0.230771967090718	TOMM40;ZNF592;LEMD2
Body mass index (adult)	3/18	0.743480789204514	0.999994527882068	0	0	0.778550440744368	0.230771967090718	GNPDA2;INTS10;GALNT10
Cardiometabolic and hematological traits	3/18	0.743480789204514	0.999994527882068	0	0	0.778550440744368	0.230771967090718	SLC2A9;HLA-B;HLA-DRA
Cerebrospinal fluid levels of Alzheimer's disease-related proteins	3/18	0.743480789204514	0.999994527882068	0	0	0.778550440744368	0.230771967090718	DCUN1D5;UBE2Q1;IL6R
Familial lung adenocarcinoma	3/18	0.743480789204514	0.999994527882068	0	0	0.778550440744368	0.230771967090718	SATB1;C1D;TMEM218
Immune reponse to smallpox (secreted IL-2)	3/18	0.743480789204514	0.999994527882068	0	0	0.778550440744368	0.230771967090718	BCAS3;RFT1;TOMM20
Immune response to measles-mumps-rubella vaccine	3/18	0.743480789204514	0.999994527882068	0	0	0.778550440744368	0.230771967090718	CDK8;IL27RA;MON1B
Interferon alpha levels in systemic lupus erythematosus	3/18	0.743480789204514	0.999994527882068	0	0	0.778550440744368	0.230771967090718	PNP;ATP8A1;ANKRD44
Renal cell carcinoma	3/18	0.743480789204514	0.999994527882068	0	0	0.778550440744368	0.230771967090718	PVT1;ITPR2;RHOBTB2
Sex hormone-binding globulin levels	3/18	0.743480789204514	0.999994527882068	0	0	0.778550440744368	0.230771967090718	BAIAP2L1;FXR2;ZNF652
Loneliness	19/104	0.74459199982073	0.999994527882068	0	0	0.869720631615478	0.2564970188171	ARFGEF2;MTCH2;CSE1L;LAPTM5;AKAP7;CAAP1;SLC39A13;HDAC9;PREX1;ZNFX1;ILVBL;EPB41L2;NMRK1;FAM120A;AMZ2;BUD13;OSTF1;ARSG;BPTF
Triglyceride levels	19/104	0.74459199982073	0.999994527882068	0	0	0.869720631615478	0.2564970188171	STARD3;LRPAP1;DR1;MAP3K1;CERK;PDXDC1;ADPGK;TYW1B;PCSK7;PLA2G6;PEPD;ARL4C;LSM8;RPS6KA1;SIK3;ATG4C;BUD13;CDK12;FADS1
Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	NCOR2
Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	LRIG1
Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	ME3
Asperger disorder	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	RNF111
Black vs. blond hair color	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	EXOC2
Black vs. red hair color	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	EXOC2
Blood pressure measurement (high sodium and potassium intervention)	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	ARL4C
Blood pressure measurement (high sodium intervention)	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	KCNQ1
Body mass index  (smoking years interaction)	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	SGK1
Bone mineral density (spine) and age at menarche	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	ABCB1
Cardiac repolarization	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	KCNJ2
Cerebellum growth	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	TBXAS1
Change in glucose in response to thiazide diuretic treatment in hypertension	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	FARS2
Chronic mucus hypersecretion	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	SATB1
Conduct disorder (symptom count)	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	SELPLG
Crohn's disease (time to surgery)	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	ZNRF1
Delta-5 desaturase activity response to n3-polyunsaturated fat supplement	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	FADS1
Diffusing capacity of the lung for carbon monoxide traits	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	GPCPD1
Electrocardiographic conduction measures	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	NFIA
Fractional excretion of metabolites in chronic kidney disease	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	MLEC
Gastric adenocarcinoma (histologically verified)	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	CHD6
Glioblastoma (age-stratified)	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	RTEL1
Hepatitis B surface antigen seroclearance in chronic hepatitis B infection	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	MPEG1
Hepatitis C induced liver fibrosis	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	RNF7
Hip shape (DXA scan)	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	RUNX2
Household income	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	AFF3
Iris color (b* coordinate)	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	HK1
L-arginine levels	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	CYP4V2
Left ventricular internal dimension in systole	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	DERL3
Lobe size	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	EDAR
Logical memory (delayed recall) in Alzheimer's disease dementia	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	PRDM2
Male fertility	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	PCSK5
Memory dysfunction in frontotemporal lobe dementia	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	FUT10
Midgestational circulating levels of PBDEs	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	TACC1
Multiple sclerosis and triglyceride levels (pleiotropy)	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	ARHGEF3
Non-obstructive azoospermia	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	HLA-DRA
Osteosarcoma	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	GDI2
Overweight status	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	MCTP2
Parkinson's disease (age of onset)	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	AAK1
Peanut allergy (parent-of-origin effect)	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	MIATNB
Percent mammographic density	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	PLA2G6
Personality traits in bipolar disorder	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	ITK
Plasma kynurenine levels in major depressive disorder	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	TMEM106B
Residual cognition	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	TMEM106B
Response to SSRI in MDD or openness	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	SNX29
Response to haloperidol in schizophrenia	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	SNRPB2
Response to iloperidone treatment (QT prolongation)	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	SLCO3A1
Sleep traits (multi-trait analysis)	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	PAX8
Sporadic pituitary adenoma	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	CDK8
Survival in colon cancer	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	PARVG
Temporomandibular joint disorder	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	SP4
Testicular germ cell cancer	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	CLPTM1L
Triglycerides-Blood Pressure (TG-BP)	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	BUD13
Vitamin B12 levels	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	CLYBL
Vitamin D levels (dietary vitamin D intake interaction)	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	NADSYN1
Weight loss (gastric bypass surgery)	1/6	0.746341094769681	0.999994527882068	0	0	0.7786588350465	0.227814202259399	FOXN3
Joint mobility (Beighton score)	6/35	0.748591998812253	0.999994527882068	0	0	0.805279301050283	0.233177618014703	VCAN;SMURF2;TNKS;BCKDHB;PIEZO1;XKR6
Periodontitis (Mean PAL)	6/35	0.748591998812253	0.999994527882068	0	0	0.805279301050283	0.233177618014703	PDCD6IP;SMURF2;ACTN1;BIRC5;FIZ1;PGPEP1
Erectile dysfunction	8/46	0.750435820521512	0.999994527882068	0	0	0.819344266525593	0.235234678865386	SPEN;XPO1;NFIA;DNAJA3;USP45;COMMD1;CORO7;NMRAL1
Late-onset Alzheimer's disease	8/46	0.750435820521512	0.999994527882068	0	0	0.819344266525593	0.235234678865386	SEC24B;SESTD1;RASSF5;SLMAP;TBXAS1;IQGAP2;TMCO4;HDAC9
Coronary artery disease (myocardial infarction, PTCA, CABG, angina or CIHD)	17/94	0.752106389221541	0.999994527882068	0	0	0.859031877213695	0.244718845019474	PRDM8;TDRKH;BCAS3;SMAD3;NOS3;SWAP70;MIA3;WDR12;HDAC9;ABO;ARNTL;NOA1;PEMT;MFGE8;IL6R;SH2B3;LDLR
Age at voice drop	4/24	0.75297788327871	0.999994527882068	0	0	0.778496203771736	0.220874493811413	ZNF483;ALMS1;PDE4B;TMEM38B
Cerebrospinal fluid t-tau levels in normal cognition	4/24	0.75297788327871	0.999994527882068	0	0	0.778496203771736	0.220874493811413	BRD3;CDCA4;WDR5;ETV6
Chloride levels	4/24	0.75297788327871	0.999994527882068	0	0	0.778496203771736	0.220874493811413	SPPL2A;HLA-DRA;CDKAL1;CLASP1
Hypospadias	4/24	0.75297788327871	0.999994527882068	0	0	0.778496203771736	0.220874493811413	EEFSEC;ADK;TAX1BP1;EXOC3
Nose morphology	4/24	0.75297788327871	0.999994527882068	0	0	0.778496203771736	0.220874493811413	DHX35;USP12;CDC5L;VPS13B
Obstructive sleep apnea trait (apnea hypopnea index)	4/24	0.75297788327871	0.999994527882068	0	0	0.778496203771736	0.220874493811413	HDAC4;ENTPD4;STX8;ZNF641
Psoriatic arthritis	4/24	0.75297788327871	0.999994527882068	0	0	0.778496203771736	0.220874493811413	HLA-B;ANXA6;TYK2;JAK2
Diastolic blood pressure (cigarette smoking interaction)	10/57	0.754774284571471	0.999994527882068	0	0	0.827997223657362	0.232945870111393	SLC4A7;CLCN6;ATXN2;NOS3;MTHFR;MDM4;LSP1;SH2B3;SIPA1;ARNTL
Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)	12/68	0.760220372608484	0.999994527882068	0	0	0.833847502191061	0.228596727622857	TNFAIP8;MAP3K1;FAM13A;BCL2;NFE2L3;ITPR2;HSD17B4;PEMT;PPARG;CCDC92;KCNJ2;WARS2
Response to methotrexate in juvenile idiopathic arthritis	7/41	0.760890792033735	0.999994527882068	0	0	0.801275951557093	0.218961023290083	LSM8;CYTH4;POLR3B;ZMIZ1;PVT1;C12ORF75;MYL12B
Glaucoma	9/52	0.762905910791391	0.999994527882068	0	0	0.814523763358692	0.220426885218715	TES;SRBD1;ME3;ELP4;ETS1;TRIOBP;EXOC2;GAS7;TMCO1
Protein quantitative trait loci	9/52	0.762905910791391	0.999994527882068	0	0	0.814523763358692	0.220426885218715	KCNQ1;SACS;CHD1L;TMEM38B;DOCK2;OSBPL1A;IL6R;PAFAH1B2;ABO
White blood cell count (basophil)	17/95	0.767773237269183	0.999994527882068	0	0	0.847965097965098	0.22408398044665	CD164;ABCC1;IFITM2;ITGA4;CRBN;HLA-B;ENO1;LARP4B;COMMD7;RUNX1;APBB1IP;EXT1;DSTYK;MAU2;BCL2;FAM53B;PABPC1L
Prostate cancer (SNP x SNP interaction)	13/74	0.771805975735549	0.999994527882068	0	0	0.829232960718511	0.214789652353756	UPF2;EEFSEC;SYK;TET2;TMTC2;THADA;TSEN2;BAIAP2L1;TTLL1;CWC22;KIF13A;PACSIN2;TNRC6B
Parkinson's disease	34/184	0.771960501359602	0.999994527882068	0	0	0.881556049017189	0.228166006545527	SCARB2;CAMK2D;CCNT2;SATB1;SPPL2B;CTNND1;GBA;STK39;SLC41A1;PRDM2;NUCKS1;TIAL1;INPP5F;OGFOD2;HLA-DQA1;CTSB;USP25;HLA-DRB5;ANXA1;GCH1;FNDC3B;HIP1R;ARHGAP27;SMARCA2;ITPKB;BCKDK;GALC;BST1;KANSL1;KLHL7;ZFP64;NDUFAF2;HLA-DRA;MICU3
Diabetic retinopathy	8/47	0.77231271411893	0.999994527882068	0	0	0.798285150332221	0.206249534294189	ARHGAP22;MPRIP;TBC1D4;AKT3;IRF8;PLXDC2;UCHL3;MYSM1
Paclitaxel disposition in epithelial ovarian cancer	8/47	0.77231271411893	0.999994527882068	0	0	0.798285150332221	0.206249534294189	CDA;WNK1;MBP;SDHC;GATA3;PMF1;SLC25A44;CAMK2G
Heart rate	6/36	0.773452761743399	0.999994527882068	0	0	0.778387650085763	0.199960533998707	PPIL1;SLC10A7;FNDC3B;ACTN4;TFPI;FADS1
Alcohol dependence symptom count	3/19	0.777169691924915	0.999994527882068	0	0	0.729845127326151	0.183991445007093	NDUFAF6;PTPN11;BPTF
Common carotid intima-media thickness in HIV infection	3/19	0.777169691924915	0.999994527882068	0	0	0.729845127326151	0.183991445007093	EXT1;MED30;KLHL23
Feeling tense	3/19	0.777169691924915	0.999994527882068	0	0	0.729845127326151	0.183991445007093	ENO1;TSNARE1;GALNT10
Heart rate response to recovery post exercise	3/19	0.777169691924915	0.999994527882068	0	0	0.729845127326151	0.183991445007093	PPIL1;NDUFA11;MCTP2
Initial pursuit acceleration in psychotic disorders	3/19	0.777169691924915	0.999994527882068	0	0	0.729845127326151	0.183991445007093	ARL4C;PCDH12;STX2
Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test)	3/19	0.777169691924915	0.999994527882068	0	0	0.729845127326151	0.183991445007093	POC1B;LSP1;TRAK1
Rhegmatogenous retinal detachment	3/19	0.777169691924915	0.999994527882068	0	0	0.729845127326151	0.183991445007093	ENSA;GOLPH3L;TAF4B
Waist circumference adjusted for BMI in active individuals	15/85	0.777185470010747	0.999994527882068	0	0	0.833725091215268	0.210162300324098	MAP3K1;BCKDHB;FNDC3B;ITPR2;PEPD;CCDC91;ZMIZ1;KCNQ1;NSD1;VPS53;ATP13A2;CCDC92;TMEM38B;ZSCAN2;MYO1F
Airway imaging phenotypes	2/13	0.777883886059176	0.999994527882068	0	0	0.707777901413152	0.177778246676465	ATG10;RPA1
Digit length ratio (right hand)	2/13	0.777883886059176	0.999994527882068	0	0	0.707777901413152	0.177778246676465	OLA1;FLI1
Dysmenorrheic pain	2/13	0.777883886059176	0.999994527882068	0	0	0.707777901413152	0.177778246676465	MAT2A;KRAS
Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	2/13	0.777883886059176	0.999994527882068	0	0	0.707777901413152	0.177778246676465	RPUSD4;PTPRM
Gambling	2/13	0.777883886059176	0.999994527882068	0	0	0.707777901413152	0.177778246676465	ATXN1;GMPR
Heart rate variability traits (RMSSD)	2/13	0.777883886059176	0.999994527882068	0	0	0.707777901413152	0.177778246676465	PPIL1;NDUFA11
Lewy body disease	2/13	0.777883886059176	0.999994527882068	0	0	0.707777901413152	0.177778246676465	IRF2;VPS36
Lipoprotein phospholipase A2 activity in cardiovascular disease	2/13	0.777883886059176	0.999994527882068	0	0	0.707777901413152	0.177778246676465	PLA2G7;LDLR
Nonsyndromic cleft lip with or without cleft palate	2/13	0.777883886059176	0.999994527882068	0	0	0.707777901413152	0.177778246676465	TMX1;MKNK2
Objective response to lithium treatment	2/13	0.777883886059176	0.999994527882068	0	0	0.707777901413152	0.177778246676465	SESTD1;TCF3
Response to anti-TNF therapy in rheumatoid arthritis	2/13	0.777883886059176	0.999994527882068	0	0	0.707777901413152	0.177778246676465	CD84;BACH2
Response to taxane treatment (placlitaxel)	2/13	0.777883886059176	0.999994527882068	0	0	0.707777901413152	0.177778246676465	ASB7;TMEM106B
Urinary metabolite concentrations in chronic kidney disease	2/13	0.777883886059176	0.999994527882068	0	0	0.707777901413152	0.177778246676465	ALMS1;ZFP64
Total cholesterol levels	35/190	0.780909799520432	0.999994527882068	0	0	0.87814858453014	0.217162306904171	LRPAP1;HBS1L;HP;CHD6;UBE3B;IKZF1;SMC6;ABO;UBE2L3;PGS1;NPEPPS;C7ORF50;ATXN2;UBASH3B;FCGRT;ALOX5;UBC;TOM1;LDLRAP1;JAK2;LDLR;FADS1;ITGA1;IRF2BP2;GAB2;FAM136A;TTC39B;ELF1;POC5;CAPZA1;NFE2L3;CDK2AP1;VIM;ERGIC3;THOP1
Alzheimer disease and age of onset	4/25	0.782019244731225	0.999994527882068	0	0	0.741378304934514	0.182287079546967	DDX18;CDC5L;CDKAL1;NR3C2
Feeling hurt	4/25	0.782019244731225	0.999994527882068	0	0	0.741378304934514	0.182287079546967	SLC26A2;ACTN1;NFATC1;HOXB2
Response to antipsychotic treatment	4/25	0.782019244731225	0.999994527882068	0	0	0.741378304934514	0.182287079546967	RNF144A;CLMN;TNFRSF11A;PPARD
Thyroid stimulating hormone	4/25	0.782019244731225	0.999994527882068	0	0	0.741378304934514	0.182287079546967	CERS4;BCAS3;SPATA13;GATA3
Post bronchodilator FEV1/FVC ratio in COPD	9/53	0.7829482906188	0.999994527882068	0	0	0.795961701368764	0.194762774459762	ITGA4;PRKCB;IREB2;MKS1;DENND3;BTBD9;CLEC4F;PAIP1;SULF2
Waist circumference adjusted for body mass index	23/128	0.78713273749922	0.999994527882068	0	0	0.85204349456318	0.203943752375577	SMAD3;MAP3K1;ARL15;BCKDHB;FNDC3B;ITPR2;PEPD;PCSK5;WARS2;CCDC91;ZMIZ1;KCNQ1;NSD1;VPS53;GNA12;NFE2L3;NLRP3;QSOX2;TMEM38B;LCORL;ZSCAN2;HLA-DRB1;MYO1F
Bilirubin levels	5/31	0.7888624436209	0.999994527882068	0	0	0.748454754456714	0.177506011459027	DGKD;SLC22A18;ORMDL1;USP40;KRCC1
Bone mineral density (total hip)	5/31	0.7888624436209	0.999994527882068	0	0	0.748454754456714	0.177506011459027	DRAM1;RBM19;CTNNB1;ZNF621;UHMK1
Smooth-surface caries	6/37	0.796421658918135	0.999994527882068	0	0	0.753230944344761	0.171455331937933	RPS6KA2;RNASET2;C1GALT1;ITPR2;BBS9;ARHGAP15
Disease progression in age-related macular degeneration	17/97	0.797068457619694	0.999994527882068	0	0	0.826661547911548	0.187498999053536	EFCAB14;STK19;FOXK1;TRAPPC9;POC5;SOAT2;METTL4;CCSER2;UQCRFS1;BBS9;SKIV2L;BUD13;KRAS;LYAR;LSM14A;KCTD15;EIF3A
Acute urticaria and angioedema (non-steroidal anti-inflammatory drug-induced)	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	IFT43
Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	GALC
Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	RXRA
Atrioventricular conduction	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	RNF19A
Biomedical quantitative traits	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	FAM3C
Bipolar disorder and eating disorder	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	FXR1
Body mass index in asthmatics	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	PRKCQ
Carotid atherosclerosis in HIV infection	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	MAST4
Cerebral cortical growth	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	SPATA13
Cerebrospinal fluid p-tau levels in normal cognition	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	CMAHP
Chemerin levels	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	PI16
Conduct disorder (maternal expressed emotions interaction)	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	RIT1
Economic and political preferences (time)	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	RPP30
End-stage renal disease	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	PVT1
Endometrial cancer (Non-endometrioid histology)	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	EXT1
Esophageal cancer (squamous cell)	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	ST6GAL1
Helping behaviour (self reported)	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	SLC30A9
Hip geometry	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	VAMP1
Hippocampal volume in normal cognition	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	RERE
Intracranial volume	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	RNF146
Intrinsic epigenetic age acceleration	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	KIF13A
Leisure-time exercise behaviour	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	DPY19L1
Lifetime average cigarettes per day in chronic obstructive pulmonary disease	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	ELMO1
Lipoprotein (a) - cholesterol levels	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	TAGAP
Lipoprotein-associated phospholipase A2 activity change in response to statin therapy	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	RNF213
Macular telangiectasia type 2	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	PSPH
Non-response to antidepressants and depression	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	RASGRP3
Non-response to bupropion and depression	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	NLK
Pediatric non-alcoholic fatty liver disease activity score	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	TRAPPC9
Phospholipid levels in medium HDL	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	ACAA2
Physical activity (overall physical activity time)	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	PML
Plasma thyroid-stimulating hormone levels	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	NR3C2
Pneumococcal bacteremia	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	DOCK2
Psychosis in Alzheimer's disease	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	ZNF320
QRS complex (Cornell)	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	EDEM2
QT interval (ambient particulate matter interaction)	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	ARSA
Response to antidepressants and depression	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	ERRFI1
Response to bupropion in depression	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	API5
Response to fenofibrate	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	CD36
Response to lithium treatment in bipolar disorder	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	HDAC9
Total cholesterol levels in HDL	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	ACAA2
Vein graft stenosis in coronary artery bypass grafting	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	ARID1B
Waist Circumference - Triglycerides (WC-TG)	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	BUD13
White blood cell count (monocyte)	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	ITGA4
antipsychotic drug dosage in schizophrenia or schizoaffective disorder	1/7	0.79819158418984	0.999994527882068	0	0	0.648841572850383	0.146253192280819	CAMKMT
Acne (severe)	41/223	0.800163192853585	0.999994527882068	0	0	0.875876594981884	0.195267561137268	CCDC167;MUS81;C2ORF42;SF3B2;SELPLG;ZFAND3;TNKS;CTSW;LIMD1;PWP1;ZDHHC3;FGD2;EIF1AD;CLEC3B;SART3;ERI1;PPP6R2;BANF1;RPL15;TBC1D22B;RRP15;SCYL1;PPIL1;SACM1L;ITGA1;UBE2E2;ALG12;FAM136A;AP5B1;LZTFL1;PACS1;C6ORF89;SPECC1L;C22ORF34;PLXNB2;LCP2;PI16;DOCK2;CLEC4F;SIPA1;ISCU
Abdominal aortic aneurysm	3/20	0.807126075024616	0.999994527882068	0	0	0.686869850780665	0.147179309357553	CDKN2A;IL6R;LDLR
C-reactive protein levels or HDL-cholesterol levels (pleiotropy)	3/20	0.807126075024616	0.999994527882068	0	0	0.686869850780665	0.147179309357553	STAG1;HLA-DRA;FADS1
C-reactive protein levels or total cholesterol levels (pleiotropy)	3/20	0.807126075024616	0.999994527882068	0	0	0.686869850780665	0.147179309357553	C7ORF50;IRF2BP2;HLA-DQB1
Cleft lip with or without cleft palate	3/20	0.807126075024616	0.999994527882068	0	0	0.686869850780665	0.147179309357553	GOSR2;ARID3B;PIK3R1
Lipid traits (pleiotropy) (HIPO component 1)	3/20	0.807126075024616	0.999994527882068	0	0	0.686869850780665	0.147179309357553	PIGU;ITPR2;ARNTL
Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	3/20	0.807126075024616	0.999994527882068	0	0	0.686869850780665	0.147179309357553	RBM19;CLN8;TRIOBP
Carboplatin disposition in epthelial ovarian cancer	4/26	0.80827508707863	0.999994527882068	0	0	0.707634760537038	0.15062205720967	STIM2;VRK1;PRDM1;RASGRP1
Epithelial ovarian cancer	4/26	0.80827508707863	0.999994527882068	0	0	0.707634760537038	0.15062205720967	MLLT10;SURF6;ABO;TGFBR1
Lupus nephritis in systemic lupus erythematosus	4/26	0.80827508707863	0.999994527882068	0	0	0.707634760537038	0.15062205720967	NIN;PRPF18;XRN2;SAV1
Molybdenum levels	4/26	0.80827508707863	0.999994527882068	0	0	0.707634760537038	0.15062205720967	TET2;IFNLR1;SIRT1;INTS8
Optic disc area	4/26	0.80827508707863	0.999994527882068	0	0	0.707634760537038	0.15062205720967	TMTC2;ASB7;CDC7;ELP4
Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	4/26	0.80827508707863	0.999994527882068	0	0	0.707634760537038	0.15062205720967	PDXDC1;NTAN1;FADS1;BEST1
Thiazide-induced adverse metabolic effects in hypertensive patients	10/60	0.810227416909294	0.999994527882068	0	0	0.778170223203336	0.163758382307534	WDR37;COX4I1;BCKDHB;GOLIM4;SLC39A11;ARRB1;BCAT1;IQGAP2;GCLM;CD44
Gout	8/49	0.811810320268904	0.999994527882068	0	0	0.759248739827433	0.158294677842524	SLC2A9;BCAS3;VDR;KCNQ1;RFX3;ALDH16A1;PRKCA;PPARD
Dialysis-related mortality	5/32	0.812268263929701	0.999994527882068	0	0	0.72068884170795	0.149848952890481	DHX35;CPSF2;TET3;PTPRM;RIN3
Orofacial clefts	5/32	0.812268263929701	0.999994527882068	0	0	0.72068884170795	0.149848952890481	GOSR2;PVT1;SPATA13;FMN1;THADA
Blood trace element (Se levels)	2/14	0.812832094432223	0.999994527882068	0	0	0.64875560995512	0.13444208999946	MED25;BIRC5
Digit length ratio (left hand)	2/14	0.812832094432223	0.999994527882068	0	0	0.64875560995512	0.13444208999946	OLA1;FLI1
Gait speed in old age	2/14	0.812832094432223	0.999994527882068	0	0	0.64875560995512	0.13444208999946	INPP5A;HLA-DPB1
Heart rate variability traits (SDNN)	2/14	0.812832094432223	0.999994527882068	0	0	0.64875560995512	0.13444208999946	PPIL1;NDUFA11
Ischemic stroke (large artery atherosclerosis)	2/14	0.812832094432223	0.999994527882068	0	0	0.64875560995512	0.13444208999946	HDAC9;SH2B3
Lipoprotein-associated phospholipase A2 activity and mass	2/14	0.812832094432223	0.999994527882068	0	0	0.64875560995512	0.13444208999946	PLA2G7;LDLR
Mood instability	2/14	0.812832094432223	0.999994527882068	0	0	0.64875560995512	0.13444208999946	EIF2B2;DLST
Osteoprotegerin levels	2/14	0.812832094432223	0.999994527882068	0	0	0.64875560995512	0.13444208999946	IFT20;POLDIP2
Periodontitis	2/14	0.812832094432223	0.999994527882068	0	0	0.64875560995512	0.13444208999946	MCM3AP;VAV1
Platelet aggregation	2/14	0.812832094432223	0.999994527882068	0	0	0.64875560995512	0.13444208999946	KCNQ1;TRIM27
Systolic blood pressure in sickle cell anemia	2/14	0.812832094432223	0.999994527882068	0	0	0.64875560995512	0.13444208999946	ACTR3;RFX3
Coronary heart disease	13/77	0.819110113284843	0.999994527882068	0	0	0.79021308910162	0.15767655611987	SMAD3;CDKN2A;MIA3;SNF8;WDR12;ABO;C12ORF43;MORF4L1;MTAP;MTHFD1L;PEMT;SH2B3;LDLR
Nasopharyngeal carcinoma (SNP x SNP interaction)	13/77	0.819110113284843	0.999994527882068	0	0	0.79021308910162	0.15767655611987	MED1;PRPF38B;SMAD3;COMMD10;RHBDD1;HLA-B;HELZ;SUMF1;REEP3;EPC1;JAK2;DLD;GAS7
Obesity	9/55	0.819266082816425	0.999994527882068	0	0	0.761258715909333	0.151754154377231	RPTOR;ASAH1;PTER;NPC1;MDFIC;GNPDA2;PITPNB;ALPK1;MAP2K5
Alzheimer's disease in APOE e4- carriers	7/44	0.823410156915973	0.999994527882068	0	0	0.736168521462639	0.143038157968924	MS4A6A;KANSL1;ACSL6;PTK2B;MKI67;SORL1;SERINC5
Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)	7/44	0.823410156915973	0.999994527882068	0	0	0.736168521462639	0.143038157968924	SLC4A7;CLCN6;LSP1;COX5A;SH2B3;SIPA1;XKR6
Pursuit maintenance gain	17/99	0.823656784000168	0.999994527882068	0	0	0.806397195421586	0.156442152704416	VEZT;YES1;SMAD3;CSNK2A1;SLC43A3;NSMCE2;USP45;PRMT3;PCSK5;TTC16;CTU2;DDX19B;LSG1;BAIAP2L1;DPP7;GSAP;ANKMY1
Post bronchodilator FEV1	22/126	0.82625093347921	0.999994527882068	0	0	0.822684265304191	0.157014851765418	EEFSEC;SP100;MCTP1;MAST4;GSTCD;DOCK8;FAM13A;IREB2;TET2;NMD3;MR1;RLF;FCER2;DPY19L1;TSPAN14;AP1G1;RUVBL1;ITGAX;RIN3;PRKD2;RICTOR;SMYD3
Age at first birth	4/27	0.831888432664114	0.999994527882068	0	0	0.676825437391517	0.124574420618022	CRTC2;CYHR1;AFF3;SLC39A1
Fasting plasma glucose	4/27	0.831888432664114	0.999994527882068	0	0	0.676825437391517	0.124574420618022	KANK1;CDKN2A;CDKAL1;YKT6
Hematology traits	4/27	0.831888432664114	0.999994527882068	0	0	0.676825437391517	0.124574420618022	HBS1L;SLC31A1;STK19;FADS1
Weight	4/27	0.831888432664114	0.999994527882068	0	0	0.676825437391517	0.124574420618022	ATG4C;ANAPC4;AIF1;KCTD15
Gut microbiota (bacterial taxa)	11/67	0.833378971222073	0.999994527882068	0	0	0.764172683302958	0.139283304151663	NDUFA9;SLC2A9;RAP2A;CD5;TGS1;KDM8;BNIP2;PTPN22;FLNB;SIPA1L3;NAPG
PR interval	11/67	0.833378971222073	0.999994527882068	0	0	0.764172683302958	0.139283304151663	EOMES;MKLN1;CAMK2D;LRCH1;XPO4;BNIP1;FRMD4B;SENP2;BCAT1;PHLDB2;PAM
Self-reported risk-taking behaviour	5/33	0.833549442997388	0.999994527882068	0	0	0.69490620844124	0.126516193975266	TBC1D5;DENND1A;AKT3;TET2;SDCCAG8
Cerebrospinal AB1-42 levels in Alzheimer's disease dementia	3/21	0.833607362429337	0.999994527882068	0	0	0.648669604962455	0.118053182070545	EGR1;TOMM40;CLPTM1
Colorectal cancer (diet interaction)	3/21	0.833607362429337	0.999994527882068	0	0	0.648669604962455	0.118053182070545	SUCLA2;GATA3;LCORL
Empathy quotient	3/21	0.833607362429337	0.999994527882068	0	0	0.648669604962455	0.118053182070545	CRTC2;KYNU;SLC39A1
Free thyroxine concentration	3/21	0.833607362429337	0.999994527882068	0	0	0.648669604962455	0.118053182070545	SNX29;NCOR1;NUCKS1
Iron status biomarkers (ferritin levels)	3/21	0.833607362429337	0.999994527882068	0	0	0.648669604962455	0.118053182070545	ABO;PMS1;LHPP
Phosphorus levels	3/21	0.833607362429337	0.999994527882068	0	0	0.648669604962455	0.118053182070545	RAD51AP1;LEMD2;ETV6
Response to fenofibrate (LDL cholesterol levels)	3/21	0.833607362429337	0.999994527882068	0	0	0.648669604962455	0.118053182070545	MAU2;AEBP2;GATAD2A
Gut microbiota (functional units)	9/56	0.835593303814503	0.999994527882068	0	0	0.745014765268749	0.13381453294134	CD86;ADAMTS13;CLMN;CD5;CACFD1;SLC9A9;CCL2;PPARG;SLC2A6
Metabolite levels (small molecules and protein measures)	6/39	0.836906231763321	0.999994527882068	0	0	0.707491479361119	0.125964077893238	BCAS3;GATM;LMAN2;HP;DVL2;PRKAG2
Anticoagulant levels	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	ELMO1
Beta thalassemia/hemoglobin E disease	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	HBS1L
Bipolar disorder lithium response (categorical) or schizophrenia	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	CMAHP
Bone mineral density (paediatric, upper limb)	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	FAM3C
Brain imaging in schizophrenia (dorsolateral prefrontal cortex interaction)	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	SLC12A2
Cannabis use (initiation)	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	SYNJ2
Chronic central serous retinopathy	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	PITPNC1
Circulating myeloperoxidase levels (plasma)	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	TAF5L
Circulating myeloperoxidase levels (serum)	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	ATP6V1B2
Epilepsy	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	GOLIM4
Food allergy (maternal genetic effects)	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	SNRPB2
HDL Cholesterol - Triglycerides (HDLC-TG)	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	BUD13
Hippocampal sclerosis	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	NEK11
Hypertension (SNP x SNP interaction)	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	XRCC4
Immune reponse to smallpox (secreted TNF-alpha)	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	CAMKMT
LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	MAU2
Language performance in older adults (adjusted for episodic memory)	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	CSGALNACT1
Lifespan	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	NRDE2
Liver enzyme levels (aspartate transaminase)	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	CELF2
Metabolite levels (HVA-5-HIAA Factor score)	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	RAB10
Metabolite levels (lipid measures)	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	FADS1
Milk allergy	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	LSP1
Multiple sclerosis (age of onset)	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	WDR7
Nephrolithiasis	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	DGKH
Neuroblastoma	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	HSD17B12
Non-alcoholic fatty liver disease histology (lobular)	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	FDFT1
Non-response to citalopram or escitalopram and depression	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	CSE1L
Osteoarthritis biomarkers	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	XRCC4
Parental longevity (both parents in top 10 percent)	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	CDKN2A
Placental abruption	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	DOCK2
Post bronchodilator FEV1/FVC ratio in smoking	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	HHAT
Post bronchodilator percent predicted FEV1 in smoking	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	HHAT
Response to TNF antagonist treatment	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	QKI
Response to tocilizumab in rheumatoid arthritis	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	RCHY1
Serum bilirubin levels x Mediterranean diet adherence interaction in metabolic syndrome	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	NAT1
Serum protein levels (sST2)	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	DENND1B
Smoking cessation in chronic obstructive pulmonary disease	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	ATXN7L1
Strenuous sports or other exercises	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	GATAD2A
Total ventricular volume	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	MGST3
Treatment response for severe sepsis	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	STARD3NL
Tumor biomarkers	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	ABO
Waist-to-hip ratio adjusted for BMI in inactive individuals	1/8	0.839445289566742	0.999994527882068	0	0	0.556114956996014	0.0973278890964085	WARS2
Stroke	12/73	0.840003387360974	0.999994527882068	0	0	0.765257970431459	0.13342223323217	ILF3;LRCH1;UBASH3B;WNK1;C6ORF62;GATA3;PMF1;PRPF8;HDAC9;SH2B3;LDLR;ABO
Atopic march	2/15	0.842775967993815	0.999994527882068	0	0	0.598813671029093	0.102429540716338	TMTC2;AP5B1
Behcet's disease	2/15	0.842775967993815	0.999994527882068	0	0	0.598813671029093	0.102429540716338	ERAP1;MICA
Common carotid intima-media thickness in HIV negative individuals	2/15	0.842775967993815	0.999994527882068	0	0	0.598813671029093	0.102429540716338	CCDC126;NCL
Dementia and core Alzheimer's disease neuropathologic changes	2/15	0.842775967993815	0.999994527882068	0	0	0.598813671029093	0.102429540716338	SLCO3A1;OSBPL1A
Digit length ratio	2/15	0.842775967993815	0.999994527882068	0	0	0.598813671029093	0.102429540716338	OLA1;FLI1
Esophageal cancer	2/15	0.842775967993815	0.999994527882068	0	0	0.598813671029093	0.102429540716338	TBL1XR1;RUNX1
Generalized epilepsy	2/15	0.842775967993815	0.999994527882068	0	0	0.598813671029093	0.102429540716338	MAST4;PNPO
Hair morphology	2/15	0.842775967993815	0.999994527882068	0	0	0.598813671029093	0.102429540716338	NAF1;THADA
Infant length	2/15	0.842775967993815	0.999994527882068	0	0	0.598813671029093	0.102429540716338	ZNFX1;LCORL
Obese vs. thin	2/15	0.842775967993815	0.999994527882068	0	0	0.598813671029093	0.102429540716338	GNPDA2;HIPK3
Paclitaxel-induced neuropathy	2/15	0.842775967993815	0.999994527882068	0	0	0.598813671029093	0.102429540716338	TRIO;LIMK2
Percentage gas trapping	2/15	0.842775967993815	0.999994527882068	0	0	0.598813671029093	0.102429540716338	SP1;AGER
Plasma clusterin levels	2/15	0.842775967993815	0.999994527882068	0	0	0.598813671029093	0.102429540716338	MTF2;THNSL2
Thrombosis	2/15	0.842775967993815	0.999994527882068	0	0	0.598813671029093	0.102429540716338	COX7A2L;ABO
Hemoglobin levels	5/34	0.852815191971762	0.999994527882068	0	0	0.670901687813614	0.106815875598526	PRKAG2;IKZF1;SH2B3;ABO;HK1
Bladder cancer	4/28	0.85302286067349	0.999994527882068	0	0	0.648583557841456	0.103104635197307	CDKAL1;LSP1;CLPTM1L;CWC27
Chin dimples	12/74	0.853202865954437	0.999994527882068	0	0	0.752867603403918	0.119523704784033	ATP6AP1L;SPCS3;ZHX2;RSRC1;TBL1XR1;DHX35;CDC5L;ASB7;DDHD1;ARHGAP15;KCNJ2;CNTLN
Migraine	12/74	0.853202865954437	0.999994527882068	0	0	0.752867603403918	0.119523704784033	UFL1;CFDP1;RNF213;INPP5A;FECH;ITPK1;CTR9;NCOA7;STAT6;NLRP1;CARF;TGFBR2
Small cell lung carcinoma	12/74	0.853202865954437	0.999994527882068	0	0	0.752867603403918	0.119523704784033	ABT1;BAG6;BTN3A1;NEU1;HLA-B;NEDD9;FOXN3;TMA16;HLA-DQA1;HLA-DRB1;HLA-E;SKAP2
Nickel levels	6/40	0.854569386811989	0.999994527882068	0	0	0.686639664442106	0.107910626671035	ZNF493;MYSM1;FAM86EP;DTL;PTK2;XKR6
C-reactive protein levels or LDL-cholesterol levels (pleiotropy)	3/22	0.856893175663637	0.999994527882068	0	0	0.614490437651425	0.094903142815347	IRF2BP2;LDLR;HLA-DQB1
Heart rate response to recovery post exercise (10 sec)	3/22	0.856893175663637	0.999994527882068	0	0	0.614490437651425	0.094903142815347	CLPB;NDUFA11;BCAT1
Waist circumference adjusted for BMI in non-smokers	11/69	0.860664860352163	0.999994527882068	0	0	0.737728841663565	0.110696282764522	ARFGEF2;CCDC91;MAP3K1;SMAD3;GNA12;FNDC3B;NFE2L3;TMEM38B;LCORL;PCSK5;WARS2
Asthma (childhood onset)	8/52	0.860921508004671	0.999994527882068	0	0	0.707348057679021	0.105926745638199	ATG3;MKLN1;KLHL5;REEP3;SMARCA2;XPR1;MICA;IL18R1
Pulse pressure	106/567	0.863786103922008	0.999994527882068	0	0	0.892477881651511	0.130685630574072	N6AMT1;PRDM8;MTCH2;KDM1A;NAB1;CTNND1;FAM13A;ICAM1;LACTB;PAIP2B;CCND2;DIP2A;PLEKHJ1;EOMES;MAP2K2;ARL15;SWAP70;SLX4IP;FNDC3B;LIG3;MORF4L1;MTAP;CFDP1;PRKD3;TBL1XR1;MSH5;SRFBP1;RIN3;MXRA7;STAM2;TRANK1;CLEC16A;ABO;ARHGAP12;INPP5B;FGGY;NADK;OSBPL7;PNPT1;SMAD3;CRADD;IDH2;MTHFR;CYBRD1;INO80;TRAPPC9;FOXN3;ARHGAP26;NDUFAF6;CNOT1;COPS8;ZCCHC2;USP36;DAZAP1;WDR1;CELF2;FHL2;PRKAG2;LSP1;CHD2;CD3D;TRIOBP;RPTOR;TCHP;PPP6C;UFL1;MCF2L;CNTRL;PHACTR4;ITGA1;SIRT1;ARID1B;CDYL2;TBC1D1;TMBIM4;MTF1;ZNF638;RNF207;PECAM1;BCAT1;MFGE8;CRK;CDC123;GOSR2;HDAC9;LRIG1;YKT6;CYTH1;SF3A3;PTCD3;TCF7L2;PTCD2;FBXL17;TTC1;PLXDC2;AIG1;SLC4A7;TSPAN14;SNX19;KANSL1;CYP20A1;CAPZA2;CCDC6;BUD13;B9D2;TNRC6B
Lumbar spine bone mineral density (trabecular)	2/16	0.868300863594789	0.999994527882068	0	0	0.556006294806784	0.0785175450119856	CCDC91;SPTBN1
Non-small cell lung cancer	2/16	0.868300863594789	0.999994527882068	0	0	0.556006294806784	0.0785175450119856	DLST;NAPG
Palmitic acid (16:0) levels	2/16	0.868300863594789	0.999994527882068	0	0	0.556006294806784	0.0785175450119856	ALG14;SLC15A4
Pulmonary function decline	2/16	0.868300863594789	0.999994527882068	0	0	0.556006294806784	0.0785175450119856	USP15;SYNE2
Resting metabolic rate	2/16	0.868300863594789	0.999994527882068	0	0	0.556006294806784	0.0785175450119856	ARFGAP3;RAMP1
Sexual dimorphism in anthropometric traits	2/16	0.868300863594789	0.999994527882068	0	0	0.556006294806784	0.0785175450119856	MAP3K1;PPARG
Vascular endothelial growth factor levels	2/16	0.868300863594789	0.999994527882068	0	0	0.556006294806784	0.0785175450119856	ZADH2;LRP12
Rosacea symptom severity	24/141	0.868575017471337	0.999994527882068	0	0	0.797490801921026	0.112367507578613	DDR1;ZNF100;PDCD6IP;TSC22D1;STARD3NL;TCF25;FANCA;DNAJC11;PIK3R1;AIF1;RPAP3;TTC27;HLA-E;STK3;FGD2;PSMB9;KIAA1109;RPS6KA1;PPP2R2D;PDE4B;HLA-DPB1;HMGN2;HLA-DQA1;MICA
LDL cholesterol levels	10/64	0.868803725382883	0.999994527882068	0	0	0.720346296750516	0.101308092627405	HBS1L;LRPAP1;TOMM40;IRF2BP2;LDLRAP1;LDLR;FADS1;ABO;SNX5;KPNA1
Smoking behavior	4/29	0.871854293499388	0.999994527882068	0	0	0.6226010286554	0.0853791242284457	SPOCK2;ACTN1;DNAJB9;CAMKK1
Sudden cardiac arrest	4/29	0.871854293499388	0.999994527882068	0	0	0.6226010286554	0.0853791242284457	PARP4;SIN3A;MCTP2;E2F6
Advanced glycation end-product levels	1/9	0.872267470528416	0.999994527882068	0	0	0.486569995105237	0.0664942516042804	AGER
Amino acid levels	1/9	0.872267470528416	0.999994527882068	0	0	0.486569995105237	0.0664942516042804	PSPH
Bone mineral density (femoral neck)	1/9	0.872267470528416	0.999994527882068	0	0	0.486569995105237	0.0664942516042804	UHMK1
Cerebrospinal fluid beta-site APP cleaving enzyme levels	1/9	0.872267470528416	0.999994527882068	0	0	0.486569995105237	0.0664942516042804	ATP6V1H
Cerebrospinal fluid p-Tau181p:AB1-42 ratio	1/9	0.872267470528416	0.999994527882068	0	0	0.486569995105237	0.0664942516042804	TOMM40
Ear morphology	1/9	0.872267470528416	0.999994527882068	0	0	0.486569995105237	0.0664942516042804	EDAR
End-stage coagulation	1/9	0.872267470528416	0.999994527882068	0	0	0.486569995105237	0.0664942516042804	ABO
Factor VII	1/9	0.872267470528416	0.999994527882068	0	0	0.486569995105237	0.0664942516042804	MCF2L
Liver transplant-free survival in primary sclerosing cholangitis (time to event)	1/9	0.872267470528416	0.999994527882068	0	0	0.486569995105237	0.0664942516042804	LCP2
Lobe attachment (rater-scored or self-reported)	1/9	0.872267470528416	0.999994527882068	0	0	0.486569995105237	0.0664942516042804	ARHGAP21
Metabolic syndrome (bivariate traits)	1/9	0.872267470528416	0.999994527882068	0	0	0.486569995105237	0.0664942516042804	BUD13
Optic nerve measurement (cup area)	1/9	0.872267470528416	0.999994527882068	0	0	0.486569995105237	0.0664942516042804	RFTN1
Putamen volume	1/9	0.872267470528416	0.999994527882068	0	0	0.486569995105237	0.0664942516042804	HELZ
Red blood cell density in sickle cell anemia	1/9	0.872267470528416	0.999994527882068	0	0	0.486569995105237	0.0664942516042804	RABEP1
Renal underexcretion gout	1/9	0.872267470528416	0.999994527882068	0	0	0.486569995105237	0.0664942516042804	SLC2A9
Response to inhaled corticosteroid treatment in asthma (change in FEV1)	1/9	0.872267470528416	0.999994527882068	0	0	0.486569995105237	0.0664942516042804	TNKS
Response to radiotherapy in cancer (late toxicity)	1/9	0.872267470528416	0.999994527882068	0	0	0.486569995105237	0.0664942516042804	ST8SIA4
Social autistic-like traits	1/9	0.872267470528416	0.999994527882068	0	0	0.486569995105237	0.0664942516042804	CBFA2T3
Staphylococcus aureus nasal carriage (persistent)	1/9	0.872267470528416	0.999994527882068	0	0	0.486569995105237	0.0664942516042804	MKLN1
Subiculum volume	1/9	0.872267470528416	0.999994527882068	0	0	0.486569995105237	0.0664942516042804	FBXW8
Tacrolimus trough concentration in kidney transplant patients	1/9	0.872267470528416	0.999994527882068	0	0	0.486569995105237	0.0664942516042804	TRIM4
Telomere length	7/47	0.872324209185762	0.999994527882068	0	0	0.680827205882353	0.0929969962243955	TTC37;RTEL1;RASGEF1A;PARP1;DHX35;ASCC2;TRDMT1
Blood sugar levels	3/23	0.877271342319739	0.999994527882068	0	0	0.583729187071499	0.0764328787557865	KCNQ1;CDKAL1;YKT6
Iron status biomarkers	3/23	0.877271342319739	0.999994527882068	0	0	0.583729187071499	0.0764328787557865	WTAP;PCSK7;ARSB
Lipid traits	3/23	0.877271342319739	0.999994527882068	0	0	0.583729187071499	0.0764328787557865	TOMM40;BUD13;ABO
Logical memory (immediate recall)	3/23	0.877271342319739	0.999994527882068	0	0	0.583729187071499	0.0764328787557865	TOMM40;CLPTM1;TRIB3
Parental longevity (father's attained age)	3/23	0.877271342319739	0.999994527882068	0	0	0.583729187071499	0.0764328787557865	ATXN2;SH2B3;MICA
Response to fenofibrate (HDL cholesterol levels)	3/23	0.877271342319739	0.999994527882068	0	0	0.583729187071499	0.0764328787557865	SATB1;CDC7;CNTLN
Squamous cell carcinoma	3/23	0.877271342319739	0.999994527882068	0	0	0.583729187071499	0.0764328787557865	SCYL2;HLA-DQA1;CNTLN
Gamma glutamyl transferase levels	9/59	0.877710189241693	0.999994527882068	0	0	0.700181461500736	0.0913308439222642	CYFIP2;KDM1A;AHNAK;SUMO2;ITGA1;APIP;ITPR1;NFE2L3;SYNJ2
HDL cholesterol levels	15/93	0.879419626124835	0.999994527882068	0	0	0.747837010729938	0.096091899432908	STARD3;ARL15;FAM13A;SNX13;IKZF1;PEPD;UBE2L3;TTC39B;PGS1;ALOX5;TAF8;AKT1;HDGF;ATG7;FADS1
Mean arterial pressure	18/110	0.883287219858478	0.999994527882068	0	0	0.760730657035699	0.0944103670992172	PRDM8;EOMES;HDAC4;CERS5;YES1;NOS3;SWAP70;GOSR2;MTHFR;PTPN11;LSP1;ST7L;SLC4A7;ATXN2;ARHGEF3;PHIP;SH2B3;SLC12A9
Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)	6/42	0.885178472817041	0.999994527882068	0	0	0.648411337090582	0.079084130723983	CLCN6;ATXN2;MTHFR;COX5A;SIPA1;ZNF652
Morning vs. evening chronotype	6/42	0.885178472817041	0.999994527882068	0	0	0.648411337090582	0.079084130723983	LMAN1;PER3;RASA4;SGSM3;TARS2;VAMP3
Resting-state electroencephalogram vigilance	6/42	0.885178472817041	0.999994527882068	0	0	0.648411337090582	0.079084130723983	SLC7A7;TMEM117;OSTF1;FRMD4B;PPARA;HDAC9
Systemic juvenile idiopathic arthritis	6/42	0.885178472817041	0.999994527882068	0	0	0.648411337090582	0.079084130723983	MTHFSD;HLA-DRA;ZNF37BP;RIN3;HDAC9;TAPT1
Cerebral amyloid deposition in APOEe4 non-carriers (PET imaging)	5/36	0.885787736934025	0.999994527882068	0	0	0.62753868280887	0.0761065934790345	ST7L;TMX3;RBM19;G2E3;PRDM2
Microalbuminuria	4/30	0.888564324455984	0.999994527882068	0	0	0.598617155560579	0.07072556175984	DAD1;PDSS2;PCBD1;ZNF444
Fat distribution (HIV)	2/17	0.889961930717737	0.999994527882068	0	0	0.51890656874745	0.0604923591669138	ARRDC4;KATNAL1
P wave duration	2/17	0.889961930717737	0.999994527882068	0	0	0.51890656874745	0.0604923591669138	CAMK2D;SSBP3
Red blood cell fatty acid levels	2/17	0.889961930717737	0.999994527882068	0	0	0.51890656874745	0.0604923591669138	FADS1;BEST1
Response to lurasidone in schizophrenia	2/17	0.889961930717737	0.999994527882068	0	0	0.51890656874745	0.0604923591669138	DYNC2H1;MTF2
Response to statins (LDL cholesterol change)	2/17	0.889961930717737	0.999994527882068	0	0	0.51890656874745	0.0604923591669138	EPB41L2;GMPR
Serum folate levels	2/17	0.889961930717737	0.999994527882068	0	0	0.51890656874745	0.0604923591669138	GM2A;MTHFR
Temperament	2/17	0.889961930717737	0.999994527882068	0	0	0.51890656874745	0.0604923591669138	SLC39A10;APBA2
Systolic blood pressure (cigarette smoking interaction)	10/66	0.892102886995515	0.999994527882068	0	0	0.694532043869792	0.0792973688436447	SLC4A7;CLCN6;ATXN2;TTYH2;NOS3;MTHFR;LSP1;SH2B3;SIPA1;ARNTL
Childhood body mass index	3/24	0.895027502437306	0.999994527882068	0	0	0.555897579403946	0.0616495041734058	GNPDA2;FAM120A;GALNT10
Diabetic kidney disease	3/24	0.895027502437306	0.999994527882068	0	0	0.555897579403946	0.0616495041734058	ITPR1;ANXA11;ITGA6
Irritable bowel syndrome	3/24	0.895027502437306	0.999994527882068	0	0	0.555897579403946	0.0616495041734058	EPSTI1;PIK3CD;KDELR2
Low tan response	3/24	0.895027502437306	0.999994527882068	0	0	0.555897579403946	0.0616495041734058	AFG3L1P;FANCA;PDE4B
Lumbar spine bone mineral density (integral)	3/24	0.895027502437306	0.999994527882068	0	0	0.555897579403946	0.0616495041734058	DUSP5;STARD3NL;SPTBN1
Presence of antiphospholipid antibodies	3/24	0.895027502437306	0.999994527882068	0	0	0.555897579403946	0.0616495041734058	PRKCSH;SESTD1;DSTN
Squamous cell lung carcinoma	23/139	0.896130119989165	0.999994527882068	0	0	0.770709594759707	0.0845234540899547	NDFIP1;XRCC4;CDCA7L;ELAC2;SRBD1;PBX3;DCAF8;BTN3A3;HLA-A;PDS5B;BTN3A2;FRY;REXO4;HLA-E;PANX1;MORF4L1;GNPDA1;WNK1;NEU1;CLPTM1L;MFGE8;HLA-DOB;HLA-DQA1
Acute insulin response	1/10	0.898381041882633	0.999994527882068	0	0	0.432479469190189	0.0463449228272206	CDKAL1
Age-related macular degeneration (geographic atrophy)	1/10	0.898381041882633	0.999994527882068	0	0	0.432479469190189	0.0463449228272206	MBP
Body mass index (SNP x SNP interaction)	1/10	0.898381041882633	0.999994527882068	0	0	0.432479469190189	0.0463449228272206	CDKAL1
Brain imaging	1/10	0.898381041882633	0.999994527882068	0	0	0.432479469190189	0.0463449228272206	TOMM40
Cerebrospinal fluid p-tau levels in Alzheimer's disease dementia	1/10	0.898381041882633	0.999994527882068	0	0	0.432479469190189	0.0463449228272206	MCTP2
Cholangiocarcinoma in primary sclerosing cholangitis	1/10	0.898381041882633	0.999994527882068	0	0	0.432479469190189	0.0463449228272206	DCTN4
Deep ovarian and/or rectovaginal disease with dense adhesions	1/10	0.898381041882633	0.999994527882068	0	0	0.432479469190189	0.0463449228272206	NFE2L3
Depressive symptoms (SSRI exposure interaction)	1/10	0.898381041882633	0.999994527882068	0	0	0.432479469190189	0.0463449228272206	RORC
Familial lung cancer	1/10	0.898381041882633	0.999994527882068	0	0	0.432479469190189	0.0463449228272206	STAT6
Fast beta electroencephalogram	1/10	0.898381041882633	0.999994527882068	0	0	0.432479469190189	0.0463449228272206	FRMD4B
Folate pathway vitamin levels	1/10	0.898381041882633	0.999994527882068	0	0	0.432479469190189	0.0463449228272206	MTHFR
Hepcidin/transferrin saturation ratio	1/10	0.898381041882633	0.999994527882068	0	0	0.432479469190189	0.0463449228272206	PAN3
Logical memory (immediate recall) in Alzheimer's disease dementia	1/10	0.898381041882633	0.999994527882068	0	0	0.432479469190189	0.0463449228272206	PSMF1
Migraine - clinic-based	1/10	0.898381041882633	0.999994527882068	0	0	0.432479469190189	0.0463449228272206	TGFBR2
Panic disorder	1/10	0.898381041882633	0.999994527882068	0	0	0.432479469190189	0.0463449228272206	USP25
Renal function-related traits (sCR)	1/10	0.898381041882633	0.999994527882068	0	0	0.432479469190189	0.0463449228272206	BCAS3
Response to citalopram or escitalopram in depression	1/10	0.898381041882633	0.999994527882068	0	0	0.432479469190189	0.0463449228272206	FAM136A
Subclinical trait of interstitial lung disease (basilar peel-core ratio of HAA on CT scan)	1/10	0.898381041882633	0.999994527882068	0	0	0.432479469190189	0.0463449228272206	SNAI3
Temperament (bipolar disorder)	1/10	0.898381041882633	0.999994527882068	0	0	0.432479469190189	0.0463449228272206	INTS7
Uterine fibroid size (maximum dimension)	1/10	0.898381041882633	0.999994527882068	0	0	0.432479469190189	0.0463449228272206	MAT2B
Very long-chain saturated fatty acid levels (fatty acid 22:0)	1/10	0.898381041882633	0.999994527882068	0	0	0.432479469190189	0.0463449228272206	MAT2B
HIV-1 viral setpoint	5/37	0.899751150576778	0.999994527882068	0	0	0.607889821166095	0.0642156894086302	GALNT14;PPP3CC;HLA-B;ZBTB20;HLA-DRA
Advanced age-related macular degeneration	9/61	0.900549511015371	0.999994527882068	0	0	0.673166522050779	0.070514283512759	CNN2;ARHGAP21;NPLOC4;GPX4;PBX2;TNFRSF10A;SKIV2L;SYN3;TGFBR1
Airflow obstruction	4/31	0.903334932413239	0.999994527882068	0	0	0.576409865657968	0.0585989126562552	SRP72;LEF1;SPATA13;ITPR1
Fasting blood glucose (BMI interaction)	4/31	0.903334932413239	0.999994527882068	0	0	0.576409865657968	0.0585989126562552	TCF7L2;CRY2;FOXN3;FADS1
Response to antidepressants (symptom improvement)	4/31	0.903334932413239	0.999994527882068	0	0	0.576409865657968	0.0585989126562552	CSGALNACT1;PTP4A3;DDX51;DISC1
Serum uric acid levels in response to allopurinol in gout	4/31	0.903334932413239	0.999994527882068	0	0	0.576409865657968	0.0585989126562552	NDE1;ZMYM6;THEM4;CDK13
Clozapine-induced agranulocytosis	11/73	0.904533857965337	0.999994527882068	0	0	0.689959321282725	0.0692274424932689	GADD45GIP1;GCDH;XRCC4;HLA-B;VPS54;NMT2;INTS7;HIGD1A;FARSA;LILRB4;MICA
Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)	12/79	0.906841354742691	0.999994527882068	0	0	0.696463693800934	0.0681056219241014	ARFGEF2;CCDC91;MAP3K1;SMAD3;GNA12;FNDC3B;NFE2L3;PEPD;TMEM38B;LCORL;PCSK5;WARS2
BMI in smokers	2/18	0.908272014123483	0.999994527882068	0	0	0.486444308445532	0.0468014734505938	INPP4B;GNPDA2
Diastolic blood pressure x smoking status (current vs non-current) interaction (1df test)	2/18	0.908272014123483	0.999994527882068	0	0	0.486444308445532	0.0468014734505938	NEDD9;ASB3
Heart rate increase in response to exercise	2/18	0.908272014123483	0.999994527882068	0	0	0.486444308445532	0.0468014734505938	MCTP2;BCAT1
Migraine without aura	2/18	0.908272014123483	0.999994527882068	0	0	0.486444308445532	0.0468014734505938	UFL1;STAT6
Obsessive-compulsive symptoms	2/18	0.908272014123483	0.999994527882068	0	0	0.486444308445532	0.0468014734505938	SAFB2;PEMT
Oleic acid (18:1n-9) levels	2/18	0.908272014123483	0.999994527882068	0	0	0.486444308445532	0.0468014734505938	PPT2;FADS1
Preeclampsia	2/18	0.908272014123483	0.999994527882068	0	0	0.486444308445532	0.0468014734505938	ERP44;RUNX1
Staphylococcus aureus nasal carriage (intermittent)	2/18	0.908272014123483	0.999994527882068	0	0	0.486444308445532	0.0468014734505938	GALC;UBE2E2
Low density lipoprotein cholesterol levels	6/44	0.910144821846382	0.999994527882068	0	0	0.614207044197114	0.0578285435413559	HP;NFE2L3;LDLR;ARID1B;ABO;NECTIN2
Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test)	6/44	0.910144821846382	0.999994527882068	0	0	0.614207044197114	0.0578285435413559	SLC4A7;CLCN6;SH2B3;SIPA1;XKR6;ZNF652
Pancreatic cancer	21/130	0.910282497823676	0.999994527882068	0	0	0.748845877877408	0.07039173004374	GABARAPL2;KLF12;WDR59;TFRC;PVT1;LPCAT1;ADAT1;GTF2H1;CCDC117;FAM91A1;ARID1B;ABO;SDHAP3;ARL4C;MKLN1;CFDP1;ADAMTS13;PAN3;EWSR1;CLPTM1L;SBF2
Aluminium levels	3/25	0.910437671432758	0.999994527882068	0	0	0.530596117887989	0.0497857475067573	SLC44A1;LRRC28;ICOS
Nicotine dependence and major depression (severity of comorbidity)	3/25	0.910437671432758	0.999994527882068	0	0	0.530596117887989	0.0497857475067573	ZFYVE28;PLXDC2;SULF2
Cerebrospinal AB1-42 levels in normal cognition	11/74	0.913496390189062	0.999994527882068	0	0	0.678964749131579	0.0614299160557461	NUDT7;RGS19;CAPZB;GPR65;MRTO4;UBR4;OPRL1;CLPTM1;PIGL;AP2B1;RUNX2
Creatinine levels	15/97	0.914258454451275	0.999994527882068	0	0	0.711177464181322	0.0637513521646556	PRDM8;MED1;BCAS3;SPPL2A;AKAP7;NFATC1;GAB2;AP5B1;PAX8;PSD4;ALMS1;MICALL2;HLA-DQA1;HLA-DRB1;DGKH
Chromium levels	4/32	0.916344415753441	0.999994527882068	0	0	0.555788810748399	0.0485553696740607	ITSN2;GALC;CRTC3;CEP170
Hematocrit	25/153	0.916381523996313	0.999994527882068	0	0	0.758987644633186	0.0662766910933034	HBS1L;L3MBTL3;PMS2CL;PVT1;POMP;PRKAG2;ABO;HK1;PTBP1;ATXN2;PSD4;MICALL2;ARHGEF40;SBF2;SH2B3;HLA-DQA1;ZNF641;EGLN1;BCAS3;AP3D1;HLA-A;FCGR2A;PRKAR1B;PPARG;ATXN10
Age-related macular degeneration (extreme sampling)	1/11	0.919156923597207	0.999994527882068	0	0	0.38920704845815	0.0328095378651573	PLEKHA1
Age-related nuclear cataracts	1/11	0.919156923597207	0.999994527882068	0	0	0.38920704845815	0.0328095378651573	MMAB
Bipolar disorder or attention deficit hyperactivity disorder	1/11	0.919156923597207	0.999994527882068	0	0	0.38920704845815	0.0328095378651573	ASCC2
Elevated serum carcinoembryonic antigen levels	1/11	0.919156923597207	0.999994527882068	0	0	0.38920704845815	0.0328095378651573	ABO
F-cell distribution	1/11	0.919156923597207	0.999994527882068	0	0	0.38920704845815	0.0328095378651573	YTHDC2
Fasting blood insulin	1/11	0.919156923597207	0.999994527882068	0	0	0.38920704845815	0.0328095378651573	TCF7L2
Homeostasis model assessment of beta-cell function	1/11	0.919156923597207	0.999994527882068	0	0	0.38920704845815	0.0328095378651573	FADS1
Hyperthyroidism	1/11	0.919156923597207	0.999994527882068	0	0	0.38920704845815	0.0328095378651573	CAPZB
Immune reponse to smallpox (secreted IL-12p40)	1/11	0.919156923597207	0.999994527882068	0	0	0.38920704845815	0.0328095378651573	ADORA2B
Neuritic plaque	1/11	0.919156923597207	0.999994527882068	0	0	0.38920704845815	0.0328095378651573	SLCO3A1
Parent of origin effect on language impairment (paternal)	1/11	0.919156923597207	0.999994527882068	0	0	0.38920704845815	0.0328095378651573	ABCC4
Proinsulin levels	1/11	0.919156923597207	0.999994527882068	0	0	0.38920704845815	0.0328095378651573	TCF7L2
Pursuit maintenance gain in psychotic disorders	1/11	0.919156923597207	0.999994527882068	0	0	0.38920704845815	0.0328095378651573	POP7
RR interval (heart rate)	1/11	0.919156923597207	0.999994527882068	0	0	0.38920704845815	0.0328095378651573	AKT3
Radiation response	1/11	0.919156923597207	0.999994527882068	0	0	0.38920704845815	0.0328095378651573	KDM4C
Response to alcohol consumption (flushing response)	1/11	0.919156923597207	0.999994527882068	0	0	0.38920704845815	0.0328095378651573	PTPN11
Response to citalopram treatment	1/11	0.919156923597207	0.999994527882068	0	0	0.38920704845815	0.0328095378651573	UBE3C
S-phenylmercapturic acid levels in smokers	1/11	0.919156923597207	0.999994527882068	0	0	0.38920704845815	0.0328095378651573	DERL3
Tanning	1/11	0.919156923597207	0.999994527882068	0	0	0.38920704845815	0.0328095378651573	EXOC2
Ticagrelor levels in individuals with acute coronary syndromes treated with ticagrelor	1/11	0.919156923597207	0.999994527882068	0	0	0.38920704845815	0.0328095378651573	STAG3
Virologic severity in Herpes simplex virus type 2 infection	1/11	0.919156923597207	0.999994527882068	0	0	0.38920704845815	0.0328095378651573	CEP120
Metabolic syndrome	6/45	0.920759781864388	0.999994527882068	0	0	0.598420447477051	0.049403258251784	GLTP;TCF7L2;TOMM40;DYRK1A;BUD13;FADS1
Dental caries	11/75	0.921739507038778	0.999994527882068	0	0	0.668313757360157	0.0544626428596385	PHTF2;IFT88;TWSG1;RTEL1;RPS6KA2;ACAD9;SIDT1;PTK2B;ATXN7L1;TGFBR1;EXOC2
Waist circumference adjusted for BMI (adjusted for smoking behaviour)	12/81	0.923166465568287	0.999994527882068	0	0	0.67619098426247	0.0540585669885402	ARFGEF2;CCDC91;MAP3K1;SMAD3;GNA12;FNDC3B;NFE2L3;PEPD;TMEM38B;LCORL;PCSK5;WARS2
Serum alkaline phosphatase levels	5/39	0.923279221017376	0.999994527882068	0	0	0.5720595440528	0.0456638382524287	ATP6AP1L;TRIM5;SURF6;TNFRSF11A;ABO
Cerebrospinal AB1-42 levels in mild cognitive impairment	2/19	0.923695758217379	0.999994527882068	0	0	0.457801137590899	0.0363368334099345	TOMM40;CLPTM1
Obsessive-compulsive disorder	2/19	0.923695758217379	0.999994527882068	0	0	0.457801137590899	0.0363368334099345	ADCK1;TUBGCP5
Cerebrospinal fluid p-tau levels in mild cognitive impairment	3/26	0.923763178447376	0.999994527882068	0	0	0.507494783460376	0.0402441031714177	TOMM40;CLPTM1;OPTN
Erosive tooth wear (severe vs none or mild)	3/26	0.923763178447376	0.999994527882068	0	0	0.507494783460376	0.0402441031714177	PTP4A3;GNPDA1;SKAP2
Amyotrophic lateral sclerosis (sporadic)	30/182	0.925259071480564	0.999994527882068	0	0	0.766754667047209	0.0595626552811324	PVT1;MAT2B;CHD2;NR3C2;INPP5B;IFT74;ZFYVE26;RNF19A;RPS6KA1;LRRC8C;HADH;DISC1;TP53I11;TAPT1;CNTLN;CRBN;RBM19;NFATC2;SMARCA2;FLI1;SREBF2;INPP4B;TBC1D1;SNX19;SP4;TBXAS1;C22ORF34;INTS6;SLC25A12;PFKP
Nonsyndromic cleft lip with cleft palate	4/33	0.927764371691203	0.999994527882068	0	0	0.536589897556732	0.0402321627402044	TAF1B;GOSR2;TMEM19;RAD54B
Social communication problems	4/33	0.927764371691203	0.999994527882068	0	0	0.536589897556732	0.0402321627402044	GORASP1;TRIM27;RNF111;RAB8B
Cognitive ability	8/58	0.928034328635881	0.999994527882068	0	0	0.622230938955626	0.0464722851302712	KANSL1;GPD2;ZNF638;IVD;TET2;EXOC4;AFF3;ST3GAL3
Visceral adipose tissue/subcutaneous adipose tissue ratio	8/58	0.928034328635881	0.999994527882068	0	0	0.622230938955626	0.0464722851302712	ZNF484;SUCLA2;UBE2E2;TMEM38B;TRAK1;LPP;BACH2;BICD2
Visceral fat	6/46	0.930259381625967	0.999994527882068	0	0	0.583423180592992	0.0421767274918686	TLE1;NSUN2;SLC35C1;CRY2;MYCBPAP;THNSL2
Body mass index x age interaction	5/40	0.933094876391025	0.999994527882068	0	0	0.555679988801008	0.0384799466418272	TOMM40;FPGT;BCL3;CLPTM1;CLASRP
Serum albumin level	5/40	0.933094876391025	0.999994527882068	0	0	0.555679988801008	0.0384799466418272	SPCS3;FCGRT;HLA-B;TNFRSF11A;ZCCHC2
Cerebrospinal fluid t-tau levels	3/27	0.935247474914985	0.999994527882068	0	0	0.486318560235064	0.0325561610814329	TOMM40;CDCA4;CLPTM1
Heart rate response to recovery post exercise (50 sec)	3/27	0.935247474914985	0.999994527882068	0	0	0.486318560235064	0.0325561610814329	NDUFA11;BCAT1;MCTP2
Knee osteoarthritis	3/27	0.935247474914985	0.999994527882068	0	0	0.486318560235064	0.0325561610814329	CRBN;WWP2;HLA-DQB1
Metabolite levels (lipoprotein measures)	3/27	0.935247474914985	0.999994527882068	0	0	0.486318560235064	0.0325561610814329	LDLR;ABO;TTC39B
Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)	1/12	0.935685939604669	0.999994527882068	0	0	0.353802340586482	0.0235191497831461	PRDM1
Caffeine metabolism (plasma paraxanthine caffeine ratio)	1/12	0.935685939604669	0.999994527882068	0	0	0.353802340586482	0.0235191497831461	ARID3B
Chronic venous disease	1/12	0.935685939604669	0.999994527882068	0	0	0.353802340586482	0.0235191497831461	SKAP2
Cleft lip with or without cleft palate (maternal periconceptional vitamin use interaction)	1/12	0.935685939604669	0.999994527882068	0	0	0.353802340586482	0.0235191497831461	COTL1
Energy expenditure (24h)	1/12	0.935685939604669	0.999994527882068	0	0	0.353802340586482	0.0235191497831461	INSIG1
Eye color	1/12	0.935685939604669	0.999994527882068	0	0	0.353802340586482	0.0235191497831461	FBXL17
Freckles	1/12	0.935685939604669	0.999994527882068	0	0	0.353802340586482	0.0235191497831461	AKAP1
Interleukin-1-receptor antagonist levels	1/12	0.935685939604669	0.999994527882068	0	0	0.353802340586482	0.0235191497831461	ASB3
Modified Stumvoll Insulin Sensitivity Index (BMI interaction)	1/12	0.935685939604669	0.999994527882068	0	0	0.353802340586482	0.0235191497831461	BCL2
Multiple sclerosis (severity)	1/12	0.935685939604669	0.999994527882068	0	0	0.353802340586482	0.0235191497831461	C1GALT1
Obstructive sleep apnea trait (average respiratory event duration)	1/12	0.935685939604669	0.999994527882068	0	0	0.353802340586482	0.0235191497831461	ARRB1
Oral cavity and pharyngeal cancer	1/12	0.935685939604669	0.999994527882068	0	0	0.353802340586482	0.0235191497831461	HLA-DQB1
PR segment	1/12	0.935685939604669	0.999994527882068	0	0	0.353802340586482	0.0235191497831461	LRCH1
Prevalent atrial fibrillation	1/12	0.935685939604669	0.999994527882068	0	0	0.353802340586482	0.0235191497831461	KIFAP3
Renal function-related traits (eGRFcrea)	1/12	0.935685939604669	0.999994527882068	0	0	0.353802340586482	0.0235191497831461	BCAS3
Response to zileuton treatment in asthma (FEV1 change interaction)	1/12	0.935685939604669	0.999994527882068	0	0	0.353802340586482	0.0235191497831461	GLT1D1
Small vessel stroke	1/12	0.935685939604669	0.999994527882068	0	0	0.353802340586482	0.0235191497831461	ATG7
Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN)	1/12	0.935685939604669	0.999994527882068	0	0	0.353802340586482	0.0235191497831461	TCF19
Thrombin-activatable fibrinolysis inhibitor levels	1/12	0.935685939604669	0.999994527882068	0	0	0.353802340586482	0.0235191497831461	RBM19
Borderline personality disorder	2/20	0.936647887768885	0.999994527882068	0	0	0.43234054127567	0.0282957606966488	STX8;PKP4
Metabolite levels (Dihydroxy docosatrienoic acid)	2/20	0.936647887768885	0.999994527882068	0	0	0.43234054127567	0.0282957606966488	PVT1;AAK1
Type 2 diabetes (SNP x SNP interaction, 2df)	2/20	0.936647887768885	0.999994527882068	0	0	0.43234054127567	0.0282957606966488	TCF7L2;YTHDF3
Venous thromboembolism	2/20	0.936647887768885	0.999994527882068	0	0	0.43234054127567	0.0282957606966488	SUSD1;ABO
White blood cell types	2/20	0.936647887768885	0.999994527882068	0	0	0.43234054127567	0.0282957606966488	HBS1L;ITGA4
Lung cancer in never smokers	4/34	0.937757555865713	0.999994527882068	0	0	0.518670911911176	0.0333317806633369	MKLN1;MTAP;FUBP1;OGDH
Periodontal microbiota	4/34	0.937757555865713	0.999994527882068	0	0	0.518670911911176	0.0333317806633369	TBC1D1;FBXO38;RUNX2;VAMP3
Serum metabolite concentrations in chronic kidney disease	4/34	0.937757555865713	0.999994527882068	0	0	0.518670911911176	0.0333317806633369	THEM4;ACADM;SYNE2;FADS1
Autism spectrum disorder, ADHD, bipolar disorder, MDD, and schizophrenia (combined)	6/47	0.938737668056283	0.999994527882068	0	0	0.569157487703277	0.0359816881883794	HDAC4;RERE;ZMIZ1;STT3A;ENO1;SMARCA2
Huntington's disease progression	6/47	0.938737668056283	0.999994527882068	0	0	0.569157487703277	0.0359816881883794	PTDSS1;CCDC12;DHX35;RNASET2;PTPRM;MFSD10
Diastolic blood pressure	117/646	0.9396504198509	0.999994527882068	0	0	0.857055515610938	0.053349448931094	PRDM8;MAPKBP1;MTCH2;CLPB;NAB1;SAYSD1;PRDM1;PREX1;SLK;UBASH3B;DPYSL2;GPBP1;CDK5RAP1;EPC1;UBAP2L;DIP2B;GTF2I;EOMES;MORC3;SWAP70;SLC35C1;HLA-B;UBE2E2;ST7L;MTAP;PRKD3;STIM2;PHIP;FAM76B;ARHGAP15;ABO;ZFP36L2;SLC5A5;ATXN2;ATXN7;ICOS;YES1;PNPT1;POU2F1;HSPA4;RAB3IP;MTHFR;INO80;GPR137B;QKI;ZZEF1;PTK2;ZBTB9;DLG1;NACA;REEP3;MDM4;PAM;ZNF652;ZSCAN2;RERE;MAST4;ZFAND2A;CHD6;ATP2A3;PRKAG2;LSP1;UFL1;OPA1;PSD4;MCF2L;METTL15;CERS5;BCKDHB;SLC39A13;GAB2;PPHLN1;SENP2;NCOR2;TBC1D1;ZAP70;PTP4A3;CREB1;PAX8;AEBP2;POC5;KIF2A;IRF1;PIGL;MCTP2;HLA-DQB1;SDCCAG8;MCPH1;HDAC4;LEF1;MRPS31;ATP10A;FOXK1;ARNTL;OGFRL1;MXI1;VPS54;BAK1;SH2B3;ZNF100;PTCD3;NOS3;C1GALT1;TTC1;PTPN11;MYO9B;RRP1B;ARID3B;KLF2;SLC4A7;CLCN6;SLCO3A1;SLMAP;CAPZA1;CYP20A1;CCM2;SIPA1
Cerebrospinal fluid AB1-42 levels	8/60	0.94305278107098	0.999994527882068	0	0	0.598223546495182	0.0350756570376923	SERPINB1;TRAPPC6A;TOMM40;ELMO1;CLPTM1;LRP8;RNF111;SULF2
Diastolic blood pressure x alcohol consumption interaction (2df test)	14/96	0.944643609914296	0.999994527882068	0	0	0.663602665980011	0.0377905493100944	TNKS;NOS3;LSP1;ST7L;SLC4A7;CLCN6;ATXN2;POC1B;CEP170;MDM4;SH2B3;SIPA1;ZNF652;SDCCAG8
Epilepsy and lamotrigine-induced maculopapular eruptions	3/28	0.945114382721369	0.999994527882068	0	0	0.466836434867777	0.0263525987842824	COTL1;PDE7A;HDAC9
Alzheimer's disease	6/48	0.946284763468445	0.999994527882068	0	0	0.555571113522596	0.0306740460721812	MS4A6A;TOMM40;STK24;FANCD2;BCL3;DISC1
Cerebrospinal P-tau181p levels	6/48	0.946284763468445	0.999994527882068	0	0	0.555571113522596	0.0306740460721812	SUN1;TOMM40;CCSER2;NFATC1;DNAAF5;EXOC1
Creatine kinase levels	6/48	0.946284763468445	0.999994527882068	0	0	0.555571113522596	0.0306740460721812	PSMA6;CSF1;SNX13;GAB2;PEPD;ABO
Bone mineral density (spine)	4/35	0.946476467327809	0.999994527882068	0	0	0.501907989855656	0.0276095426789657	STARD3NL;CCZ1B;TNFRSF11A;SPTBN1
Alzheimer's disease in APOE e4+ carriers	2/21	0.947494202714022	0.999994527882068	0	0	0.409560007730464	0.0220893980805756	PEX6;SORD
Homeostasis model assessment of beta-cell function (dietary factor interaction)	2/21	0.947494202714022	0.999994527882068	0	0	0.409560007730464	0.0220893980805756	CYB5B;NFKB1
Interleukin-6 levels	2/21	0.947494202714022	0.999994527882068	0	0	0.409560007730464	0.0220893980805756	SYN3;BACH2
Iron status biomarkers (iron levels)	2/21	0.947494202714022	0.999994527882068	0	0	0.409560007730464	0.0220893980805756	FIG4;HLA-DQB1
Age-related macular degeneration	9/67	0.948678848005325	0.999994527882068	0	0	0.603300299335374	0.0317848452604935	DDR1;TOMM40;ATF6B;PLEKHA1;STK19;TNFRSF10A;SKIV2L;SYN3;TGFBR1
Hearing function	1/13	0.948836034009775	0.999994527882068	0	0	0.324298417360091	0.0170319170987115	SIK3
Magnesium levels	1/13	0.948836034009775	0.999994527882068	0	0	0.324298417360091	0.0170319170987115	PRMT7
Metabolite levels (MHPG)	1/13	0.948836034009775	0.999994527882068	0	0	0.324298417360091	0.0170319170987115	TCHP
Response to anti-depressant treatment in major depressive disorder	1/13	0.948836034009775	0.999994527882068	0	0	0.324298417360091	0.0170319170987115	SACM1L
Skin aging (microtopography measurement)	1/13	0.948836034009775	0.999994527882068	0	0	0.324298417360091	0.0170319170987115	ZNF518B
Skin pigmentation	1/13	0.948836034009775	0.999994527882068	0	0	0.324298417360091	0.0170319170987115	PRPF18
Body mass index (joint analysis main effects and physical activity interaction)	13/91	0.949116990980931	0.999994527882068	0	0	0.647807232858779	0.0338305730333982	TCF7L2;MTCH2;ADPGK;FBXL17;LEMD2;TRIM8;POC5;GNPDA2;TBX21;RASA2;BBS4;KCTD15;MAP2K5
Lipoprotein (a) levels	5/42	0.949418287930735	0.999994527882068	0	0	0.525577022392309	0.0272805012912746	TAGAP;PHF11;DLEU2;SYNJ2;ARID1B
Myopia (pathological)	5/42	0.949418287930735	0.999994527882068	0	0	0.525577022392309	0.0272805012912746	DENND1A;SEMA4F;SPTBN1;FLI1;PML
Coronary artery calcification	7/55	0.950843630699411	0.999994527882068	0	0	0.567070057189543	0.028583538309872	RGS2;IFT88;CDKN2A;NUMB;FBXO3;PRKCA;WDR33
Endometriosis	6/49	0.952986234989779	0.999994527882068	0	0	0.542616663722412	0.0261296073931439	VEZT;C7ORF50;CDKN2A;ITPK1;NFE2L3;HLA-DRA
Metabolite levels  (X-11787)	3/29	0.953567424843394	0.999994527882068	0	0	0.448852934528743	0.0213407771573928	COMMD10;ALMS1;DGKH
Monoclonal gammopathy of undetermined significance	3/29	0.953567424843394	0.999994527882068	0	0	0.448852934528743	0.0213407771573928	PREX1;ETNK1;CRYL1
Obesity (extreme)	3/29	0.953567424843394	0.999994527882068	0	0	0.448852934528743	0.0213407771573928	GNPDA2;CEP120;RTN4
Body mass index in physically active individuals	11/80	0.953612005709961	0.999994527882068	0	0	0.61968966449062	0.0294342631413866	TRIM8;TCF7L2;MTCH2;POC5;GNPDA2;ADPGK;RASA2;FBXL17;BBS4;KCTD15;MAP2K5
Venous thromboembolism adjusted for sickle cell variant rs77121243-T	12/86	0.953705532842492	0.999994527882068	0	0	0.630303432266622	0.0298765849944575	CMTM7;ABCC1;TBC1D4;ZNF71;CLMN;DSCC1;DAPK2;ZFP64;CD48;IQGAP2;JAKMIP2;LHPP
Emphysema imaging phenotypes	4/36	0.954062520051448	0.999994527882068	0	0	0.486192750428606	0.0228637367636287	ARL15;ANKRD12;AGER;HLA-DQB1
Logical memory (immediate recall) in normal cognition	4/36	0.954062520051448	0.999994527882068	0	0	0.486192750428606	0.0228637367636287	PI4K2B;ANAPC4;ZCCHC4;LMF1
Cerebrospinal fluid t-tau:AB1-42 ratio	5/43	0.956142055802809	0.999994527882068	0	0	0.511713814177777	0.0229497418274205	RABGAP1L;TOMM40;DAPK2;BRAF;ZDHHC3
Prostate-specific antigen levels	5/43	0.956142055802809	0.999994527882068	0	0	0.511713814177777	0.0229497418274205	APIP;SLC41A1;COMMD3;NUCKS1;CLPTM1L
Heart rate response to recovery post exercise (30 sec)	2/22	0.956554250601481	0.999994527882068	0	0	0.38905752753978	0.0172810692858465	NDUFA11;BCAT1
Dupuytren's disease	7/56	0.956723322227286	0.999994527882068	0	0	0.55546218487395	0.0245742240783601	ISG20;ZNF264;RAB31;CFDP1;EIF3E;CARD11;SAV1
Mean arterial pressure x alcohol consumption interaction (2df test)	11/81	0.958396284013391	0.999994527882068	0	0	0.610798401794476	0.0259552238641895	ST7L;SLC4A7;CLCN6;ATXN2;POC1B;LSP1;MRPL23;COX5A;SH2B3;SIPA1;ZNF652
Inflammatory skin disease	13/93	0.95848224670461	0.999994527882068	0	0	0.631532277859597	0.0267796454094701	RAP1GAP2;ERAP1;IFNLR1;ADAM19;KIAA1109;RNF114;UBLCP1;TBL1XR1;ANXA6;ELMO1;POLI;KPNA3;EXOC2
Waist circumference	10/75	0.958713892445377	0.999994527882068	0	0	0.598026452331088	0.0252143429728454	TCF7L2;TOMM40;MAP3K1;GNPDA2;DENND1A;QPCTL;CEP120;ZFP64;SLC39A13;MAP2K5
Caffeine consumption	1/14	0.959297801430395	0.999994527882068	0	0	0.299333559245454	0.0124384226107512	COX5A
Corneal curvature	1/14	0.959297801430395	0.999994527882068	0	0	0.299333559245454	0.0124384226107512	CMPK1
Excessive daytime sleepiness	1/14	0.959297801430395	0.999994527882068	0	0	0.299333559245454	0.0124384226107512	ASB3
Immune reponse to smallpox (secreted IL-1beta)	1/14	0.959297801430395	0.999994527882068	0	0	0.299333559245454	0.0124384226107512	VPS26A
Periodontitis (DPAL)	1/14	0.959297801430395	0.999994527882068	0	0	0.299333559245454	0.0124384226107512	LRP12
Plasma PCSK9 levels in stable coronary artery disease	1/14	0.959297801430395	0.999994527882068	0	0	0.299333559245454	0.0124384226107512	TOM1
Subcortical brain region volumes	1/14	0.959297801430395	0.999994527882068	0	0	0.299333559245454	0.0124384226107512	RNF146
Thyroid cancer	1/14	0.959297801430395	0.999994527882068	0	0	0.299333559245454	0.0124384226107512	SMAD3
Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	1/14	0.959297801430395	0.999994527882068	0	0	0.299333559245454	0.0124384226107512	CCDC149
Hip circumference	9/69	0.959354681353991	0.999994527882068	0	0	0.583116723884257	0.0241960946089983	TCF7L2;CLIP1;L3MBTL3;PDXDC1;GNPDA2;GNA12;NF1;SLC39A13;LIN7C
Urinary albumin excretion	8/63	0.960401799833414	0.999994527882068	0	0	0.56548619314003	0.0228476443582819	MAPKBP1;MAT2A;SPATA5L1;ARL15;ACTN1;CWC27;SBF2;NR3C2
Lipid metabolism phenotypes	4/37	0.960645678507497	0.999994527882068	0	0	0.471429949754711	0.0189277422131713	FCGR2A;PPP1R11;LDLR;FADS1
Adiponectin levels	3/30	0.960789947466562	0.999994527882068	0	0	0.432201545325933	0.0172878331530077	ARL15;ATP6V0A2;PEPD
Glomerular filtration rate in chronic kidney disease	3/30	0.960789947466562	0.999994527882068	0	0	0.432201545325933	0.0172878331530077	KYNU;RBM19;TAPT1
Refractive error	3/30	0.960789947466562	0.999994527882068	0	0	0.432201545325933	0.0172878331530077	PCCA;KCNJ2;CNDP2
Heel bone mineral density	163/898	0.963779791758933	0.999994527882068	0	0	0.857799552032842	0.0316463204366868	ERO1A;CRTC3;ZBTB25;NAB1;GPATCH1;MSMO1;FGFRL1;UBE2L3;PPP1CB;STK10;HHAT;CCDC91;RPS6KA5;EPSTI1;COTL1;PIEZO1;LUC7L;SMARCAD1;TRIM27;ATXN7L1;FAM3C;DLEU2;PDE8A;GTF2I;USP8;PDHX;MAP2K2;SLX4IP;ARRDC2;FAM118A;HLA-A;TRPC4AP;RUNX1;PRKD3;SPATA13;ANAPC4;PRKD2;ANAPC1;LLGL2;MACF1;L3MBTL3;ITPR2;TMTC2;THADA;TNFRSF11A;ARHGAP15;ABO;ZFP36L2;SAV1;CAMSAP2;STK3;PGS1;SBNO2;BCL2L11;INPP5A;DPP8;EPB41L2;VTI1A;SLC38A9;ATG7;RAB11FIP3;MARK3;ARSB;SPTBN1;CNTLN;ARL14EP;PRELID1;SMAD3;CRADD;XRCC4;HSPA4;IRF2BP2;CYBRD1;NFATC1;FOXN3;ARHGAP26;FLI1;ZZEF1;CNOT4;CYLD;DLG1;RGCC;TBXAS1;BCL2;RAB5A;PLEKHM3;DHRS12;RERE;ITK;USP36;DENND1A;DOCK8;ITGB2;SRP54;SNX13;N4BP2L2;CLYBL;FLCN;TMEM43;CAPZB;PPP6R2;CTLA4;LINC01547;ZNF800;MRPS28;DUSP5;ZNF484;ACTR2;BCAS3;KLF12;STARD3NL;ITGA1;TET2;VPS13B;SYN3;ARID1B;ZNF75A;TGFBR2;MS4A6A;FAM234A;ZNF638;PPARG;LCORL;PPARD;GAS7;MCPH1;HDAC4;AHCY;AHNAK;NUFIP2;IGHMBP2;FOXK2;FOXK1;SPG7;AIF1;SNX29;EXOSC10;POLR2A;LRRC8C;RAB28;PCNT;MICA;CYB5B;SF3A3;SPEN;TCF7L2;ZNF460;PCGF3;PLXDC2;SORL1;KLF2;MPP7;MKLN1;RSL1D1;NFIA;VAPA;APC;CCDC6;CTNNB1;CDK2AP1;EIF3E;ATXN10;CD68
Adolescent idiopathic scoliosis	2/23	0.964104950484732	0.999994527882068	0	0	0.370507664510112	0.0135439523223548	CHD2;ABO
Cardiac hypertrophy	2/23	0.964104950484732	0.999994527882068	0	0	0.370507664510112	0.0135439523223548	PHF11;SLC2A1
Electrocardiographic traits	2/23	0.964104950484732	0.999994527882068	0	0	0.370507664510112	0.0135439523223548	KCNH2;KCNQ1
Heart rate response to recovery post exercise (40 sec)	2/23	0.964104950484732	0.999994527882068	0	0	0.370507664510112	0.0135439523223548	NDUFA11;BCAT1
Response to metformin (IC50)	2/23	0.964104950484732	0.999994527882068	0	0	0.370507664510112	0.0135439523223548	SH3TC1;GOLIM4
Uric acid levels	3/31	0.966945798826776	0.999994527882068	0	0	0.416739541066182	0.0140077978281809	SLC2A9;WDR1;VPS45
Blood trace element (Cu levels)	1/15	0.967620718164696	0.999994527882068	0	0	0.277935109432907	0.00914825874227857	DFFB
D-dimer levels	1/15	0.967620718164696	0.999994527882068	0	0	0.277935109432907	0.00914825874227857	ABO
Pancreatic ductal adenocarcinoma	1/15	0.967620718164696	0.999994527882068	0	0	0.277935109432907	0.00914825874227857	STARD3
Personality dimensions	1/15	0.967620718164696	0.999994527882068	0	0	0.277935109432907	0.00914825874227857	DENND1A
Response to taxane treatment (docetaxel)	1/15	0.967620718164696	0.999994527882068	0	0	0.277935109432907	0.00914825874227857	SLC6A6
Sense of smell	1/15	0.967620718164696	0.999994527882068	0	0	0.277935109432907	0.00914825874227857	TOMM40
Subjective response to lithium treatment in bipolar disorder	1/15	0.967620718164696	0.999994527882068	0	0	0.277935109432907	0.00914825874227857	G3BP2
Urinary albumin-to-creatinine ratio	1/15	0.967620718164696	0.999994527882068	0	0	0.277935109432907	0.00914825874227857	CELF2
Body mass index in physically inactive individuals	2/24	0.970384666727106	0.999994527882068	0	0	0.353644152664961	0.0106315060108482	GNPDA2;TBX21
Cerebrospinal fluid p-tau levels	2/24	0.970384666727106	0.999994527882068	0	0	0.353644152664961	0.0106315060108482	CLPTM1;OPTN
Fasting insulin (dietary factor interaction)	2/24	0.970384666727106	0.999994527882068	0	0	0.353644152664961	0.0106315060108482	SNX29;MAP3K1
Liver enzyme levels (alkaline phosphatase)	2/24	0.970384666727106	0.999994527882068	0	0	0.353644152664961	0.0106315060108482	ABO;FADS1
Tuberculosis (SNP x SNP interaction)	2/24	0.970384666727106	0.999994527882068	0	0	0.353644152664961	0.0106315060108482	LPCAT2;SPATS2L
Bronchopulmonary dysplasia	4/39	0.971266155962878	0.999994527882068	0	0	0.444435114236731	0.0129573916435732	KLF12;STXBP5;CEP170;PLXDC2
Nose size	4/39	0.971266155962878	0.999994527882068	0	0	0.444435114236731	0.0129573916435732	EIF4E3;TNKS;DHX35;SMARCA2
Menarche (age at onset)	33/212	0.971269975353965	0.999994527882068	0	0	0.715510992660535	0.0208577256201357	ZNF131;WDR25;SLC44A1;TCF7;NUCKS1;PIK3R1;LIN7C;GALNT10;ARNTL;TMEM245;FPGT;AKT3;SMARCAD1;WDR6;TMEM38B;MAP2K5;GTF2I;EEFSEC;SMAD2;ZNF483;KLF12;KDM4C;VDR;WWP2;HLA-A;GAB2;SIRT3;SEC23IP;GNPDA2;ALMS1;C22ORF34;NCOA7;SSBP3
Neurociticism	13/97	0.972765359239567	0.999994527882068	0	0	0.601307361432545	0.0166035260008697	BTN2A2;ACTN1;PLCL2;FBXL17;GALNT10;FBXO31;ARNTL;AGO2;TMEM106B;ACP2;TRIM27;PRR14;PAFAH1B1
Body mass index (age <50)	6/53	0.972868388150025	0.999994527882068	0	0	0.496311396351541	0.0136517744959341	DTNB;FPGT;FIGNL1;IKZF1;EIF3F;TMEM9B
Regular attendance at a pub or social club	6/53	0.972868388150025	0.999994527882068	0	0	0.496311396351541	0.0136517744959341	ADSL;UBA6;SGSM3;STAP1;LZTS2;TNRC6B
Aging	1/16	0.974241973326502	0.999994527882068	0	0	0.259389786262033	0.00676892526379434	MAT2B
Alcohol consumption (maxi-drinks)	1/16	0.974241973326502	0.999994527882068	0	0	0.259389786262033	0.00676892526379434	PTPN11
Cotinine glucuronidation	1/16	0.974241973326502	0.999994527882068	0	0	0.259389786262033	0.00676892526379434	FAM107B
Macular thickness	29/191	0.974537679765386	0.999994527882068	0	0	0.694830817346014	0.0179211424778621	GTF2A2;DENND1A;STK39;NEDD9;LRRC37A4P;ARHGAP22;COTL1;ARSB;KCNJ2;BPTF;LIN52;EOMES;BCAS3;DTNB;BOD1;INO80;SORL1;MPP7;SENP1;SLC4A7;ARHGAP32;MTAP;NDUFAF6;KANSL1;NUMB;FAM76B;EIF3E;GLCCI1;SKAP2
Spherical equivalent or myopia (age of diagnosis)	29/191	0.974537679765386	0.999994527882068	0	0	0.694830817346014	0.0179211424778621	L3MBTL3;ANTXR2;RCBTB1;APH1B;POLR2A;SSR1;ARID2;METTL15;KCNJ2;CD55;MED1;ARL14EP;USP25;TCF7L2;METAP1D;PNPT1;CCZ1B;API5;FNDC3B;AP5B1;SYN3;TGFBR1;CAMKMT;GATAD2A;PCCA;GPD2;HAT1;LSM14A;KCTD15
Intraocular pressure	67/401	0.975475739726288	0.999994527882068	0	0	0.777395209580838	0.0193027143522021	TES;SLC44A1;TMEM181;PRKAG2;AFF3;PCSK5;ETS1;TRIOBP;UBE2L3;AKAP13;BBS9;ME3;RALGPS1;BRD3;BCAS3;TANGO2;FNDC3B;TBC1D8;GAB2;SCAMP1;SYN3;RUNX2;ST7L;COL6A2;FEZ2;EXOC6;GNB1L;GLCCI1;SOS2;EXOC2;ANAPC1;ISCU;GAS7;MCPH1;UBIAD1;ATF6B;SEL1L;THADA;MFF;LPP;ABO;ATXN2;EXOSC10;RXRA;LRIG1;CAMTA2;HLA-DQA1;SPTBN1;BANP;TRAPPC3;PTPN1;TCF7L2;PNPT1;SMAD3;PTCD2;FANCA;FBXL17;SYNJ2;TMCO1;LSM8;STAG1;NUDT7;NPLOC4;NDUFAF6;CAPZA1;ATP13A2;ZNF652
Post bronchodilator FEV1 in COPD	4/40	0.975507373819022	0.999994527882068	0	0	0.43206248129099	0.0107140952744642	IREB2;EFCAB2;MKS1;CLEC4F
Zinc levels	4/40	0.975507373819022	0.999994527882068	0	0	0.43206248129099	0.0107140952744642	FBXO38;GPBP1;MICALL2;HDAC9
Blood pressure	13/98	0.975562534773916	0.999994527882068	0	0	0.594195616390886	0.0147010030255803	PRDM8;GOSR2;STK39;MTHFR;PTPN11;ST7L;SLC4A7;PPP3CA;ATXN2;RXRA;CAPZA1;POC1B;ZNF652
Breast cancer (survival)	2/25	0.975597398771551	0.999994527882068	0	0	0.33824703315417	0.0083564873012338	TMEM218;STT3A
Heart rate response to recovery post exercise (20 sec)	2/25	0.975597398771551	0.999994527882068	0	0	0.33824703315417	0.0083564873012338	NDUFA11;BCAT1
Homeostasis model assessment of insulin resistance (dietary factor interaction)	2/25	0.975597398771551	0.999994527882068	0	0	0.33824703315417	0.0083564873012338	SNX29;MAP3K1
Spherical equivalent (joint analysis main effects and education interaction)	2/25	0.975597398771551	0.999994527882068	0	0	0.33824703315417	0.0083564873012338	KCNJ2;CD55
Anorexia nervosa	5/47	0.975628290389535	0.999994527882068	0	0	0.462862509040853	0.0114204914022696	PPP3CA;MCTP1;PA2G4;ESYT1;SGPP2
Prudent dietary pattern	5/47	0.975628290389535	0.999994527882068	0	0	0.462862509040853	0.0114204914022696	TPX2;KIF26B;BCKDHB;TMEM260;KCNJ2
Bone mineral density (hip)	6/54	0.976444629670232	0.999994527882068	0	0	0.485940945846606	0.0115834876085702	PDHX;PRPF38B;SERBP1;CTNNB1;PIK3R1;CD44
Hematological and biochemical traits	3/33	0.976621942890113	0.999994527882068	0	0	0.388907933398629	0.00919987343554964	HBS1L;FCGRT;ABO
Pelvic organ prolapse	3/33	0.976621942890113	0.999994527882068	0	0	0.388907933398629	0.00919987343554964	MAML2;SPATS2L;SGK1
Hippocampal volume in Alzheimer's disease dementia	7/61	0.977640141507117	0.999994527882068	0	0	0.503871641249092	0.011394366927202	GRAMD1A;SF3B3;TOMM40;CASP3;IRF2;CLPTM1;SPC25
Breast size	12/93	0.978440499461713	0.999994527882068	0	0	0.575578277664167	0.0125449023306129	EPB41L5;NEDD1;CCDC91;CLMN;SGSM3;ELMO1;ATP2B4;DCAF8;NAGA;CCDC117;TBC1D22A;TNRC6B
Waist-to-hip ratio adjusted for BMI (age <50)	22/153	0.978967918855864	0.999994527882068	0	0	0.652007924659399	0.0138593453495398	MAP3K1;TMEM63B;FAM13A;MAD2L1BP;TSEN2;TARBP2;DOK3;NSD1;LMAN2;GRK6;UIMC1;XPO5;R3HCC1;MKRN2;ECHDC1;NFE2L3;FAM193B;PPARG;ZNF346;POLH;PDLIM7;HERC6
Ovarian cancer	8/68	0.97902537305291	0.999994527882068	0	0	0.518198904960366	0.0109846350174862	MLLT10;ZNF274;IMPA1;SYNRG;LMNA;ZFAND1;GCLM;CNTLN
Cerebral amyloid deposition (PET imaging)	4/41	0.979154544794326	0.999994527882068	0	0	0.420358639315289	0.00885518642493588	TOMM40;RIPK2;CYP4V2;DAPK2
Brain structure	1/17	0.979509410177364	0.999994527882068	0	0	0.243162628487518	0.00503430155667437	FBXW8
Fractional exhaled nitric oxide (childhood)	1/17	0.979509410177364	0.999994527882068	0	0	0.243162628487518	0.00503430155667437	SMYD3
QT interval (drug interaction)	1/17	0.979509410177364	0.999994527882068	0	0	0.243162628487518	0.00503430155667437	CCND2
Cognitive ability (MTAG)	10/81	0.97960628534841	0.999994527882068	0	0	0.547281728141722	0.0112764869918126	CEP57;GPD2;IVD;PLCL2;TET2;EXOC4;AFF3;RBM23;SDCCAG8;ST3GAL3
Coronary artery aneurysm in Kawasaki disease	2/26	0.979916868561115	0.999994527882068	0	0	0.324133006935944	0.00657586099168037	GRK5;TMTC2
Response to fenofibrate (triglyceride levels)	2/26	0.979916868561115	0.999994527882068	0	0	0.324133006935944	0.00657586099168037	APH1B;SUMF1
Bipolar disorder	29/194	0.98004095962568	0.999994527882068	0	0	0.68206759562107	0.0137511052197949	SF3B2;MCTP1;RAB1B;TRANK1;TWF2;ZDHHC24;RASGRP1;SLC2A8;ZMIZ1;CTSH;FADS1;BBS1;EIF5B;SFMBT1;SPHK2;IRF2BP2;CDKAL1;DHRS4;TTC39B;MRPL30;PAN3;NFIA;UBE2R2;PACS1;MGAT4A;RFT1;MITD1;SLC29A2;DGKH
Pulse pressure x alcohol consumption interaction (2df test)	6/56	0.982322122642057	0.999994527882068	0	0	0.466444498897329	0.0083195028165906	SLC4A7;CLCN6;TNKS;LSP1;TRAK1;CORO2A
Insomnia	3/35	0.98356166901367	0.999994527882068	0	0	0.36455527668952	0.00604248165384173	ACBD4;RFX3;TRAV8-3
Cognitive decline rate in late mild cognitive impairment	17/126	0.983636819688658	0.999994527882068	0	0	0.605612785429299	0.00999172418562757	BNIP3L;ACTN1;HP1BP3;TBC1D8;TMTC2;FOXK1;YWHAZ;CDC25B;TGFBR2;HIRA;LASP1;TRIM6;BTLA;TSNARE1;TMEM38B;SLC15A4;ASB3
Aggressiveness in attention deficit hyperactivity disorder	1/18	0.9836997823796	0.999994527882068	0	0	0.228844548098241	0.00376095206238933	PHLPP1
Urinary metabolites	1/18	0.9836997823796	0.999994527882068	0	0	0.228844548098241	0.00376095206238933	HIBCH
Epstein-Barr virus copy number in lymphoblastoid cell lines	6/57	0.984717474114444	0.999994527882068	0	0	0.457269700332963	0.00704218534129457	GALC;CAND1;CPQ;SLC39A11;ZNF75A;FGD2
Axial length	7/64	0.98521075498805	0.999994527882068	0	0	0.477261781905745	0.00711105557845675	PEX16;SLC35C1;CRY2;CDCA8;ACTR8;SPTAN1;IL17RB
Prostate cancer	65/399	0.985517857160809	0.999994527882068	0	0	0.75381435041404	0.0109966683590265	GMEB2;STMN3;STK19;TRIM8;CASP8;FLAD1;HLA-DOA;MAP2K1;ACTN1;TET2;GOLPH3L;CDKAL1;LARP4B;RAD23B;LIME1;SIDT1;GEMIN4;ATG4B;ITGA6;ADNP;DOCK2;MTRF1L;HLA-DQB1;RTEL1;ATF6B;ARL3;PPT2-EGFL8;NEDD9;SLC41A1;PBXIP1;THADA;AGER;BCL2L11;TAF1B;VPS53;CEACAM21;ATP9B;HLA-DQA1;EIF4B;FARP2;TCF7L2;HLA-DRB5;TOR1A;BOD1;STYX;PBX2;MYO9B;DDHD1;TPD52L2;UCKL1;ATAT1;TTC9;PPFIBP2;PSMC6;GLOD4;BCL2;RNF181;HLA-DRA;MDM4;NOL10;SKIV2L;PPT2;HLA-DRB1;ZNF652;TNRC6B
Chronic obstructive pulmonary disease-related biomarkers	3/36	0.986243372173576	0.999994527882068	0	0	0.353485887276289	0.00489653142949256	AHNAK;APIP;ANXA11
Hair greying	3/36	0.986243372173576	0.999994527882068	0	0	0.353485887276289	0.00489653142949256	FAM13A;USP40;TBC1D22A
Information processing speed	2/28	0.986442327016539	0.999994527882068	0	0	0.299162037472931	0.00408368669727458	CRTC3;TRIB3
Urinary albumin excretion (no hypertensive medication)	2/28	0.986442327016539	0.999994527882068	0	0	0.299162037472931	0.00408368669727458	CWC27;NR3C2
Initial pursuit acceleration	5/51	0.986782084938006	0.999994527882068	0	0	0.422507083058177	0.00562190003275545	MAP3K1;DNAAF5;TTC7A;PCDH12;SMG7
Craniofacial microsomia	6/58	0.986805844291753	0.999994527882068	0	0	0.448447778636458	0.00595627078376616	KLF12;PRPF18;ACBD4;NMT1;GATA3;ARID3B
Manganese levels	6/58	0.986805844291753	0.999994527882068	0	0	0.448447778636458	0.00595627078376616	NEDD1;AEBP2;WNK1;BUD13;ETS1;RABL6
Blood trace element (Zn levels)	1/19	0.987033279036167	0.999994527882068	0	0	0.216117365529994	0.00282066071400899	FNTB
Cardiac Troponin-T levels	1/19	0.987033279036167	0.999994527882068	0	0	0.216117365529994	0.00282066071400899	BCL2
Severe malaria	1/19	0.987033279036167	0.999994527882068	0	0	0.216117365529994	0.00282066071400899	INPP4B
Post-traumatic stress disorder	1/20	0.989685084053578	0.999994527882068	0	0	0.204729886389984	0.00212273842291598	TBC1D2
Gallstone disease	2/30	0.990883669539807	0.999994527882068	0	0	0.277758349361777	0.0025437494288791	MLLT10;TTC39B
Hypertension	6/61	0.991573569733171	0.999994527882068	0	0	0.423906796462543	0.00358715583460072	SLC4A7;MKLN1;CERS5;NOS3;L3MBTL4;SLC12A9
Response to serotonin reuptake inhibitors in major depressive disorder	1/21	0.991794572974751	0.999994527882068	0	0	0.194481155163975	0.00160238407694848	REPS1
Pelvic organ prolapse (moderate/severe)	4/47	0.992302345260409	0.999994527882068	0	0	0.361567247065256	0.00279398725725623	ABCC1;RNF7;DISC1;SGK1
Attention deficit hyperactivity disorder and conduct disorder	2/31	0.992534516065134	0.999994527882068	0	0	0.268163592622294	0.00200948123552505	PITRM1;YWHAZ
Regular attendance at a religious group	10/89	0.992562982322808	0.999994527882068	0	0	0.491612410465625	0.00366979332351778	NFIA;UBXN2A;TNKS;TET2;AMZ2;MDM4;ARSG;AFF3;IFT57;BPTF
Body mass index (age>50)	7/69	0.992759852595473	0.999994527882068	0	0	0.438634566729918	0.00318733126783883	TCF7L2;TOMM40;DTNB;BCL3;CLPTM1;VTI1A;CLASRP
Systolic blood pressure x alcohol consumption interaction (2df test)	14/115	0.992803008540545	0.999994527882068	0	0	0.53811990577894	0.00388684800982197	TNKS;NOS3;LSP1;MRPL23;PIK3C2A;COX5A;SLC4A7;ATXN2;POC1B;SGK1;SH2B3;XKR6;ZNF652;SIPA1
Alcohol dependence	5/55	0.992980591070378	0.999994527882068	0	0	0.388608525232729	0.0027374209702459	CAST;PECR;NEIL2;USP12;ERAP1
Tourette's syndrome or obsessive-compulsive disorder	3/40	0.993332537838883	0.999994527882068	0	0	0.315191783360246	0.00210856652031455	CHMP2B;NFATC2;WDR7
Ability to confide in someone	1/22	0.993472630666193	0.999994527882068	0	0	0.185208493578538	0.00121288704271342	FAM120A
Alcohol consumption	1/22	0.993472630666193	0.999994527882068	0	0	0.185208493578538	0.00121288704271342	TLR1
Nicotine dependence	1/22	0.993472630666193	0.999994527882068	0	0	0.185208493578538	0.00121288704271342	SULT1B1
Response to cognitive-behavioural therapy in anxiety disorder	1/22	0.993472630666193	0.999994527882068	0	0	0.185208493578538	0.00121288704271342	ARL5A
Urinary albumin-to-creatinine ratio in non-diabetics	1/22	0.993472630666193	0.999994527882068	0	0	0.185208493578538	0.00121288704271342	SPATS2L
Cognitive performance	14/116	0.9936016912634	0.999994527882068	0	0	0.532810521704385	0.00342003915421659	JUN;API5;RIPK2;FAM91A1;DNAJC15;BACH2;NCOR2;NIN;SEC14L1;MTHFD1;GORASP2;MDM4;MCTP2;PHLDB2
Corneal astigmatism	6/63	0.993787963912018	0.999994527882068	0	0	0.408981286836302	0.00254853051598106	AMN1;SMAD3;MAML2;DTNBP1;PIK3R1;FLI1
Sleep duration	5/56	0.994025513179442	0.999994527882068	0	0	0.380964732781893	0.00228289514952198	PAX8;PRKCB;KAT6A;PBX3;CBWD2
Hypertriglyceridemia	3/41	0.994451820290826	0.999994527882068	0	0	0.306877931852157	0.00170735466182523	REEP4;INTS10;BUD13
Liver enzyme levels (gamma-glutamyl transferase)	3/41	0.994451820290826	0.999994527882068	0	0	0.306877931852157	0.00170735466182523	DENND2D;ITGA1;CEPT1
Metabolite levels	13/111	0.994581527457207	0.999994527882068	0	0	0.514950457355254	0.00279783176531285	TNKS;PLEK;HP;ABO;CYP4V2;GRK6;ALMS1;DHX38;ACADM;LDLR;RNF111;FADS1;HERC6
Contrast sensitivity	1/23	0.99480747453708	0.999994527882068	0	0	0.17677880122814	0.000920319892134946	INPP5D
Erectile dysfunction and prostate cancer treatment	1/23	0.99480747453708	0.999994527882068	0	0	0.17677880122814	0.000920319892134946	TTC7A
Metabolite levels (HVA/MHPG ratio)	1/23	0.99480747453708	0.999994527882068	0	0	0.17677880122814	0.000920319892134946	RAB10
Refractive astigmatism	5/57	0.994920491646343	0.999994527882068	0	0	0.373614932348396	0.00190261644926003	NPLOC4;STIM2;CHD6;AFF3;MFF
Daytime sleep phenotypes	38/263	0.995235310354301	0.999994527882068	0	0	0.654366235833265	0.00312530350574801	CYFIP2;L3MBTL1;ITK;FH;CRTC3;NAB1;DDO;ARHGAP22;CDC42;GLIPR1;SNX29;MFSD6;MAPK8;EFCAB2;GNA12;RICTOR;TRIM27;ACADM;CHML;EIF4E;HIBCH;CHURC1;C1GALT1;RBM19;ZNF77;AIG1;QRSL1;CDC40;CPPED1;KIF26B;CCDC88C;PSMG1;RAD1;SRSF6;ZNF555;SMAP1;CARD11;EXOC1
Photic sneeze reflex	6/65	0.995440680516872	0.999994527882068	0	0	0.395067676167772	0.00180535849071768	KLF12;STIM2;DPH6;PLXDC2;TRIM44;CBR4
Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder	1/24	0.995869287071986	0.999994527882068	0	0	0.169082125603865	0.000699876213202948	TPX2
Initial alcohol sensitivity	2/34	0.995919413022758	0.999994527882068	0	0	0.242977356181151	0.000993518686530178	RARS2;MAN1B1
Post bronchodilator FEV1/FVC ratio	28/206	0.995927692170242	0.999994527882068	0	0	0.609797619937384	0.00248835373930782	RB1;KANK1;SP100;MCTP1;MAST4;ZFAND3;FAM13A;IREB2;NMD3;LYST;RLF;CEP128;RUVBL1;RALGPS1;EEFSEC;CD74;WDR59;TET2;BTBD9;PRPF18;NPEPL1;SLCO3A1;MSH2;ATG2A;RIN3;BUD13;CD68;MCPH1
Resting heart rate	15/127	0.996309537545636	0.999994527882068	0	0	0.51969679694078	0.00192146925666066	PPIL1;CBY1;FRMD4B;GTPBP1;TOMM22;MKLN1;CDC23;ADCK1;RNF207;ZNF219;ZNF800;ARHGEF40;TP53I11;FADS1;SLC12A9
Mercury levels	2/35	0.996668331072405	0.999994527882068	0	0	0.235599569748897	0.000786250257159384	GCH1;LANCL2
Waist-to-hip ratio adjusted for BMI (age >50)	35/250	0.996780821347142	0.999994527882068	0	0	0.630673339608347	0.00203352505098065	PIGU;TNFAIP8;TMEM63B;ARL3;HSD17B4;ITPR2;TSEN2;TRIM8;RAB43;XPO5;CPNE1;PLCG2;ATP6V0A2;TOM1;CCDC92;RBM12;POLH;MBD4;EDEM2;MAD2L1BP;TRPC4AP;TARBP2;NCOR2;RNF146;MKLN1;RILPL2;RILPL1;R3HCC1;ECHDC1;MKRN2;NFE2L3;PPARG;CENPN;MCM5;ERGIC3
Cerebrospinal T-tau levels	3/44	0.996821309064211	0.999994527882068	0	0	0.284369699720504	0.000905363085166223	TOMM40;ADCK1;BRAF
Body mass index x sex x age interaction (4df test)	12/109	0.996932390118689	0.999994527882068	0	0	0.480151793055468	0.00147518218522515	TCF7L2;TOMM40;DTNB;FPGT;FIGNL1;BCL3;VTI1A;CLPTM1;IKZF1;CLASRP;EIF3F;TMEM9B
Autism spectrum disorder or schizophrenia	125/752	0.996988099531306	0.999994527882068	0	0	0.769169148376885	0.00232015671564796	CTNND1;LST1;ZSCAN9;NUDT1;ZDHHC5;STK19;TNF;GALNT10;GOLGA4;CDC23;TATDN2;MSANTD2;OGFOD2;TRIM27;HLA-DOA;HLA-DOB;ABT1;DAXX;HLA-H;SFMBT1;ANKRD44;NFKBIL1;HLA-L;TAP2;MRPS18B;HLA-B;HLA-A;HLA-F;HLA-G;HLA-E;PLPP5;DDX39B;TMX2;C6ORF136;MSH5;CSNK2B;TSNARE1;FTCDNL1;CUTA;SHMT2;ARL3;IREB2;TRANK1;TWF2;KLC1;AGER;BAG6;PPP4C;ZFP57;MAN2A1;NEU1;ZKSCAN3;ZKSCAN4;MARK3;HLA-DQA1;ST3GAL3;EGR1;HLA-DRB5;BTN2A2;PBX2;PRRC2A;ZBTB9;STAG1;CNOT1;NDUFAF2;HLA-DRA;SPATS2L;ESAM;SKIV2L;PPT2;HLA-DRB1;ZSCAN2;DDR1;RERE;PPP1R13B;PPP1R11;SETD6;PRR3;TCF20;TRIM8;EPM2AIP1;ARL5B;ACP2;HLA-DPA1;NCK1;TCF19;SEC13;BTN3A1;ACTR5;TUBB;NSUN6;BTN3A3;BTN3A2;TAPBP;RILPL2;RFT1;LTB;ALDOA;PFDN6;HLA-DQB1;ZNF592;ATF6B;PPT2-EGFL8;TOB2;AIF1;HLA-DMA;VPS52;PTK2B;BAK1;SF3B1;SEC11A;MICA;MAPK3;DDHD2;NAGA;MLH1;PSMB9;ATAT1;MPHOSPH9;SNX19;TRIM39;HLA-DPB1;CDK2AP1;TAF5;HLA-DPB2
Waist-to-hip ratio adjusted for BMI	55/367	0.997168019605352	0.999994527882068	0	0	0.682087371540497	0.00193439844755404	PIGU;TNFAIP8;TMEM179B;ADPGK;FAM13A;TSEN2;TRIM8;RAB43;RPS6KA5;UIMC1;XPO5;CPNE1;CCDC92;KIFAP3;DUS4L;BBS4;POLH;HERC6;ROM1;WDR74;TRPC4AP;NCOR2;DOK3;RILPL2;RILPL1;FAM193B;PPARG;ERGIC3;DLD;TMEM63B;AHNAK;ARL3;HSD17B4;ITPR2;LMAN2;NSD1;GRK6;ATP6V0A2;STX5;ZNF346;PDLIM7;KCNJ2;MBD4;MAP3K1;B3GAT3;EDEM2;MAD2L1BP;TARBP2;RNF146;CCDC88C;R3HCC1;CAPZA2;ECHDC1;MKRN2;NFE2L3
General cognitive ability	43/299	0.99736009704165	0.999994527882068	0	0	0.650318179710683	0.00171904694471368	MTCH2;CSE1L;SPPL2A;GMPR;CMAHP;AFF3;PREX1;CLN3;PPP3R1;SNX29;ATXN1;XPO4;AP1G1;ZMIZ2;HSF5;CCT7;ST3GAL3;ABT1;ARFGEF2;BTN3A1;BTN2A2;SFMBT1;HLA-L;PCGF3;TET2;CYHR1;KLHL2;CDKAL1;BTN3A2;ARHGAP27;FOXN3;SND1;SREBF2;EXT1;PSMA5;RBL2;ZNFX1;GPD2;SP4;EXOC4;ANAPC4;TMBIM6;TSNARE1
Palmitoleic acid (16:1n-7) levels	1/26	0.997385738674844	0.999994527882068	0	0	0.15553597650514	0.000407144110783476	FADS1
Coffee consumption	1/28	0.998345194667939	0.999994527882068	0	0	0.143996664309929	0.000238483824518025	OAS2
Type 2 diabetes (age of onset)	4/56	0.998397259054608	0.999994527882068	0	0	0.298818741875318	0.000479313243020639	BECN1;ATP8A1;SFMBT1;HDAC9
Response to statin therapy	10/102	0.998741901720044	0.999994527882068	0	0	0.421798850390846	0.000530998502398765	RBM38;RNGTT;CLMN;GPD2;NSMCE2;TTC7A;BCAT1;DISC1;FADS1;MEGF9
Iron status biomarkers (total iron binding capacity)	2/40	0.998801664260423	0.999994527882068	0	0	0.204535205823617	0.000245248821720104	IPP;COMMD1
Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)	62/419	0.998880509646234	0.999994527882068	0	0	0.671205525688536	0.000751829022635694	PIGU;TNFAIP8;TMEM179B;ADPGK;FAM13A;TSEN2;TRIM8;RAB43;RPS6KA5;UIMC1;XPO5;TOM1;CPNE1;DUS4L;CCDC92;KIFAP3;BBS4;POLH;HERC6;ROM1;WDR74;TRPC4AP;NCOR2;DOK3;RILPL2;RILPL1;PPARG;MCM5;FAM193B;ERGIC3;DLD;EXOC1;AHNAK;TMEM63B;ARL3;ITPR2;HSD17B4;LMAN2;NSD1;GRK6;PLCG2;ATP6V0A2;STX5;ZNF346;RBM12;KCNJ2;PDLIM7;MBD4;MAP3K1;B3GAT3;EDEM2;MAD2L1BP;TARBP2;RNF146;MKLN1;CCDC88C;R3HCC1;CAPZA2;NFE2L3;ECHDC1;MKRN2;CENPN
Regular attendance at a gym or sports club	2/41	0.999024702517747	0.999994527882068	0	0	0.199278159620877	0.000194450326224015	L1TD1;LEMD2
Logical memory (delayed recall) in normal cognition	5/67	0.999048990612023	0.999994527882068	0	0	0.313156896524474	0.000297956850852936	COG8;NIP7;RAB3IP;NAA35;SNTB2
Idiopathic dilated cardiomyopathy	5/69	0.999326232353564	0.999994527882068	0	0	0.303332465703087	0.000204444483280319	CCDC149;FAM120B;ARHGEF3;TMEM106B;ICOS
Bipolar disorder and schizophrenia	1/32	0.999336199740237	0.999994527882068	0	0	0.125384870446687	8.32581460204707e-05	COMMD10
Urate levels in overweight individuals	2/43	0.999354647983124	0.999994527882068	0	0	0.189533391049945	0.000122355241528365	SLC2A9;BOD1
Loneliness (multivariate analysis)	1/33	0.999471497265229	0.999994527882068	0	0	0.121458945178659	6.4208353329427e-05	MACF1
Intelligence (MTAG)	51/366	0.999534184856993	0.999994527882068	0	0	0.625716173486243	0.000291535975043035	CEP57;BMPR2;CSE1L;DCAF5;AFF3;TTC27;PREX1;ZMIZ2;CPNE3;ARID2;ABT1;ZNF19;BTN3A1;SFMBT1;USP4;TET2;PSMA5;RBL2;IVD;GPD2;EXOC4;ANAPC4;PHIP;GLCCI1;TSNARE1;PIK3R1;CLN3;PPP3R1;SNX29;CUX1;MAN2A1;GRK6;FAM120A;RPL15;HSF5;FNIP2;ST3GAL3;ARFGEF2;BTN2A2;CCDC14;PCGF3;FBXL17;FOXN3;MPHOSPH9;REEP3;ALMS1;PPP2R2D;NDUFAF2;CDK2AP1;TAB1;AVL9
Hepcidin/ferritin ratio	1/34	0.999579101597219	0.999994527882068	0	0	0.11777095477536	4.95800415712281e-05	FRMD4B
Alcohol use disorder (total score)	2/46	0.999653221886154	0.999994527882068	0	0	0.176577278290865	6.12437551244735e-05	KANSL1;SLC39A13
Body mass index	202/1246	0.99995306998305	0.999994527882068	0	0	0.740528212942006	3.47538170901466e-05	FAAH;RNH1;IPP;IKZF1;ADARB1;ZDHHC4;GOLGA2;HERC4;SPATA24;COG8;GOLPH3L;RC3H2;PRKD3;KCNQ1;KDELR2;HOXB2;ALPK1;PLBD2;KCTD15;CUTA;L3MBTL3;PDXDC1;HNRNPLL;MRPL10;CHTF8;ZNHIT3;FIGNL1;VTI1A;PNPO;ICOS;RHBDL1;HLA-DQA1;B3GALNT2;HLA-DRB5;CCZ1B;SETDB1;DTNB;PUM2;FAM220A;CYLD;STAG1;WNK1;FUBP1;CREBRF;AVL9;TMEM9B;HLA-DRB1;ZNF133;ZNF131;PMS2CL;DENND1A;TRIM8;RPTOR;RSRC1;SLC22A17;RAC1;RRP12;SPTAN1;BBS4;PRMT7;NSUN4;TSC22D1;STRBP;ITPK1;TCF12;IL16;NME4;GAB2;LRRC41;IL17RB;POC5;MDFIC;CINP;PPARG;EXOC6;PABPC1;TKT;CDC123;TOMM40;NIP7;NOL9;ARNTL;SNX27;CLPTM1;NQO1;WWP2;RIT1;PDXDC2P;SGSM3;SCARB2;MTCH2;CCNT2;UBE3C;CEP120;NUCKS1;GALNT10;PPP1CB;NPEPPS;FPGT;CWC22;FPGS;KNTC1;TMEM38B;CAST;PUS1;GTF3A;CDKAL1;ATAD3B;TMEM251;LEMD2;TUFM;ACAP2;CLIP1;ANKS6;CSNK1G2;KHDRBS1;CCL3L1;STK39;PDS5B;KLC1;ATXN2;UBR7;TNFRSF14;MARK3;NADK;MAP2K5;BPTF;OSBPL7;ODF2;CDK9;PAN3;REEP3;ZFP64;BCL3;NFE2L3;BCL2;HLA-DRA;CLASRP;COPS8;LSM14A;SLC35E2B;PPP1R13B;PLEKHF1;ADPGK;PIK3C2A;CHTF18;SYNE3;PGPEP1;NCK1;ADSL;RBM19;DDX54;DDX51;ACTR8;RAD23B;YWHAZ;RCN1;CREB1;RABEP1;UBE2R2;RER1;OAS1;OAS2;RASA2;ATG4C;POLR1D;MCTP2;ST6GALNAC4;MTRF1L;ST6GALNAC6;SFSWAP;GOSR2;HSD17B12;MTIF3;MRM1;CLMN;TBX21;VPS52;FAM120A;CCL3;BAK1;BUB3;SH2B3;SLC25A25;CYB5B;TCF7L2;CDK11A;KDM4C;ERAP2;ASCC1;QPCTL;ERAP1;FBXL17;PTPN11;MYO19;WARS2;GNPDA2;EIF3F;ZNF853;SSBP3;SNTB2;TNRC6B
Alcoholic chronic pancreatitis	12/145	0.999977706155944	0.999994527882068	0	0	0.34938880944693	7.78930646000971e-06	CFDP1;OPA1;ARL15;KIDINS220;TRBV30;EFHD2;TAX1BP1;DNAJC16;EIF3A;MCPH1;JAKMIP2;TTC39B
Obesity-related traits	119/804	0.99998140756818	0.999994527882068	0	0	0.66669560866494	1.23956078811839e-05	PANK4;CD83;CSF1;UBXN2A;ECI2;SRP14;CWC27;ETS1;TOMM20;BACH2;FGFRL1;TPGS2;ALKBH5;BAIAP2L1;CCDC91;CCND2;MPRIP;ADORA3;EPSTI1;TRAPPC12;FAM53B;PIP4K2A;ATXN7L1;KPNA3;RARS2;SP110;TSC2;CDKAL1;RNASE1;LEMD2;ARMC1;ILF3;STIM2;PKP4;ANAPC1;KCTD15;ANKRD16;COX15;IREB2;ITPR1;CLEC16A;HIGD1A;LPP;ABO;HMBOX1;PTDSS1;FGGY;GRK5;NCKAP1L;SMYD3;ICOS;RAB6A;LHPP;WDR59;ATP8B3;HPS1;CPSF2;KLHL23;NUP153;TRAPPC9;AP4B1;EXT1;ISG20;ARPC2;UBXN11;TBXAS1;NFE2L3;CRYL1;TMEM45B;PHTF2;C2ORF42;CELF2;DOCK8;ECE1;PTPN22;CLYBL;PHTF1;DSTYK;RASGEF1A;METTL15;ACAD8;CD53;BCAS3;PARP4;IFNGR2;PAX5;AEBP2;ARHGEF3;BDP1;TSEN34;CCDC69;BRAT1;TUBD1;DENND3;HDAC9;SNX29;IFI16;RSBN1L;RICTOR;PCBD1;RAB28;BAK1;ZNF585B;PMS1;KCNJ2;GCH1;MBOAT7;IL10RA;SUSD1;MPP7;NUDT7;SLCO3A1;RPS6KB1;SLMAP;S100P;SNRNP48;RAMP1;ASB3;MPHOSPH6
Night sleep phenotypes	74/555	0.999989459572042	0.999994527882068	0	0	0.591615710479403	6.23591563973433e-06	TMEM45B;HDDC2;PHTF2;OXNAD1;WDSUB1;HEXB;KDM8;ECI2;NR3C1;MRPL35;TOMM20;MYSM1;FAM107B;UFL1;SENP5;C1RL;MYO18A;ZNF826P;RCC1;CD36;ZNF486;TCF19;IL4R;CSNK2A1;ANXA2;ARL15;ACSL1;GTF3A;VRK1;PRPF4B;LIG3;ETV6;TGFBR2;TBC1D20;SLC9A9;IRF2;WDFY1;NCOA7;RBCK1;GLCCI1;MCTP2;FXN;GLYR1;KANK1;SNAP47;ASAH1;SP100;SP140;SEL1L;MTIF3;HSPA14;KRCC1;HDAC9;MYL12A;ORC5;SCFD1;COX11;POC1B;RFFL;JUN;GCH1;C1GALT1;RFTN1;MYO9B;TPD52L1;ARHGAP26;ISG20;POLR3B;NAT1;DNAJC10;SFXN1;SIGLEC1;CCDC66;SP140L
Blood protein levels	306/2091	0.999991034669675	0.999994527882068	0	0	0.640556164280047	5.74282334761798e-06	SPON2;ECI2;LST1;OGFOD3;IPP;TESK2;UBE2L6;ENO1;TXNDC15;IL27RA;ICAM1;CRHBP;PNP;C19ORF54;UBASH3B;CPNE1;TRIM27;LGALS9;FBXO7;ABT1;IL15RA;GABARAPL2;ZNF19;ENTPD1;ST6GAL1;PRKCB;HLA-L;ENTPD5;DAPK2;SERPINF1;NFKBIL1;ECH1;GOLPH3L;HLA-B;RNASE6;RECQL;MRPS18B;PRKCA;HLA-A;RNASE1;DDX39B;CSNK2B;SIK3;TARS2;KDELR2;MXRA7;LRPAP1;SHMT2;SHMT1;FUT10;TAPBPL;PLA2G7;ARPP19;LY9;ABO;INPP5B;ADAMTS13;NEU1;DHX36;PLCG2;DHX38;SURF6;ST3GAL6;LTA4H;RBM12;HLA-DQA1;ARSB;FDFT1;NUS1;HLA-DRB5;EDEM2;LNPEP;IFNLR1;NMI;LYZ;SIGLEC17P;PRDX6;PRRC2A;BST1;TCN2;WNK1;FBXL5;PAM;HLA-DRB1;SIGLEC9;ZBED6CL;PPP1R11;CCDC126;GDI2;OLA1;AKR1B1;PCSK7;ING1;DSTYK;GNLY;CTSH;QSOX2;CD36;TPSAB1;CTSC;LIN52;CTSB;CBR1;MANBA;TPI1;DBNL;ANXA1;ANXA2;TUBB;IL16;BTN3A3;SYN3;VAV1;IL17RB;NCR1;FCER2;CD200R1;OAF;CINP;ARHGEF3;TMEM106B;CD48;CRELD1;MFGE8;PAFAH1B2;HLA-DQB1;SELPLG;CAPG;AIF1;LILRA4;LILRA5;NT5C;TRBV30;LMAN2;FAM177A1;APBB1;EXOSC1;CD55;MICA;CBR3;NQO1;NQO2;IL10RB;C1GALT1;GTF2H1;LILRB2;PLXDC2;LILRB4;MPP7;DCBLD2;PSMB9;ATAT1;KLHL7;HLA-DPB1;HDGF;SIGLEC1;IL18R1;C1QC;FCN1;POGLUT1;PDCD5;ZSCAN9;SIRPG;HP;STK19;TNF;POFUT1;RUVBL2;C1RL;PLXNC1;IL6R;HLA-DOB;CAST;USP4;STX8;SWAP70;APLP2;CSGALNACT2;TAP2;TRPC4AP;TPST2;ADAM19;EDAR;MAPKAPK3;C6ORF136;RPL7L1;NAAA;MSH5;DNAJB11;PPIF;PPIE;SIDT2;IFNAR1;NOTCH2;DDX6;CSF1R;CCL3L1;UBA5;ARL3;TNFRSF11A;RASAL3;PRPF8;LPP;AGER;HSP90B1;BAG6;EIF1AD;ZFP57;DPP7;GRK6;ESD;ZKSCAN3;TNFRSF17;ZC3H13;NADK;TXNDC5;ANKRD27;UROS;GGH;ISG15;COQ6;NMRAL1;IL7;MAN2B2;REEP3;TBCE;DNAJC10;PLXNB2;HLA-DRA;MANSC1;SKIV2L;ESAM;IL7R;LRP12;LGALS3BP;B4GALT1;CPQ;YWHAB;CALCOCO2;HAPLN3;NAGPA;ELAVL1;SIRPB1;ADGRE2;FCGR3B;ADGRE5;MAN1A2;CASP3;CYP4V2;KYNU;WDR6;COLGALT1;HIBCH;PLA2G12A;PLAUR;DUSP28;TNFRSF1B;REXO4;TAPBP;RCN1;RRM2B;OAS1;CAT;XCL1;ITGA6;EVL;LCP1;LTB;GAPDH;MTRF1L;SMPDL3A;ST6GALNAC6;PDXK;ATF6B;CLEC12A;POLDIP2;LRP8;PRIMPOL;MAPK9;CLEC3B;IFI16;RBBP5;SPOCK2;CCL5;CCL3;POC1B;PCBD1;CCDC71;SH2B3;MAPK3;PPIL1;TAF15;ERAP2;B3GAT3;QPCTL;ERAP1;PLCL2;HNRNPAB;MAPK13;GZMK;CUL4A;FCGR2A;TRIM39;CDK2AP1;CHPT1;SMAP1
Schizophrenia	127/882	0.999991670507245	0.999994527882068	0	0	0.643877851361295	5.3631982341096e-06	POP7;CTNND1;NUDT1;ZDHHC5;CISD2;STK19;ZDHHC2;GALNT10;ZFYVE28;HHAT;RASSF1;MSANTD2;AKT3;OGFOD2;CWC22;TRIM27;HLA-DOB;BNIP3L;NOM1;IK;TLE1;SFMBT1;ANKRD44;MED8;HLA-B;ADAM10;LEMD2;MAU2;TMX2;PRKD3;TSNARE1;FTCDNL1;SHMT2;TNKS;ARL3;CUL3;IREB2;TRANK1;TWF2;LPAR2;TMTC1;KLC1;BAG6;FXR1;PPP3R1;PPP4C;MAN2A2;ATXN7;ERI1;MAN2A1;SLC38A7;ZKSCAN3;ZKSCAN4;HLA-DQA1;ST3GAL3;EGR1;BTN2A2;GPN1;NMRAL1;PRRC2A;STAG1;ARHGAP31;CNOT1;SP4;STT3A;SPATS2L;ESAM;TAB1;CORO7;HLA-DRB1;ZSCAN2;DDR1;RERE;PPP1R13B;SETD6;TCF20;PEPD;TRIM8;PDE4B;CEP170;RALGPS1;NCK1;POLG;BTN3A1;PRMT1;ACTR5;NSUN6;VPS37A;BTN3A2;SREBF2;SLC7A6;BDH2;RILPL2;IRF3;TBC1D5;RFT1;GNB1L;ERGIC3;ALDOA;EXOC2;HLA-DQB1;SDCCAG8;ZNF592;ARNTL;MKNK1;CTNNA1;PTK2B;CEACAM21;STAT6;BAK1;SF3B1;SEC11A;MAPK3;KDM4C;HIP1R;DDHD2;NAGA;MLH1;SCAF1;GATAD2A;MPHOSPH9;SNX19;KIF26B;DNAJA3;CDK2AP1;TAF5;VPS45
Diisocyanate-induced asthma	23/261	0.999994527882068	0.999994527882068	0	0	0.372738908555548	2.03967684606081e-06	DYNC2H1;IL15RA;MBD4;CCNT2;DCUN1D5;XRCC4;ENTPD6;SRBD1;PIK3CD;C20ORF194;ARHGAP15;MYOM2;QKI;PITPNC1;ARHGAP21;VCAN;DPH1;FMC1;GPD2;IL2RA;NOL11;E2F6;LUC7L2
